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Copy number Variants (CNVs), which comprise deletions, insertions and inversions of genomic 
sequence, are a main form of genetic variation between individual genomes. CNVs are 
commonly present in the genomes of human and other species. However, they have not been 
extensively characterized as their ascertainment is challenging.  
 
I reviewed current CNV studies and CNV discovery methods, especially the algorithms which 
infer CNVs from whole genome Single Nucleotide Polymorphism (SNP) arrays and compared 
the performance of three analytical tools in order to identify the best method of CNV 
identification. Then I applied this method to identify CNV events in three European population 
isolates—the island of Vis in Croatia, the islands of Orkney in Scotland and villages in the South 
Tyrol in Italy - from Illumina genome-wide array data with more than 300,000 SNPs. I analyzed 
and compared CNV features across these three populations, including CNV frequencies, genome 
distribution, gene content, segmental duplication overlap and GC content. With the pedigree 
information for each population, I investigated the inheritance and segregation of CNVs in 
families. I also looked at association between CNVs and quantitative traits measured in the study 
samples. 
 
CNVs were widely found in study samples and reference genomes. Discrepancies were found 
between sets of CNVs called by different analytical tools. I detected 4016 CNVs in 1964 
individuals, out of a total of 2789 participants from the three population isolates, which clustered 
into 743 copy number variable regions (CNVRs). Features of these CVNRs, including frequency 
and distribution, were compared and were shown to differ significantly between the Orcadian, 
 v
South Tyrolean and Dalmatian population samples. Consistent with the inference that this 
indicated population-specific CNVR identity and origin, it was also demonstrated that CNV 
variation within each population can be used to measure genetic relatedness. Finally, I 
discovered that individuals who had extreme values of some metabolic traits possessed rare 
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1.1 Copy Number Variation as a source of genetic variation 
 
Genetic variation in the human genome takes many forms, from single nucleotide changes 
(including single nucleotide polymorphisms, SNPs), to fine-scale copy number changes such as 
small insertions and deletions (INDELS), microsatellite and minisatellite repeats, larger scale 
structural variations such as inversions, translocations and copy number variations (CNVs), to 
large microscopically visible chromosome anomalies (Sharp et al., 2006, Table 1). The above 
variations and polymorphisms constitute the architecture of the human genome and underline the 
differences between individuals at the DNA (Deoxyribonucleic Acid) level.  
 
SNPs are common polymorphic markers that are uniformly distributed throughout the genome. 
With the guidance of the DNA reference sequence (e.g. HapMap (The International HapMap 
Consortium, 2005)) and the use of high-throughput genome-wide SNP microarrays, numerous 
studies have successfully found genetic determinants of human complex traits in a fast and 
economic way. SNPs may be associated with phenotypic variation either through direct causal 
effects or by indicating the location of causal variants which are in linkage disequilibrium with 
them (Stranger et al., 2007). So far, SNPs are considered to be the most common form of 
genomic variation and to account for a large proportion of normal phenotypic variation. During 
the last few years, structural variants such as copy number variants have attracted much attention, 
as they are also found to be widely spread all over the genome. Despite the advance of 
technologies to detect variants in different forms in the genome, genomic rearrangements of 
median size, between 500bp and 5Mb, have remained largely unnoticed until recently. That has 
changed with the advent of studies that have discovered an abundance of submicroscopic copy 
number variation of DNA segments. 
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Table 1.1 Type of genetic variants and their relative sizes (Sharp et al., 2006) 
 
 
Copy number variation (CNVs, or copy number changes, copy number alterations), are defined 
as a DNA segment that is 1kb or larger and present at variable copy number in comparison with 
a reference genome (Redon et al., 2006), exclusive of the insertion/deletion events caused by 
transposable elements (Freedman et al., 2004). CNVs are discovered as deletions, insertions, 
duplications and complex multi-site variants. They are a subset of structural variation, which is 
defined as genomic alterations that involve segments of DNA that are larger than 1kb or 
translocation between one chromosome and another that may result in no loss of genetic material, 
but do involve loss of genetic coding information.  
 
CNVs have been studied as gene copy number differences between individuals at specific loci, 
especially for rare diseases for some considerable time , for example large deletions on 
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chromosome 15 which caused Prader-Willi syndrome, and hemizygosity at the elastin locus in 
Williams syndrome, The common α-globin gene deletions widely detected in different isolated 
populations and the well established study of identical duplications of gene PMP22 in autosomal 
dominant and sporadic forms of Charcot Marie-Tooth disease type 1  are other examples (Sebat, 
2007). However, the knowledge of such genomic rearrangements was limited until recently, and 
the prevalence and impact of CNVs was assumed to be small. Since 2004, a wave of structural 
variant studies in normal human individuals leads to a whole new understanding of CNVs, 
revealing them as a major source of human genetic variation (Conrad et al., 2006; Iafrate et al., 
2004; Redon et al., 2006; Sebat et al., 2004; Tuzun et al., 2005; McCarroll et al., 2005).  
 
The advance of microarray technology and availability of complete human genome sequencing 
enabled researchers to capture genome wide CNVs in multiple individuals, and also shed light 
on their location and frequencies. The first attempt was made in 2004 by two independent groups, 
Iafrate et al. (2004) and Sebat et al (2004). Both groups surveyed the genome wide copy number 
changes in a number of human genomes, and revealed the extent of this category of genetic 
variation at a previously unanticipated level. Iafrate et al.(2004) detected 255 loci which contain 
genomic imbalances among 55 unrelated individuals, while Sebat et al. (2004) found 221 CNVs 
which represented 76 Copy Number Polymorphisms (CNP, defined as CNVs at >1% frequency) 
in 20 individuals. Some of these loci influence genes that have important biological roles such as 
neurological functions and metabolism (Iafrate et al., 2004; Sebat et al., 2004). More studies 
followed in the subsequent years, which made use of existing SNP genotyping data and clone 
paired-end sequencing data to detect CNVs (Tuzun et al., 2005; Conrad et al., 2006; McCarroll 
et al., 2005). 
 
In 2006, a first generation CNV map across the whole human genome was published by Redon 
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et al., (2006). This map was based on 270 individuals from four different ethnic populations of 
European, Asian or African descents, each of whom contributed to the original International 
HapMap Project. 1447 copy number variable regions (CNVRs) were reported, which in total 
covered 12% of the genome. They also observed enrichment of genes in functional categories 
such as cell adhesion, sensory perception of smell and of chemical stimulus, and also 
neurophysiologic processes (Redon et al., 2006). Other studies utilizing HapMap data also 
emerged. Comprehensive investigation of CNVs in this representative sample set of humans 
revealed a series of characteristics of CNVs,   such as chromosomal distribution, correlation 
with segmental duplications (SDs) in the genome and gene content (Kohler and Cutler, 2007; 
Korn et al., 2008; Lin et al., 2008; Locke et al., 2006; McCarroll et al., 2008; Redon et al., 2006; 
Wang et al., 2007). Although platform choice and algorithm differences in these studies resulted 
in a degree of discrepancy of CNVs detected even for the same individuals (see Chapter 5 for 
details), these studies have greatly broadened the dimension of human genetics research and 
have brought a population perspective into such investigations. 
 
Whilst conventional CNV detection methods such as mining SNP genotyping data or using 
array-based Comparative Genome Hybridization (array-CGH) were widely adopted in CNV 
studies, some early fruits were harvested from fine-scale CNV detection based on whole genome 
sequencing technologies, which enabled detection of CNVs at unprecedented resolution. To date, 
whole genome sequencing has been reported in at least 33 individual genomes; 30 of them have 
had CNVs determined (Ahn et al., 2009; Bentley and et al., 2008; Drmanac et al., 2010; Kim et 
al., 2009; Levy et al., 2007; Lupski et al., 2010; McKernan et al., 2009; Pelak et al., 2010; 
Pushkarev et al., 2009; Schuster et al., 2010; Wang et al., 2008; Wheeler et al., 2008. See 
Chapter 4 for details). These studies have demonstrated that compared to SNP, CNVs confer 
higher level differences between individuals. Pioneer study of CNVs detected from two partially 
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sequenced genomes estimated the total amount of sequence divergence to be 0.5%, with the 
majority of variation being due to CNVs (Korbel et al., 2008), which is contrary to our 
traditional view that human genomes share 99.9% similarity. An analysis of deletions detected 
from whole genome sequence for five individuals (Ahn et al., 2009; Bentley and et al., 2008; 
Levy et al., 2007; Lupski et al., 2010; McKernan et al., 2009; Wang et al., 2008; Wheeler et al., 
2008) showed that there was only a small fraction of total detected CNV loci shared between any 
two individuals among these five (see Chapter 4 for details). In the future, the human genome 
similarity rate may further be revised, with knowledge of accurate whole genome CNV calls 
from more sequenced individuals.  
 
The presence of copy number variation is not limited to human genomes, but also widely found 
in genomes of other species. Genome-wide CNVs have been characterized in great apes, 
chimpanzees, mice, dogs and drosophila (Perry et al., 2007; Dopman and Hartl, 2007; Pielberg 
et al., 2002; Locke et al., 2003; Li et al., 2004; Chen et al., 2009; Snijders et al., 2005). The 
impact of specific CNVs on phenotypes of other species, for example domestic pigs and black 
sheep, have also been studied (Norris and Whan, 2008; Pielberg et al., 2002).  
 
Since CNVs are of thousands to millions base pairs long, they frequently span entire genes 
leading to different gene copy numbers between individuals, or alter the intron/exon structure of 
genes by disrupting exons or fusing genes together (Korbel et al., 2008), therefore CNVs could 
contribute to disease susceptibility or phenotypes through alterations in gene dosage. Disease 
relevance of DNA copy number alteration is not a new topic. Recurrent deletions of tumor 
suppressors and amplifications of oncogenes have been investigated in cancer studies for a long 
time. The discovery of CNVs in germline DNA in diseased and healthy individuals extends the 
frontier of such researches from cancer to more and more common and rare diseases. Since then, 
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a number of CNVs were shown to be associated with disease (see Chapter 1.5). Of equal 
importance to SNPs, CNVs as a major source of genetic variation has brought a new dimension 
























1.2 Characteristics of copy number variants 
 
1.2.1 How many CNVs are there in the human genome? 
Before 2004, the scale of copy number variants in human genome was underestimated. Ever 
since the pioneer genome-wide CNV discoveries, more and more new CNVs have been revealed 
from various studies. Redon et al. in 2006 estimated 12% of the human genome is covered by 
CNVs (Redon et al., 2006); now the proportion of genome regions showing evidence of copy 
number variation has been revised to be 35.07%, according to Database of Genomic Variants 
(DGV, http://projects.tcag.ca/variation/). 
 
DGV is a database where publicized CNV results from various platforms are centralized and 
deposited. Up to early 2011, it has received 42 publications with available CNV data. It now 
contains 66741 CNVs underlying 15963 loci (CNVRs); the number of identified CNVRs has 
dramatically increased over the last few years (Figure 1.1).  
 
Not only has the total number of CNV’s discovered increased, but it is also clear that only a 
small portion of CNVRs identified in each new study overlap those found by others (Freedman 
et al., 2004; McCarroll and Altshuler, 2007; Redon et al., 2006; Smith et al., 2007), indicating 
that the catalogue of copy number variability remains incomplete. This may be due to 1) the 
difference of CNV size detected by use of different methods, 2) CNV frequency differences 
between different population, 3) the limitation to detect rare CNVs and variable false positive 
rates and 4) false negative rates to detect CNVs across different studies (Smith et al., 2007). 
Therefore there is still a great potential to identify novel CNVs and make a contribution to the 




Figure 1.1 Increase in published CNV and InDel data that have been added to DGV since 2004. 
The numbers reflect the year of publication. The studies published are all included in the 2004 
total. (From http://projects.tcag.ca/variation/, last accessed in April 2011) 
 
 
Figure 1.2 CNV size distributions in DGV (From http://projects.tcag.ca/variation/, last accessed 
in April 2011) 
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1.2.2 Length of CNVs 
The size distribution of the CNVs in DGV is shown in Figure 1.2. Most CNVs are of small to 
median sizes, while only a small portion of CNVs are large.   
 
The detection method of choice might result in different size ranges of predicted CNVs. First of 
all, the targeted length of CNVs is limited by resolution of assays. The insertion size of BAC 
(Bacterial Artificial Chromosome) CGH arrays is typically 80-200kb, therefore the identification 
of CNVs smaller than 50 kb is difficult. Fosmid and cosmid clones of approximately 40 kb in 
length improve the resolution to about 20kb. Resolution of SNP arrays is variable across the 
genome and for many array types there is a lower limit of 10-40kb (Carter, 2007). Whole 
genome sequencing potentially provides the highest resolution, but the short read length limits 
the size of detected CNVs. Secondly, density and coverage of probes in an array is positively 
correlated to the number of CNVs detected.  Third, breakpoint determination affects the size of 
actual CNVs. For example, the size of CNVs detected by BAC arrays is significantly 
overestimated, due to long insert sizes of BACs (but breakpoints are determined as the 
boundaries of the first and last probes in a region showed signal change).    
 
1.2.3 Chromosomal location of CNVs 
The distribution of CNVs on chromosomes is not uniform (Fig 1.3).  Enrichment of CNVs is 
observed in peri-telomeric and/or sub-centromeric regions for most chromosomes. The CNVRs 
cluster in functional categories such as cell adhesion, sensory perception of smell and of 




1.2.4 CNVs and segmental duplications 
Copy number changes are found to preferentially enrich near segmental duplications (SD), 
which are defined as duplicated sequences of >1kb with 90% or more sequence identity in the 
reference human genome assembly (Bailey et al., 2002). A number of studies which specifically 
focus on structural variants in SDs also argue that these loci are hotspots for chromosomal 
rearrangement and copy number variations (Locke et al., 2006; Sharp et al., 2005).   
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Figure 1.3 Genome-wide view of CNVs. Blue bars indicate reported CNVs, red bars indicate 
reported inversion breakpoints, green bars to the left indicate segmental duplications. (Adapted 
from http://projects.tcag.ca/variation/, last accessed in April 2011) 
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1.3 Detection of copy number variants 
 
1.3.1 Classical cytogenetic techniques to detect structural variants 
Cytogenetics is the study of chromosome structure. Classical cytogenetic techniques include 
routine Giemsa-banding (G-banding) to reveal large structural variations which are 
microscopically visible. Another category of cytogenetics is molecular cytogenetics. One 
well-known example of classical cytogenetics application is the diagnosis of trisomy 21, which 
leads to Down syndrome. This procedure was established in 1950s and has been widely used in 
routine prenatal examinations. A large number of abnormalities of chromosome structure (partial 
deletion, duplication or inversion) or number (aneuploidy) have been described to be associated 
with a very wide range of congenital abnormalities (James et al., 1971).   
 
1.3.2 Fluorescence in situ hybridization (FISH) and chromosome based comparative 
genome hybridization (CGH) 
Fluorescence in situ hybridization (FISH) is a type of molecular cytogenetic techniques 
introduced in the 1980s. It is an in situ hybridization technique in which a labeled probe of 
specific DNA sequences, for example a Bacterial Artificial Chromosome (BAC) clone or fosmid 
clone, is hybridized to a preparation of metaphase chromosomes or interphase DNA, which is 
usually attached to solid media (e.g. a glass slide). Then the chromosome DNA and probe 
mixture is denatured, so that the single-stranded probe and single stranded DNA can re-anneal, 
and at the same time the probe hybridize to the complementary DNA sequences, and now a 
double stranded molecule is reformed. Following hybridization, unbound probes are washed 
away, and the hybridized probes can be visualized directly if they were tagged with 
fluorochromes such as Cyanine (Cy) or Alexa Fluor dyes, or can be detected by antibodies 
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against hapten-tagged probes, or affinity agents such as avidin or streptavidin if probes are 
labeled with the biotin and digoxigenin systems (Bauman et al., 1980).  
 
Compared to classical cytogenetic karyotyping, FISH has the advantage of increased the 
resolution to ~100kb, which enables the detection to submicroscopic copy number changes. 
Over the years FISH techniques have evolved, for instance multi-colour hybridization which 
allow visualizing of rearrangements involving multiple chromosomes and Fiber-FISH which 
benefit from extended chromatin fibers in the DNA preparation to detect small copy number 
changes. Fiber-FISH can detect deletion gaps or tandem duplications down to the size of a 
fosmid clone (40kb) or even smaller; it was utilized in the survey of  and related segmental 
duplication in human and chimpanzees (Perry et al., 2008).   
 
Another type of molecular cytogenetic techniques is chromosome-based comparative genome 
hybridization (CGH). The first step of CGH is to labeled test and reference DNA differentially, 
then those DNA simultaneously hybridize to chromosome metaphase spreads (at the same time 
unlabelled Cot-1 DNA is also hybridized to block DNA repeats). The hybridization will then be 
detected with two fluorochromes, and genomic regions of gains or losses would be illustrated as 
changes in the ratio of intensities of the two fluorophores along the chromosomes. The technique 
was first introduced in the analysis of amplification of the myc locus at 8q24 in tumor cell line 
(Kallioniemi et al., 1992). Thereafter, it has been widely applied in the analysis of tumor 
chromosomal aberrations. The advance of CGH is that it allows whole-chromosome or 
whole-genome surveys of chromosomal rearrangement and aberrations, while previous 
approaches only target specific genomic regions. However, the use of metaphase chromosomes 
largely limits the resolution of CGH. 
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1.3.3 Array-based comparative genome hybridization (array-CGH) 
Array-based comparative genome hybridization (array-CGH) is an upgrade to the traditional 
CGH technique. By applying comparative genome hybridization to a solid surface with 
immobilized DNAs targeted in small spots, it greatly enhanced the resolution and application 
range for copy number detection.   
 
A CGH array consists of mapped DNA sequences spotted or directly synthesized onto a solid 
surface, for exame a glass slide. Different sources of DNA sequences which could be generally 
classified as genomic inserts are used in array approaches, such as BAC, cosmid or fosmid 
clones, cDNA clones, genomic polymerase chain reaction (PCR) products or oligonucleotides. 
For the hybridization experiment, uniquely labeled subject and control DNA are co-hybridised 
onto arrays with Cot-1 blocking agent which would count out signal from common repetitive 
sequences (Figure 1.4 a)). Then the test and reference DNA signal intensity is recorded for all 
probes on the array. Significant deviation from the test/reference ratio of 1 (equivalent to log2 
(test/reference)=0) for a probe (or a series of consecutive probes) would be interpreted as DNA 
copy number changes (Figure 1.4 b)) (Solinas-Toldo et al., 1997; Pinkel and Albertson, 2005). 
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Figure 1.4 (a) Array comparative genomic hybridization (CGH). Genomic DNA from two cell 
populations is differentially labeled and hybridized to a microarray. The fluorescent signal 
intensity ratios measured at each array spot are normalized so that the median log2 ratio is 0. 
Plotting of the data for chromosome 9 from pter to qter shows that most elements have a ratio 
near 0. The two elements nearest pter have a ratio near −1, indicating a reduction of a factor of 
two in copy number. Fluorescent in situ hybridization (FISH) with a red-labeled probe for the 
deleted region and a green-labeled control probe (genome locations indicated by the red and 
green arrows on the ratio profile) shows that the cells contain two copies of the green probe and 






1.3.3.1 BAC array CGH 
Bacterial Artificial Clones array CGH is the first generation CGH, and is also used for the 
earliest genome-wide human CNV surveys (Iafrate et al., 2004; Redon et al., 2006; 
Solinas-Toldo et al., 1997). BAC arrays targets specific regions of the genome, or tiling the 
genome at an average resolution of about 1 Mb. Now the BAC arrays can be synthesized with 
over 30,000 features at a tiling path resolution 80-150kb, due to the availability of overlapping 
sequencing clone contigs generated for public domain of the Human Genome Project (Fiegler et 
al., 2006). The DNA preparation for BAC arrays was problematic, because substantial effort was 
required in bacterial culture handling to extract enough DNA from the BAC clones; this problem 
was tacked later by applying DNA amplification methods such as rolling circle replication, 
linker adaptor PCR or degenerated oligonucleotide primer PCR (DOP-PCR). The whole-genome 
tiling path (WGTP) array platform was generated using the DOP-PCR strategy, with BAC DNA 
amplified using three different, specifically designed degenerated oligonucleotide primers. At 
that point complete amplification of the clone DNA was achieved and the effect of E. coli host 
vector DNA contamination was minimized. After years of improvement, the technique of BAC 
array CGH has matured and it has been a sensitive and reliable platform for the detection of 
genomic aberrations (Fiegler et al., 2006).  
 
1.3.3.2. Oligonucleotide Array CGH (OaCGH) 
Alongside BAC arrays, oligonucleotide-based arrays are also among the most popular methods 
to detect genomic imbalances.  25~85 mer oligonucleotides are synthesized in-situ onto the 
solid base of the array which serve as the probes or features for CNV detection. Different oligo 
arrays are combined with different labeling and hybridization techniques to yield high-resolution 
copy number measurements. Oligonucleotide arrays are usually commercially available, from 
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suppliers such as Affymetrix, Roche Nimblegen and Agilent Technologies. Non-commercial 
oligonucleotide array CGH platforms have also been applied , where 60~70 mer oligonucleotide 
libraries are spotted as elements on the arrays (Ylstra et al., 2006).  
 
Compared to BAC arrays, early oligonucleotide arrays had low signal-to-noise ratio, which leads 
to variable reported signals for CNV detection (Carter, 2007). Another issue which hindered the 
wider application of OaCGH is the higher costs to purchase commercial arrays and experimental 
reagent; therefore OaCGH were mostly used for validation (Conrad et al., 2006; Locke et al., 
2006; Wang et al., 2007) or breakpoint mapping (Sharp et al., 2005) rather than whole genome 
discovery of CNVs, in the early years of its application. New technologies, such as the use of 
digital mask photolithography, has allowed oligo arrays to be constructed at much higher density, 
providing better resolution and precision for CNV detection. Flexibility of array design also 
expanded the usage of oligo arrays: the arrays can be optimized to avoid highly repetitive 
regions, but can also cover low copy repeats such as segmental duplications where CNVs are 
abundant. Designs can also be customized to target clinically relevant regions for disease studies. 
With improved signal-to-noise ratio, enhanced reproducibility, better quality control and the 
reducing cost, oligo arrays are now recognized as an accurate method for high resolution CNV 
detection (Cronin et al., 2008; Ylstra et al., 2006; Urban et al., 2006). The latest commercially 
available oligo arrays include the Agilent SurePrint G3 Human CGH Microarray 1M with 
963,029 biological features and NimbleGen Human CGH 4.4M Whole-Genome Tiling Array. 
 
Representational oligonucleotide microarray analysis (ROMA) is a member of the OaCGH 
technology family. “Representations” of the test and reference genomes are prepared by 
digesting the genomes with restriction enzymes. After differential PCR amplifications, 
representations of the entire genome are amplified to show relative increases, decreases or 
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remain equal copy number in the two genomes.  Oligonucleotide probes from human genome 
sequence are hybridized with differently labeled test and reference genome fragments, so that 
change of copy numbers could be detected from signal intensity changes (Lucito et al., 2003). 
ROMA, which was developed from a previous method called Representational Difference 
Analysis, has the advantage of reducing the complexity of a genome with taking restriction 
enzyme cleaved DNA fragments. This approach has been used in several CNV discovery and 
disease association studies (Sebat et al., 2004; Sebat et al., 2007; Walsh et al., 2008). 
 
1.3.4 CNV detection using Single Nucleotide Polymorphism data 
Single Nucleotide Polymorphism is the most well studied genetic variants in human genomes. 
Since the 1990s, enormous effort has been put into the SNP discovery, validation and 
characterization. The International HapMap project is an important landmark in the history of 
human genetics studies, which provides a catalogue and database of well-characterized SNPs in 
sampled human individuals from four major ethnic populations (The International HapMap 
Consortium, 2005). The release of reference SNP map in human genome has enabled the 
development of high-throughput array technologies for SNP genotyping, for example SNP 
genotyping platforms by Affymetrix and Illumina Inc. With the guidance of DNA reference 
sequence and the use of high-throughput genome-wide SNP microarrays, numerous studies 
showed success in finding genetic determinants of human complex traits in a fast and economic 
way.  
 
Many genome-wide SNP association studies with large sample sizes (hundreds to thousands of 
participants) are already established. Intuitively one may argue whether these SNP genotyping 
data can be mined for copy number analysis at no extra cost and further, make the data a 
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potential source for CNV-disease association studies complementing SNP-disease association, 
which may aid understanding of the contribution of a higher level of genetic variants to the 
disease susceptibility or disease related traits.  
 
A number of algorithms have been introduced to indicate CNVs from SNP array genotyping 
results (Gunderson and Peitter, 2006; Li and Wong, 2001; Colella et al., 2007; McCarroll et al., 
2008; Korn et al., 2008).Compared with array-CGH, SNP genotyping provides extra information 
to estimate copy number by combining the normalized intensities and allelic ratio.  SNP 
genotyping platform are different in that a combination of two genotyping parameters is 
analyzed: normalized intensity measurement and allelic ratio. Together, these parameters provide 
a more sensitive and precise profile of chromosomal aberrations. SNP array data also provides 
genetic information (haplotypes) of the involved locus. Importantly, the SNP genotyping 
platform has the capability of identifying copy-neutral LOH (Loss of Heterozygosity) events, 
such as gene conversion, which cannot be detected with array-CGH (Gunderson and Peitter, 
2006). 
 
1.3.4.1 SNP-tagging based on linkage disequilibrium 
It is hypothesized tht SNPs could tag adjacent common copy number changes, or CNPs, based 
on linkage disequilibrium (LD), therefore LD could be utilized for CNV investigation. However, 
whether SNP can serve as a good proxy for CNV detection still remains unclear (Redon et al., 
2006; McCarroll and Altshuler, 2007). Only a small proportion of CNVs has to date been 
accurately genotyped, making the assessment of linkage disequilibrium around CNVs difficult. 
Some studies suggested that deletion polymorphisms are generally in strong linkage 
disequilibrium and segregate on ancestral SNP haplotypes (Hinds et al., 2006; McCarroll et al., 
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2005) while some others argued although a number of CNVs are in strong linkage 
disequilibrium with nearby markers, accurate genotypes can only be captured for small 
proportion of the tested CNVs (Redon et al., 2006). CNVs are commonly found in regions rich 
in segmental duplications, but those regions are not favored in SNP selection in commercial SNP 
genotyping assays, whose design is based on SNP tagging which aims to capture most common 
variants in the genome, because regions harboring CNVs usually tend to be gene-poor and 
common CNPs usually cause SNP genotyping assays to fail Hardy-Weinberg and Mendelian 
inheritance checks. Consequently, these regions are often filtered out during the selection of 
high-performance SNP assays (McCarroll and Altshuler, 2007; Locke et al., 2006). Other 
reasons may be high recombination rate in regions of CNV or high rate of spontaneous 
recurrence of CNVs (Lee and Jeon, 2008; Lee et al., 2007).  
 
1.3.4.2 CNV detection using whole-genome SNP genotyping arrays 
SNP arrays originally designed to genotype SNPs in genome-wide association studies can be 
used to estimate copy number variations. Hybridization signals of probes at each SNP locus can 
be compared to those from a single or a group of references genomes hybridized on the same 
array type. The CNV calls can thus be generated (Figure 1.5). Apart from directly utilizing 
signal intensities, CNVs, in particular deletions, can be inferred from regions with extended loss 
of heterozygosity (LOH), non-Mendelian inconsistency among families and enrichment of 






1.3.4.2.1 CNV studies utilizing whole-genome SNP data 
The first SNP based CNV studies were carried out in 2005, with Affymetrix GeneChip Human 
10k arrays to analyze copy number changes from a variety of different sources, including 
primary tumors, cell lines and blood from patients with unbalanced translocations (Conrad et al., 
2006; Herr et al., 2005; McCarroll et al., 2005). Thereafter the resolution of SNP arrays 
gradually increased, and the companion analytical tools also developed. For example 
Affymetrix’s Genome-Wide Human SNP Array 6.0 which consists of more than 906,000 SNP 
and 946,000 CNV probes are now available for underlying CNV profile in human samples (Kidd 
et al., 2008).  
 
The SNP data from International HapMap project was often mined by CNV researchers to 
generate example maps of CNVs in human genome from multiple population cohorts or served 
as reference for testing SNP-base CNV detection algorithms (Komura et al., 2006; Conrad et al., 
2006; Locke et al., 2006; Redon et al., 2006; Kohler and Cutler, 2007; Ting et al., 2007; Wang et 
al., 2007; Korn et al., 2008; Lin et al., 2008; McCarroll et al., 2008; Rigaill et al., 2008; Sanders 
et al., 2008; Shen et al., 2008; Cooper et al., 2008; Pique-Regi et al., 2009; LaFramboise et al., 
2005). SNP genotyping data from already established association studies has been routinely 
recycled for CNV determination (see 1.5 for references). The advantage of such a study design is 
that knowledge of SNPs, CNVs and other clinically useful data such as uniparental disomy 
(which is a copy number neutral LOH detectable by analyzing hybridization signals) (Dunbar et 







Figure 1.5 Protocol outline of CNV detection from hybridization signal intensity data of SNP 





The major problem of using earlier generation SNP arrays to detect CNVs is uneven probe 
spacing, with particularly low density of SNPs near or at repeat-rich regions such as segmental 
duplication, centromere and telomeres. This will directly cause inaccurate CNV calls which in 
practice are inferred from signal intensity data for SNPs. The later SNP genotyping platforms 
with denser SNPs perform better in detecting CNVs. Several recent SNP genotyping platforms 
have taken copy number detection into account, which include non-polymorphic probes 
specifically selected for their genomic positions and for linear response to copy number changes. 
For example Affymetrix Genome-wide Human SNP array 5.0 and 6.0, and Illumina Human 
1M-Duo Bead Chip, with over 1.2 million markers including probes designed to target known 
CNV regions and gaps between HapMap SNPs. These platforms have greatly enhanced power to 
detect CNVs in association studies, integrating both SNP and CNV assessments in the pipeline 
of such researches (Korn et al., 2008).                                                              
 
1.3.4.2.2 SNP-based CNV detection algorithms  
A number of bioinformatics tools have been designed to detect CNVs using the intensity data 
from hybridization of sample DNA to the probes on the array. LogR Ratio (LLR) and B Allele 
Frequency (BAF) are the two most important parameters of singnal intensity for CNV detection. 
The detection algorithms fall into generally two major categories: Hidden Markov model (HMM) 
and circular binary segmentation (CBS). Building upon the statistical principles of HMM and 
CBS a number of algorithms have been developed; some examples can be viewed in Table 1.2. 
 
The assumption of HMM is that the observed intensities of each SNP probe are related to an 
unobserved copy number state at each locus, so that a DNA segment of copy number change can 
be determined if consecutive probes within this segment all show the same non-neutral copy 
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number state (Details in Chapter 2).  
 
With prior knowledge of modeling statistics, algorithms have been developed to infer copy 
number changes with genomic SNP data. HMMseg is one of the earliest algorithms designed for 
this purpose, which is command line operated (Day et al., 2007). However application of correct 
modeling procedures is not an obvious process to non-statisticians. For these reasons software 
with user-friendly interface has been developed which allows guided applications of HMM 
methods (Winchester et al., 2009). QuantiSNP and PennCNV are two academically developed 
software tools that are freely available for CNV prediction. Users can apply HMM to their own 
data using these tools.  
 
QuantiSNP (Colella et al., 2007) was initially designed for Illumina Infinium array platforms, 
but the later versions of this software have been proved to have satisfactory accuracy on 
Affymetrix and Illumina GoldenGate data where SNP coverage is suitable. The output of 
QuantiSNP gives a log Bayes factor with its prediction which is a post-process parameter to 
indicate the likelihood of the results. The user can rank events in order of Bayes factor and chose 
a satisfactory cutoff to define their list of CNVs. QuantiSNP is widely used in CNV discovery 
and disease associations, as highlighted by  CNV studies in Autism spectrum disorders and 
schizophrenia (Moreno-De-Luca et al., 2010; Pinto et al., 2010; Stefansson et al., 2008; 
Vrijenhoek et al., 2008; Wang et al., 2007; Wang K. et al., 2010). 
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PennCNV (Wang et al., 2007) was also tailored for Illumina genotyping platforms at first, and 
later modified to be compatible to Affymetrix platforms in a version called “PennCNV-Affy”. It 
has a number of downstream analyses including the use of family trio data in analysis, in which 
the family information (when applicable) is taken into account to give more confidence of a 
CNV detected to be passed on from parent(s) to offspring. It also includes a number of options to 
handle results such as scripts which allow the viewing of PennCNV results in BeadStudio 
Chromosome Browser or the web-based UCSC browser (http://genome.ucsc.edu/). The 
application of PennCNV to detect CNVs can be found in over 60 published articles 
(http://www.ncbi.nlm.nih.gov/pubmed, last accessed April 2011), in population CNV profiling  
(Cooper et al., 2008; McQuillan et al., 2008; Perry et al., 2008), tumor studies (Cooper et al., 
2008; Jacobs et al., 2007; McQuillan et al., 2008; Perry et al., 2008; Toujani et al., 2009), and 
CNV association with diseases (Glessner et al., 2009a; Wang K. et al., 2010; Glessner et al., 
2009b; Glessner et al., 2010; Bademci et al., 2010).  
 
Other HMM based programmes include: the Birdsuite package which integrate calling of 
common CNVs (with the knowledge of categorized CNVs from publications) and the discovery 
of rare CNVs  (McCarroll et al., 2008); dChip software which was originally developed for 
Affymetrix platforms and outputs and LOH score alongside each prediction (Li et al., 2008); 
Copy Number Analyzer for GeneChip arrays (CNAG) (Nannya et al., 2005),  and many more.  
 
Another category of algorithms are based on Circular Binary Segmentation (CBS). These 
algorithms were originally developed for arrayCGH analysis to convert noisy intensity values 
into regions of equal copy number (Olshen et al., 2004), but have been modified for SNP 
genotyping arrays. CBS continuously divides a region into segments until it finds a segment with 
a different copy number compared to the neighboring region. This detection of change-point 
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along chromosomes is designed to identify all the places which partition the chromosome into 
segments of the same copy number. Segment ends were joined to form a circle to allow a further 
likelihood ratio test. The median LLR values are then given to the final set of segments within 
the region, and this median values are used to define copy number status of each segment.  
 
DNAcopy and cnvPartition are two packages among many CBS based algorithms.  
Traditionally, CBS scans a chromosome multiple times and generate a permutation reference 
distribution to obtain the corresponding P value for each segment of CN change, which is time 
consuming. As the number of markers increases, the number of computations increase 
exponentially, which is not favoured in CNV detection from newer arrays which contain 
hundreds of thousands markers.  DNAcopy implements a ‘stopping rule’ into the basic CBS 
algorithm; this will stop a computation process early when there is strong evidence for the 
presence of copy change of the segment being assessed (Venkatraman and Olshen, 2007a).  
cnvPartition was developed by Illumina for their proprietary software BeadStudio. As a plug-in, 
it can easily be applied to LRR and BAF data organized and analyzed in BeadStudio. 
cnvPartition contains two modules: one for breakpoint identification using LRR, and another for 
assigning copy number to the regions between identified breakpoints with information of BAF 
(BeadStudio TechNotes of CNV algorithms). Other examples of computational tools utilizing 
CBS are The Genome Alteration Detection Algorithm (GADA) (Pique-Regi et al., 2008), and 




1.3.4.2.3 Choice of algorithm for SNP based CNV detection 
Accurate CNV prediction from hybridization singnal intensities largely relies on the 
 29
performance of sophisticated algorithms or statistical methods to discover copy number changes. 
To date a number of commercial and in-house CNV detection software have been developed to 
process SNP array data, which one or ones to chose from the large collection should be an 
important concern in the primary stages of any study that intend to mine SNP data for CNV 
discovery. It has been shown that output from different algorithms showed large scale variability 
(Korn et al., 2008) ,  but it is only recently that researchers have started to assess the impact of 
algorithm choices on resulting CNV calls in a systematic way (Dellinger et al., 2010; Tsuang et 
al., 2010; Winchester et al., 2008; Zhang et al., 2011).    
 
No consistent conclusion could be made for the algorithms considered in the already published 
comparison studies. For example, all four studies assessed QuantiSNP but its ranking amongst 
all algorithms tested was different in each study. The large scale of discrepancy of results from 
different methods makes one question the power and accuracy of these algorithms. To increase 
confidence of CNV predictions in the data, it is recommended using a second algorithm on the 
single dataset to produce the most informative results (Winchester et al., 2009). But it should be 
noted that, the trade-off of taking overlap of two algorithms is the chance of missing true 









1.3.5 Validation and detection of locus-specific CNVs 
The CNV prediction is often followed by quantitative or semi-quantitative measurements of 
copy variation at selected targeted loci. These measurements serve as independent platforms to 
validate array-based CNV discoveries and they can precisely determine breakpoints of CNV 
regions. The detection/confirmation of CNVs at targeted loci can be expended in a wider context, 
where candidate CNV loci can be genotyped in a large number of samples for disease 
association studies or in clinical diagnostic settings. Table 1.3 shows some example of 
locus-specific CNV detection. 
 
Conventional methods such as FISH, RFLP (Pulsed field gel electrophoresis)-Southern Blot, 
PFGE and long range PCR can be applied for validating a small number of CNVs in limited 
samples. However, these methods are low-throughput and technically demanding.  
 
Newer techniques such as quantitative fluorescent real-time PCR (qPCR), multiplex quantitative 
Fluorescent Real-time PCR, pyrosequencing, invader assays and Ligation detection reaction 
(LDR) have been developed along with the progress of CNV discoveries. These new methods 
are more cost effective and faster in detecting CNVs at targeted loci, and have the potential to be 









Table 1.3 Example of locus-specific CNVs and the methods applied for the detection. (Lee and 
Jeon, 2008) 
 
1.3.6 Whole genome sequencing and detection of CNVs 
The sequence of original consensus human genome is the bedrock of most CNV discoveries to 
date. Genomic insert clones, for example BACs or oligonucleotides are representative segments 
of the reference genome sequence compiled by the HGSC (Human Genome Sequencing 
Consortium, 2004; Human Genome Sequencing Consortium, 2001). The other major CNV 
detection platform, namely SNP genotyping arrays, have depended upon SNP information 
derived from the International HapMap Project, which has identified and catalogued common 
genetic polymorphisms at single nucleotide level.  
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On the other hand, the option of directly detecting copy number change of DNA segments from 
sequence data is considered in a few whole genome sequencing studies. Thus, 666 CNVs were 
found in the first published DNA sequence from a sole individual, Dr J. C. Venter (Levy et al., 
2007), using first-generation shotgun sequencing technology; 602 CNVs detected in Dr J. D. 
Watson’s genome on Roche/454 platform (Wheeler et al., 2008); 5704 in the genome of an 
African individual (Bentley and et al., 2008) and 2682 in the first Asian genome (Wang et al., 
2008), both on Illumina Genome Analyzer platform.    
 
The computational tools to detect CNVs from sequence data fall into two main categories, 
paired-end read mapping/paired-end read sequencing/end-sequence profiling (PEM/PES/ESP), 
and read depth (RD) (Koboldt et al., 2010). Whole genome sequencing allows detection of 
structural variants at unprecedented resolution, however it is still too early to announce unbiased 
whole genome CNV profiling can be achieved by solely analyzing DNA sequencing data. The 
state-of-art bioinformatics methods developed for this purpose each has its drawbacks. First of 
all, due to the short length of sequenced bases, many reads cannot be uniquely mapped to the 
genome. Second, the alignment is particularly problematic at segmental duplication rich regions; 
read-depth methods could detect variants at those locations, but their resolution is relatively poor. 
Third, PEM-based methods have the advantage to detect dosage-invariant SVs, but these 
algorithms have limited power in detecting insertions larger than the insert size. Fourth, the G+C 
content throughout the genome, amplification error and uneven likelihood of fragmentation all 
may cause different representation of certain regions compared to others. Last but not least, 
many of the data sets do not have sufficient coverage to infer all SVs with statistical significance 




Therefore more advanced and sophisticated platforms and algorithms for detecting SVs from 
sequence data are required. It is also advisable that the results from direct DNA sequencing are 
combined with conventional platforms such as CGH and SNP array which has a better 
specificity in detecting longer CNVs, so that the relative advantages of these methods can 






















1.4 Mechanisms for the formation of genomic rearrangements  
One fundamental question to be asked in CNV studies is what mechanisms contribute to the 
generation of CNVs. The knowledge of underlying mutation processes for CNV will yield 
insights into the genomic distribution, evolution and frequency of CNVs in the human 
population. Four major mechanisms for the formation of genomic rearrangement have been 
proposed; they are non-allelic homologous recombination (NAHR), non-homologous end 
joining (NHEJ), fork stalling and template switching (FoSTeS) and L1 retrotransposition.  
 
1.4.1 Non-allelic homologous recombination  
It has long been observed that copy number variable regions often coincide with repeat 
sequences, for instance segmental duplications (Sharp et al., 2005) or Alu repeats (Lee et al., 
2007). Some genetic disorders, known to be caused by large scale microdeletion or 
microduplication of the genome, such as Williams Syndrome and Charcot Marie Tooth Disease, 
often have breakpoints in or around highly homologous segmental duplications or low copy 
repeats (LCRs) (Lee et al., 2007). It has been suggested that SDs or LCRs can serve as substrates 
for NAHR, and that NAHR account for most cases of recurrent CNV formations (Stankiewicz 
and Lupski, 2006; Lee et al., 2007; Stankiewicz and Lupski, 2006). Other repeats such as SINEs 
(eg. Alu), LINEs and human endogenous retroviruses (HERVs) can all act as substrates for 
NAHR, which are observed in less recurrent CNV events (Cooper et al., 2007). 
 
NAHR happens during meiosis, when two sister chromosomes align. In this process, 
misalignments or unequal cross-over of the homologous sequences will lead to germline 
rearrangements (Figure 1.6a). Different distribution and participation of the homologous 
sequences cause different type of CNVs in NAHR, from simple deletion or duplication to more 
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complex rearrangement, such as tandemly duplicated arrays, or other complicated structural 
variations involving multiple homologous duplicons (Zhang et al., 2009).  
 
1.4.2 Non-homologous end joining 
NHEJ is an alternative mechanism for repair of DNA double strand breaking (DSB) in cells. 
When there are no extensive homologous sequences to act as the repair template for NAHR near 
a random DSB, the nucleases will remove the broken ends which is followed by filling of 
missing nucleotides by the Pol X family of DNA polymerases(Zhang et al., 2009) (Figure 1.6a). 
It is an error-prone repair mechanism, which often generates gains and losses of nucleotides at 
the junctions.  Compared to NAHR, the knowledge of NHEJ is limited (Lee et al., 2007).  
 
NHEJ more usually appears in unstable regions of the genome, for example subtelomeric regions 
(Kim et al., 2008). Moreover, many 17p translocations and other nonrecurrent  disease-causing 
deletions have one of their breaking points in LCRs (Stankiewicz and Lupski, 2006). These may 
implicate the contribution of NHEJ to CNV formation with the absence of NAHR substrates. 
 
1.4.3 Fork stalling and template switching 
In 2007, Lee et al. proposed a new model apart from NAHR and NHEJ as a mechanism for 











Figure 1.6 Comparisons and characteristics of the four major mechanisms underlying human 
genomic rearrangements and CNV formation. (a) Models: NAHR, between repeat, sequences 
(LCRs/SDs, Alu, or L1 elements); NHEJ, recombination repair of double strand break; FoSTeS, 
multiple FoSTeS events (×2 or more) resulting in complex rearrangement and single FoSTeS 
event (×1) causing simple rearrangement; and retrotransposition. TS, target site; TSD, duplicated 
target site. Thick bars of different colors indicate different genomic fragments; completely 
different colors (as orange and red or orange/red/green in FoSTeS×2) indicate that no homology 
between the two fragments is required. The two bars in two similar shades of blue indicate that 
the two fragments involved in NAHR should have extensive homology with each other. The 
triangles symbolize short sequences sharing microhomologies. Each group of triangles (either 
filled or empty) indicates one group of sequences sharing the same microhomology with each 
other. (b) Characteristic features for each rearrangement mechanism: variation type that each 
mechanism generates; type of homology sequences flanking breakpoint; the way the breakpoints 
formed and favorable sequence feature recognized by each mechanism. Specific features of 
certain mechanisms are shown in red. Abbreviations: dup, duplication; del, deletion; inv, 




In this process, when a DNA replication fork stalls, the lagging strand detangles from the 
original template and switches to another replication fork if it finds a micro homologous 
sequence in the new fork. Then DNA synthesis restarts on the new fork and finally a 
rearrangement is made between the sites of original and new replication fork (Figure 1.6a). The 
difference between NAHR and FoSTeS are the required size of homologous sequences 
(intensive repeats for NAHR and microhomology for FoSTeS) and that NAHR happens in 
chromosome recombination process while FoSTeS in DNA replication process(Figure 1.6b). 
 
1.4.4 Retrotransposition 
Transposons are one type of mobile genetic elements in the human genome which can move, or 
transpose, themselves to new positions within the same genome. They act either by transcribing 
a segment of targeted DNA into RNA (Ribonucleic Acid), then from RNA back to DNA at a 
different location by reverse transcription and therefore result in a duplication of the targeted 
sites (named retrotransposition, and known as “copy and paste”), or by cutting out a DNA 
segment and inserting it into a new site in the genome via transposase activity (known as “cut 
and paste”). Long interspersed element-1 (L1) elements are a major class of retrotransposons. 
They are abundant in human genome, and are the only currently active autonomous 
retrotransposons (Zhang et al., 2009).   
 
In a survey of eight end-pair sequenced genomes, it was declared that retrotransposition 
accounted for 30% of all the detected SV indels (Kidd et al., 2008). Another study which 
analyzed SVs associated with mobile element in J. C. Venter’s genome claimed that about 10% 
of the indels of >100 bp were associated with transposable DNA sequences, including L1, Alu 
and SVA (composite retrotransposon) (Kidd et al., 2008; Xing et al., 2009) 
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1.5 Disease and phenotypic relevance of copy number variation 
 
1.5.1 Approaches to identify the genetic components of phenotypic variation 
It has been shown that most medical disorders, including cancer, heart disease and mental illness, 
have a significant genetic component. However, the isolation of disease susceptibility loci (DSL) 
remains difficult (Smith et al., 2006). 
 
Linkage studies have proven to be very powerful in localising genes for monogenic Mendelian 
disorders, but are poor for fine mapping genes of small effect size or low penetrance, thus may 
be much less effective for common complex diseases.  
 
It is widely accepted that association studies, which use large numbers of SNPs or other markers 
that are genotyped in known linkage regions or candidate genes, are an important complement to 
linkage studies, in the attempt to localize genes for complex traits. This method involves 
mapping hundreds of thousands, even millions of single nucleotide polymorphisms (SNPs) 
throughout the whole genome of multiple individuals in either case-control or population based 
study design, comparing frequencies of different alleles or haplotypes at the same genetic variant 
locus in people with the disease (cases) and similar people without (controls). The allele 
frequency differences together with other information is analyzed with statistical techniques, if 
one allele or haplotype appears more often in one group (cases or controls) than the other, this 
variant is suggested to be associated with an elevated risk of or protection against this disease. 
The association study design has greater power to detect smaller effects compared to linkage 
analysis, but requires many more markers to be examined. In recent years, with the identification 
of tightly spaced SNP variants through the human genome, the improvements in genotyping 
technology and associated cost reduction have made high resolution association studies practical, 
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and given them greater power and resolution for gene mapping than linkage studies. 
In the last few years, accumulating evidence has been found to reveal the universal existence of 
CNVs distributed in human genome and it has been suggested that CNVs may serve as a useful 
class of markers in genetic association studies (Redon et al., 2006; Sharp et al., 2006; Shelling 
and Ferguson, 2007).To carry out an association analysis using CNVs as markers, all levels of 
copy number should be measured. However, only a small percentage of common CNVs can 
yield genotypes of the quality that could be used for linkage disequilibrium analysis (Redon et 
al., 2006). And in the existing collection of CNVRs identified, only a very small number of 
CNVs have been genotyped  (McCarroll and Altshuler, 2007). This is inadequate to establish a 
robust and comprehensive CNV marker map. 
 
The current methodologies of CNV genotyping fall into two categories: use raw copy-number 
measurements such as log2R ratio (Stranger et al., 2007) or dichotomize over CNVRs and define 
the CNV variations as ‘gain’ or ‘lose’. It has been argued that summarizing raw copy-number 
measurements into such ‘calls’ may lose information present in the original measurements and is 
of uncertain relationship to the true genotype (McCarroll and Altshuler, 2007).  
 
The genetic variance underlying heritable traits related to complex disease can be partly 
explained by common variants of small effect, which form the basic principle of association 
studies: common-variant-common-disease hypothesis. However, the phenotypic variation will 
also have a contribution from rarer variants. A spectrum of the observed allelic frequency of 22 
functional quantitative trait nucleotide (QTN) variants influencing the trait (Figure 1.7), 
obtained in various resequencing studies, suggests that rare variants (with frequencies<0.05) 
may be very important causal factors in quantitative trait variation (Blangero, 2004).  On the 
other hand, it is shown in an L-shaped or exponential distribution of mutation effect sizes that 
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there are many variants with small effects, a small number with intermediate effects and 
relatively few with large effects (Wright et al., 2003). It could be argued that a collection of 
multiple rare variants could make a very significant contribution to human phenotypic variation.  
 
However, the current popular methods to detect genetic variants have limitations when it comes 
to the case of multiple rare variants.  Linkage studies conducted among families with multiple 
cases of disease were successful in identifying variants of large effects with high penetrance. 
Association studies conducted in general populations samples using common genetic markers 
typically find low penetrate variants with (very) small effects. It is not unexpected given that 
these common genetic variants are ancient and will have been subject to some selective pressure 
over time. Usually the rare SNPs are not in linkage disequilibrium (LD) with any other variants 
within the gene and are uncorrelated with any common haplotype, so the HapMap strategy base 
solely on tagging common SNP variants could easily fail even with very large sample sizes 
(Blangero, 2004).  
 
Figure 1.7 Observed allelic frequency spectrum from 22 QTNs obtained from 7 different 
resequenced genes (Blangero, 2004). 
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1.5.2 The study of CNV in human traits and diseases 
1.5.2.1 Single causative CNVs in human traits and diseases 
The first attempt to link structural variants to human disease was made by Lupski et al in the 
early 1990’s. Their study revealed an association between a gene duplication on chromosome 
17p and a common inherited neurological disorder,  Charcot-Marie-Tooth (CMT) disease type 
1A (Lupski et al., 1991). However, the publication of that pioneering study was not without 
difficulty. Both Science and Nature rejected Lupski’s submission without even sending it out for 
review. At that time, “there was no appreciation that copy number was a mechanism of disease”, 
said Lupski (Cohen, 2007). This study finally appeared in Cell later that year.  
 
The study of association between gene copy number and CMT brought a refreshing new way of 
thinking to all geneticists. This discovery not only offered understanding to the etiology of the 
devastating disease but it also started the search for finding connections between genetic disease 
and a wider variety of genetic variation, which can be anything from a single base pair to very 
long stretches of DNA on chromosomes. This marked the opening of a new era in human 
genetics.  
 
Since then, alongside the progress of technology to detect structural variants, more and more 
scientific groups studied the CNV-disease association and several fruits were presented in this 
field. An important discovery of CNV association in 2005 should not be missed out here. 
Gonzalez et al. discovered significant interindividual and interpopulation differences in the copy 
number of a duplication influencing CCL3L1 gene, and found out lower copy of CCL3L1 was 
associated with higher HIV/AIDS susceptibility (Gonzalez et al., 2005). This became a classical 
example of CNV-disease association via gene dosage effect in the early years.  
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1.5.2.2 Genome-wide CNV association  
Genome-wide association studies (GWAS) have been proposed as a powerful strategy to detect 
potential genes which may account for complex disease outcomes or phenotypes. The first 
genome-wide association study was carried out in 94 myocardial infarction patients and 658 
controls, based on 92,788 SNPs (Ozaki et al., 2002). Two SNPs in the lymphotoxin-alpha (LTA) 
gene were found to be significantly associated with myocardial infarction. One of them has a 
functional impact on transforming amino acid residual from threonine to asparagine (Thr26Asn) 
while another in intron 1 of the LTA gene influences the level gene transcription. Since then, the 
number of GWAS has grown nearly exponentially. To date, dbGaP by NCBI (Database of 
Genotypes and phenotypes, http://www.ncbi.nlm.nih.gov/gap, last accessed in March 2011) 
categorized 5684 analyses on 124656 clinical variables from 132 studies.  Numerous novel 
genetic loci underlying disease susceptibility have been discovered, and many of these 
associations hold up to rigorous standards for replication. NHGRI’s ‘A Catalog of Published 
Genome-Wide Association Studies’ listed 817 publications which attempted to assay at least 
100,000 SNPs in the initial stage, as of the time of writing. In total, 3998 SNPs were reported to 
be significantly (P<10
-5
) associated with disease or disease-related traits (http://www.genome. 
gov/gwastudies/).   
 
A database called DECIPHER (Database of Chromosomal Imbalances using Ensembl Resources) 
was developed to catalog CNVs identified by array CGH which links to disease, using a variety 
of bioinformatics applications (https://decipher.sanger.ac.uk/application/syndrome/). To date, 59 
syndromes for over 4200 consented patients investigated in more than 150 institutions 
worldwide were categorized in DECIPHER. These diseases included Charcot-Marie-Tooth 
syndrome (CMT), Adult-onset autosomal dominant leukodystrophy (ADLD), Miller-Dieker 
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syndrome, Angelman syndrome and many more.  
 
SNP genotyping platforms are widely used to construct CNV genotypes that are used in 
association and linkage studies, to map chromosomal regions containing genetic variants account 
for complex phenotypes and diseases in GWAS. A number of studies have used SNP array to 
detect CNVs and performed association studies between CNVs and disease outcome. Table 1.4 
lists some CNV GWAS with positive results between 2005 and 2009. Only one association of a 
common CNV reached significance out of all the 26 studies (Bae et al., 2008); most studies with 
positive findings claimed a general enrichment of CNVs in cases, especially de novo or rare 
CNVs. It should be noted that although CNVs are ubiquitous in the human genome, the 
frequencies of this type of genetic variation are often observed to be low, therefore only a small 
portion of CNVs can reach acceptable marker allele frequency for GWAS. For the rare ones only 
the general enrichment could be tested; more analysis and experiments are needed to address the 
biological roles of each rare CNVs.  
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Autism spectrum disorders ascertainment neurexins Multiple CNVs Familial Affymetrix 10K Szatmari et al., 2007
ascertainment Multiple Multiple Multiple CNVs Case control Affymetrix 550K Glessner et al., 2009
ascertainment Multiple Multiple Multiple CNVs Case control Affymetrix 500K Marshall et al., 2008
16 16p11.2 Duplication
Schizophrenia ascertainment 22 22q11.2 Hemizygous deletion Case control Affymetrix 250K Bassett et al., 2008
acertainment Multiple Multiple Multiple CNVs Case control Affymetrix 5.0/6.0 ISC, 2008
acertainment Multiple Multiple Multiple CNVs Case control Illumina 550K Kirov et al., 2009
17 17p12 Deletion
22 22q11.2 Deletion
acertainment 11 chr11:112772031-112778135Deletions in this region Case control Illumina 550/610K Need et al, 2009
acertainment 1 1q21.1 de novo deletions Case control Illumina 300/550K,
Affy 6.0
Stefansson et al., 2008
15 15q11.2
15 15q13.3
Multiple Multiple Multiple CNVs Case control Affymetrix 250K Vrijenhoek et al., 2008
acertainment Multiple Multiple Novel SVs Case control Affymetrix 500K Walsh et al., 2008




acertainment Multiple Multiple Multiple CNVs Case control Affymetrix 6.0 Zhang et al., 2009
Autosomal recessive mental retardation ascertainment 8 TUSC3 Homozygous deletion Familial Affymetrix 250K Garshasbi et al., 2008
Amyotrophic lateral sclerosis acertainment Multiple Multiple Heterozygous deletion Case control Illumina 300K Blauw et al., 2008
Blepharophimosis-Ptosis-Epicanthus inversus syndrome ascertainment Multiple Multiple Multiple CNVs Patients Affy262K, Illumina
300/370K
Gijsbers et al., 2008
Myelodysplastic/myeloproliferative disease survival Multiple Multiple Multiple CNVs Case control Affymetrix 250K Gondek et al., 2008
ascertainment 4 TET2 Various deletions Patients Affymetrix 250K Langemeijer et al., 2009
acertainment 5 del(5q) Deletion Case control Affymetrix 50K Wang L et al., 2008
Multiple Multiple Multiple CNVs
Autosomal recessive juvenile nephronophthisis acertainment NPH1 Heterozygous deletion MR patients Affymetrix 100K Hoyer et al., 2007
Systemic lupus erythematosus acertainment 6 C4 Deletion Case control unkown Kamatani et al., 2008
Osteoporosis acertainment 4 4q13.2 Deletion Case control Affymetrix 500K Yang T et al., 2009
Acute myeloid leukemia survival Multiple Multiple Multiple CNVs Case control Affymetrix 250K Gondek et al., 2008
Subarachnoid aneurysmal hemorrhage acertainment 14 14q31.1 Heterozygous deletion Case control Illumina 300K Bae et al., 2008
Li-Fraumeni syndrome acertainment Multiple Multiple Multiple CNVs Case control Affymetrix 250K Shlien et al., 2008
Renal cell carcinomas expression level Multiple Multiple Duplication Gene expression Affymetrix 100K Cifola et al., 2008
Neuroblastoma expression level Multiple Multiple Duplication Gene expression Affymetrix 100K Fix et al ., 2008
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It can be predicted that resequencing studies will identify many variants, including rare variants 
of intermediate effect associated with common complex disease. This paradigm shift has already 
begun with the seminal work of Cohen et al., who compared non-synonymous sequence 
variations in individuals at the extremes of the population distribution of HDL-cholesterol levels, 
and determined that a significant fraction of genetic variance is due to multiple alleles with 
intermediate effects that are present at low frequencies in the population (Cohen et al., 2004). 
Furthermore, genotyping only the individuals with extreme phenotypic values is proved to 
greatly increase power while reducing cost, in linkage and association studies(Abecasis et al., 
2001). Romeo et al. has demonstrated that targeting extremes is a powerful strategy to identify 
rarer variants (Romeo et al., 2007). Until many more such studies are reported it would be 
premature to decide on the relative importance of the common variant-common disease model 
and the alternative rare variant-common disease model which states that disease susceptibility to 
common diseases is the result of multiple low frequency/rare variants with larger phenotypic 
effects. Although individually rare, these variants may be collectively common in the population 
(Cohen et al., 2004). 
 
1.5.3 The ways that CNVs influence phenotypic variation 
Genetic changes at the DNA level could alter gene expression and eventually confer phenotypic 
effects. CNVs discovered as deletions, insertions, duplications and complex multi-site variants 
often span thousands of base pairs, therefore they can potentially influence gene expression. 
Stranger et al. surveyed the impact of CNV on expression patterns by examining mRNA levels 
in lymphoblastoid cell lines from 210 HapMap individuals from four ethnic groups (Stranger et 
al., 2007), with knowledge of the CNVs from the same set of samples (Redon et al., 2006). Copy 
number changes were found to account for 8.75% of variation at expression levels of 972 genes. 
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Effects of some CNVs on gene expression were found in all four ethnic groups, while some were 
population specific. More than half of the expression probes associated with CNVs were away 
from the CGH clone harboring the CNV, some were as far away as 2Mb apart, indicating distant 
regulation (Stranger et al., 2007). The major molecular mechanisms suspected include: 1) gene 
dosage effect, 2) interruption of a gene, e.g. interrupting protein coding sequences, 3) 
influencing regulatory sequence, 4) gene fusion, 5) unmasking mutations or functional SNPs in 
the remaining allele. 
 
The effect of CNVs on dosage-sensitive genes is the most prominent. For instance gene copy 
number of the human salivary amylase gene (AMY1) can vary from 2 to 15. Populations which 
bear a diet habit to consume more starch were found to have higher AMY1 copy numbers. A 
correlation of levels of mRNA and AMY1 protein level for different copy numbers was observed; 
it was therefore argued that this CNV locus influence gene expression at both transcriptional and 
translational levels (Perry et al., 2007). 
 
CNVs may disrupt protein coding sequences of a gene to cause functional loss or modification 
of that gene.  One example comes from a schizophrenia study, where genome-wide CNVs were 
determined in cases and controls. Multiple CNVs were found to be enriched in schizophrenia 
patients, including a deletion of 400 kb in size which disrupts the ERBB4 (receptor 
tyrosine-protein kinase erbB-4) gene (Walsh et al., 2008).  cDNA ends amplification 
experiment confirmed absence of erbB-4’s  receptor intracellular kinase domain in the mutant 
transcript by the authors (Walsh et al., 2008).  
 
CNV can also have a long range position effect on gene expression. Velagaleti et al. discovered a 
pair of translocations whose breakpoints was 900 kb upstream and 1.3 Mb downstream of SOX9 
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gene, respectively, could cause compomelic dysplasia, a disease which has been proved 
previously to be associated with mutations within SOX9 (Velagaleti et al., 2005). 
 
Genomic rearrangements can cause fusion of different genes or their regulatory sequences, thus 
generating a gain-of-function mutation. This mechanism is prominently observed in cancers 
associated with specific somatic chromosomal translocations (Zhang et al., 2009), and also 
found in disease studies. Glucocorticoid-remediable aldosteronism (GDA) is an autosomal 
dominant disorder which has syndrome of hypertension with variable hyperaldosteronism. 
NAHR causes gene fusion of two GDA candidate genes on chromosome 8q, one encoding 
aldosterone synthase and another coding steroid 11 beta-hydroxylase. This fusion can account 
for hypertension in animals and humans (Lifton et al., 1992). 
 
Hemizygous deletion at a locus may diminish one allele and unmask another recessive allele or 
functional polymorphism. For example, the plasma coagulation factor 12 (FXII) is a gene that 
underlies Sotos syndrome. The activity of FXII is low in normal individuals but high in 
individuals who have a single deletion at this loci, remaining only one copy of FXII allele 
(Kurotaki et al., 2005).  
 
1.5.4 CNV and evolution 
CNVs can influence human traits and disease susceptibility, therefore they can be potentially 
exposed to selection pressure during evolution. Both positive and negative selection on CNV 




CNVs are usually found to be located out of functional sequences in human genomes, which 
suggests purifying selection on CNVs. Conrad et al. (2006) investigated the SNP density within 
deletions in coding sequence and introns, and observed a strong underrepresentation of SNPs in 
deletion regions compared with the HapMap average. Many of the genes containing deletions 
had disease-associated OMIM (Online Mendelian Inheritance in Man) entries (Conrad et al., 
2006). The gene-poor phenomenon in CNV regions and the lower number of deletions than 
duplications that overlap disease-related genes are also confirmed in a number of other studies 
(Nguyen et al., 2008; Redon et al., 2006).   
 
Gene duplication has long been considered to be a main mechanism driving positive selection. 
The variable copy of AMY1 in different human populations in response to changing diet is a 
good example (Perry et al., 2007), a duplicated gene and its regulatory elements could be 
modified for new functions, resulting diversification in a species.   
 
CNVs could also be under reduced purifying selection, resulting in more variants in nonessential 
genes. The frequency of neutral CNVs will fluctuate under genetic drift. There is good evidence 
suggesting that CNVs significantly enrich in regions with genes that respond to the environment, 
such as sensory perception and immunity (Redon et al., 2006). Such variants can arise and 
remain in the genome by reduced purifying selection as in an unstable or changing environment 







1.6 CNVs at familial and population level 
 
CNV should behave in just the same way as other genetic variants, in terms of segregation 
between individuals across generations. Redon et al. investigated heritability of 67 bi-allelic 
CNVs in 90 HapMap parents-offspring trios (30 trios each from three human populations). They 
showed only 0.2% of the CNVs exhibited Mendelian discordance; they argued the small 
proportion probably reflected genotyping error rate rather than the rate of de novo events at these 
loci (Redon et al., 2006). In a study of association between CNVs and schizophrenia, Xu et al. 
detected CNVs in parents-offspring trios in 200 affected families and 152 control families. Out 
of the total 11,268 unique CNVs identified, only 19 were de novo (Bademci et al., 2010; Xu et 
al., 2008). Due to the complex inheritance of CNVs, SNPs located within CNV regions often 
display inconsistency of Mendelian inheritance or are not in Hardy-Weinberg equilibrium. This 
special behavior of markers has been used to successfully identify polymorphic deletions and 
inversions (Conrad et al., 2006; Hinds et al., 2006; McCarroll et al., 2005). 
 
Studying CNV at population level is useful in a number of respects: first, recurrent CNVs 
detected in a large number of individuals can be used to construct a human CNV map; second, 
CNVs provide detailed information about haplotype structure that could facilitate the selection 
of tagging SNPs for use in association studies; last but not least, cataloging CNV frequency, 
distribution and map location between different populations may help geneticists to understand 
human migrations, recent natural selection and evolution of recombination hotspots. The 
HapMap data derived from samples from four ethnic groups (European, African, Asian-Chinese 
and Asian-Japanese) was first to be used to demonstrate variation of copy number at population 
level (Redon et al., 2006). Later on, a couple of studies extended high-resolution surveys of 
variation in genotype, haplotype and copy number to a wider range of human population groups. 
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Jacobsson et al. (2008) surveyed 396 CNV loci in a worldwide sample of 29 populations. They 
found the frequencies of CNVs were generally low (only one CNV frequency exceeded 10%), 
and CNVs private to one population were more common than private SNP alleles. Partial 
similarity was found between population structure inferred for CNVs and that inferred from SNP 
and haplotype data sets (Jakobsson et al., 2008). Li et al. discovered and characterized 3900 
CNVs from 985 Caucasians and 692 Asians. Many CNVs showed significant ethnic differences 
in frequencies (Li et al., 2009). However, comparisons of CNVs in multiple populations are still 
rare. First, there are few well designed population genetics studies, which have data available for 
CNV analysis and at the same time involve multiple populations with family information; 
second, the discrepancies in study design, platform choice and analytical methods between 
studies, leads to difficulties when merging CNV information from different studies each focus on 
different populations. Here, I take advantage of data collected from three different study cohorts, 
each from an isolate population, all with family data and all genotyped with the same SNP 
GWAS panel. This has allowed me to undertake a captive analysis of CNV frequency and 












1.7 Aims of this thesis 
 
The aim of this thesis is to a) address the advantages and limitations of current copy number 
variants (CNV) detection methods, b) apply and compare alternative calling algorithms for CNV 
detection in three European populations from Illumina 300K whole-genome genotyping data, 
and c) investigate association between CNVs and quantitative traits in the study samples. This 
thesis comprises the following experimental sections: 
 
In Chapter 3, I demonstrate the extent of copy number variation between individuals. Using 
downloaded information from five human individuals who had their genomes sequenced, I 
compared CNVs called directly from whole-genome sequencing data for these five genomes. I 
also examined the characteristics of these CNVs and discuss limitations of the methods which 
categorize CNVs from raw DNA sequence data. 
 
In Chapter 4, I investigate population level CNV profiles, drawing on published studies, 
focusing on those that detected CNVs from whole genome SNP genotyping data. A structured 
review was constructed to retrieve CNVs identified specifically in HapMap samples, from 
various types of genotyping platforms and using different calling algorithms. Two HapMap 
samples were in common to six of the identified studies and used to evaluate the impact of 
platform choice on CNV calling. Also the CNVs detected in SNP genotyping studies were 
compared against those identified by another physical mapping technique on the same 
individuals, to address the robustness and / or limitations of CNV detection methods using SNP 
genotyping data. 
 
Chapter 5 compares CNVs called by four different algorithms from whole-genome genotyping 
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data, for a subset of our study samples. The false positive and false negative rates of each 
algorithm were estimated from the extent of overlap in CNV detection and the relative 
performance of these four algorithms evaluated.  
 
In Chapter 6, CNVs of individuals from three European population isolates were determined, 
using algorithms chosen on the basis of method evaluation concluded in Chapter 5. The 
characteristics of these CNVs are described, and genetic difference at population level in context 
of copy number difference will be examined. Also I investigate the inheritance of CNVs with the 
knowledge of pedigree information for the three study populations. 
 
Chapter 7 comprises an analysis of association between CNVs and seven metabolic-related 
quantitative traits. The overall burden of CNVs on metabolic phenotypes is assessed. Regression 
analysis was performed for common CNV association and for the rare CNVs, to test whether 
there is an enrichment of rare CNVs in metabolic pathways in individuals with extreme trait 






























2.1 Study populations 
The study samples come from three population genetics projects: CROAS in Island of Vis, 
Croatia, ORCADES in Orkney Isles, UK and MICROS in South Tyrol, Italy, (Figure 2.1) which 
are under the banner of a large collaboration project, EUROSPAN.  
 
2.1.1 EUROSPAN 
The EUROSPAN project (http://homepages.ed.ac.uk/s0565445/index.html) was initiated in 2006 
and involves five population isolates from Italy (MICROS), Croatia (CROAS), Scotland 
(ORCADES), Sweden, and the Netherlands. The project aims at assessing the genetic structure 
of European isolates and at identifying genes underlying common traits, taking advantage of the 
genetic and environmental homogeneity that usually characterizes population isolates. In the 
current context, population isolates are "secondary isolates", i.e. groups that, for some reasons, 
detached or were detached from larger populations. In particular, EUROSPAN cohorts were 
derived from small population samples which have grown slowly, with little influx from outside 
the groups. 
 
As inclusion criteria these populations had to a) represent local populations occupying 
a well defined geographic area and have limited exchange with surrounding populations 
enabling the inclusion of large family groups, b) have historical records enabling their genealogy 
and migration patterns to be defined, c) span the geographic range and environmental diversity 
inhabited by European populations. The Scottish, South Tyrolean and Croatian populations are 
small populations founded by a limited number of individuals and/or have undergone a 









2.1.2 The Dalmatian samples: CROAS study 
The Croatian Anthropogenetic Study (CROAS) is funded by the Medical Research Council 
(MRC) and involves the Universities of Zagreb and Split, the Institute for Anthropological 
Sciences, Zagreb, the University of Edinburgh and the MRC Human Genetics Unit, Edinburgh. 
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The research focuses particularly on the isolated population on the island of Vis. Residents from 
the villages Komiza and Vis on Island of Vis were asked to volunteer and give their consent to 
take part in the study.  The Komiza survey was carried out in May 2003 and the Vis survey in 
May 2004. 1062 volunteers were recruited (584 from Komiza and 478 from Vis), which 
represented a very high proportion of the permanent resident adult population (65-70%). Data 
were successfully recorded for 1030 of these individuals. The volunteers ranged from 19 to 93 
years of age and all gave informed consent (426 males and 604 females). All participants were 
asked to give some basic family information, such as the names of their parents and any siblings. 
More extensive genealogical data were extracted from the Komiza and Vis parish registers which 
dated back to 1838. Using both sources of information, pedigrees were constructed. 134 
participants could be joined up into a single pedigree. 588 of phenotyped and genotyped 
individuals could be placed in 125 pedigrees, of which the largest pedigree links 134 individuals. 
The remaining individuals were singletons (those who were unable to be connected to any 
relatives).  
 
2.1.3 The Orcadian samples: ORCADES study 
The Orkney Complex Disease Study (ORCADES) is an ongoing, family-based, cross-sectional 
study that seeks to identify genetic factors influencing cardiovascular and other disease risk in 
the population isolate of the Orkney Isles in northern Scotland. The North Isles of Orkney, the 
focus of this study, consist of a subgroup of ten inhabited islands with census populations 
varying from ~30 to ~600 people on each island. The North Isles have experienced a period of 
severe population decline over the last 150 years, fueled by high emigration and low fertility. 
The population fell from an estimated peak of 7700 in the 1860s to 2217 by 2001. Endogamous 
marriage was widespread during the nineteenth century and into the twentieth century. The 
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combined effects of steep population decline and endogamy have led to inflated levels of 
parental relatedness in the current population. Data collection was carried out in Orkney between 
2005 and 2007.  
 
2.1.4 The South Tyrolean samples: MICROS study 
Samples from South Tyrol were collected as part of the Genetic Study of Three Population 
Microisolates in South Tyrol (MICROS) from settlements in Venosta Valley. The MICROS study 
was an extensive survey carried out in Val Venosta (South Tyrol, Italy) in 2001. Participants 
were from three isolated villages located in the Italian Alps, in a German-speaking region 
bordering with Austria and Switzerland. Due to geographical, historical and political reasons, the 
entire region experienced prolonged isolation from surrounding populations. Information on 
participants’ health status was collected through a standardized questionnaire. Laboratory data 
were obtained from standard blood analyses. Initially 1175 people were enrolled in the study, 
which has subsequently risen to approximately 1400.  
 
2.2 Ethical approval and consent 
 
Ethical approval was given for the patient recruitment in Vis, Orkney and South Tyrol by the 
relevant Research Ethics Committee of the Faculty of Medicine, University of Zagreb, Croatia 
and Local Research Ethics Committee of NHS Lothian; the Local Research Ethics Committee of 
NHS Orkney and the North of Scotland Research Ethics Committee in Aberdeen; and the Local 
Research Ethics Committee South Tyrol, respectively. In all three sites, volunteers gave written 
informed consent to all parts of the study, with the research medical doctors or research nurse or 
research co-ordinator present to answer questions. They were made aware that they need not 
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take part in all parts of the study and were free to withdraw at any time without consequences for 
them. In Orkney and Tyrol, volunteers chose whether to consent to their family doctor being 




Clinical history questionnaires were filled out and core quantitative traits were measured for 
participants in Vis and Orkney. Clotted blood was obtained and the following traits were a subset 
of those measured: height, weight, body mass index (BMI), waist and hip circumference, 
subscapular skinfold thickness and suprailiac skinfold thickness. Levels of fasting fasting 
glucose and insulin were measured in the NHS Orkney laboratories and laboratory of Dr Salzer 
from the University of Zagreb, for Orcadians and Dalmatians, respectively.   
 
2.4 Genotyping 
Fasting blood samples were taken from all participants (EDTA blood to be used for DNA 
extraction and clotted blood for serum biochemistry). DNA samples were genotyped according 
to the manufacturer's instructions (http://www.illumina.com/) on Illumina Infinium 
HumanHap300v1 for Dalmatian samples and on Illumina Infinium HumanHap300v2 for 
Orcadians and South Tyroleans, by technicians at the Wellcome Trust Clinical Facilities in 
Edinburgh (for Vis and Orkney samples) and University of Lübeck in Germany (for MICROS 
samples). The first and second version of HumanHap 300 arrays had 317,525 and 318,235 SNPs, 
respectively. SNPs with >10% missing genotypes were excluded. After data cleaning, 308,300 
and 318,237 autosomal SNPs remained for version 1 and version 2 arrays, respectively.  
 
Samples in Vis and Orkney with a call rate below 95% and those in South Tyrol with a call rate 
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below 98% were excluded from the analysis. Sex checking was performed with PLINK, and 
individuals with discordant pedigree and genomic data were removed. In total, on completion of 
data-cleaning and quality-control procedures, SNP genotyping data from a total of 2861 
individuals from three populations were available.  
 
2.4.1 Infinium II Whole Genome Genotyping Assay  
The Infinium
TM
 II Assay enables flexible SNP selection using a tagSNP content strategy and 
provides even coverage across the genome (http://www.illumina.com/). The Infinium
TM
 II 
procedure takes three days to complete and has four automated steps that are all performed on a 
Tecan robot system: (1) whole genome amplification, (2) hybridization to an oligonucleotide 
probe array (performed offline in a hybridization oven), (3) array-based SNP scoring assay, and 
(4) signal amplification. For the Infinium II assay, one bead type is used per SNP and the alleles 
are scored by SBE (Single-Base Extension) using differentially-labeled terminators (Figure 2.2).  
 
Illumina manufactures several high density tag SNP genotyping arrays including Sentrix® 
HumanHap300 BeadChip. BeadChips are constructed by random assembly of bead pools into 
micro-well patterned stripes on a silicon substrate.  
 
Each stripe is loaded with a unique bead pool composed of tens of thousands of different bead 
types for a total complexity of hundreds of thousands of bead types across the BeadChip. Each 
bead type is immobilized with a decoding sequence and a locus-specific 50-mer oligonucleotide 
probe. The identity is determined by a hybridization-based decoding procedure. These 
BeadChips utilize the single-base extension (SBE) Infinium II assay to genotype tag SNPs 
selected from Phase I and II of the HapMap project. The median SNP spacing on the 
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HumanHap300 is 5 kb and the HumanHap550 is 2.8 kb, enabling an effective resolution of ~50 
kb and ~28 kb (10 SNP smoothing), respectively. (Gunderson and Peiffer, 2006) 
 
2.4.2 BeadChip Imaging 
After completion of the assay, the BeadChips are scanned with a two-color confocal Illumina 
BeadArray™ Reader at a 0.84–1.0-µm pixel resolution. Image intensities are extracted and 
genotypes are determined using Illumina’s BeadStudio software. Aberrations were detected by 
visualizing SNP-CGH data in the Illumina Genome Viewer and Chromosome Browser. 
 




2.4.3 Analyzing SNP-CGH Data in BeadStudio 
Genotyping data consist of two channel intensity data corresponding to the two alleles, allele A 
and allele B. The raw intensity of allele A and B (X and Y, respectively) of each SNP are 
imported to BeadStudio software (Illumina Manual 1) and normalized using a proprietary 
algorithm. The normalized X and Y are then combined as raw A versus raw B allele intensities to 
produce a value called “normalized R”. 
 
Next, the normalized R intensities were compared to 120 normal reference HapMap individuals 
with GenTrain software. Finally, the data were converted to polar coordinates R and Theta (Fig. 
2.3). Theta (θ) represents the angle deviation from pure A signal, where 0 represents pure A 
signal and 1.0 represents pure B signal. It can be calculated by the equation: θ= (2 / ∏)* 
arctan(B/A). Each genotype has a specific expected cluster position from the reference data set 
as in figure 2.3. Each SNP genotype of each individual was determined according to its relation 
to these clusters. Values which lie between these clusters were discarded and labelled as NC (no 
call). Theta was then transformed to allele frequency (e.g. B Allele Frequency), which is more 
discriminative, using linear interpolation of the canonical clusters (Gunderson and Peiffer, 2006).  
Figure2.3 Polar plotting of genotyping clusters.  The AA genotype lies near the zero theta 
value and BB near theta of 1, with AB in between both genotypes. The yellow dots indicates an 




2.5 CNV detection 
Copy number variation was determined for study samples using genotyping data on the Illumina 
platforms. Log R ratio (LRR) and B allele frequency (BAF) at each SNP loci are two important 
types of values for CNV detection. LRR and BAF information was analyzed with various 
methods in the current study, which included Hidden Markov Model (HMM) based algorithms 
QuantiSNP and PennCNV, and Circular Binary Segmentation (CBS) based algorithms DNAcopy 
and cnvPartition. QuantiSNP, cnvPartition and DNA copy were run on a desktop computer with 
a 2.76GHz processor and 4GB of RAM. PennCNV were performed on a computer of 1.77GHz 
processor and 3GB of RAM.  
 
2.5.1 Log R Ratio and B Allele Frequency 
The comparison of normalized intensities between a reference and subject sample is the 
foundation of traditional array-CGH. SNP-CGH is different in that a combination of two 
genotyping parameters is analyzed: normalized intensity measurement and allelic ratio. 
Collectively, these parameters provide a more sensitive and precise profile of chromosomal 
aberrations.  
 
Illumina has developed two modes of SNP-CGH analysis. The first is a single sample mode in 
which reference values are derived from canonical genotyping clusters created from clustering 
on normal reference samples. This mode is often used in general copy number detections, and is 
the mode chosen for the analysis in this thesis. The second is a paired sample mode in which 
direct intensity comparisons between a subject sample and its corresponding matched pair are 
performed. This mode is often applied in copy number change discoveries in paired tumor and 
normal samples. 
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Normalized intensity measurement, log R ratio (LRR), and allelic ratio, B allele frequency 
(BAF), are two key parameters to be considered in detecting chromosomal aberrations. LRR is 
the log, base 2, of the normalized signal intensity (Normalized R) of subject versus normalized 
signal intensity (Normalized R) of the reference. An LLR value of zero indicates no difference 
between individual and reference values. A significant departure from the zero value is an 
indicator of copy number changes (a gain if the R ratio is greater than one and a loss if the R 
ratio is less than one). BAF is the ratio of intensity at the B allele versus that at the A allele; for 
example BAF of 0 indicates an absent B allele at this locus (genotype AA or A_ etc.). The 
combination of the two parameters provides information to predict copy number change (Figure 
2.4): LRR indicates overall copy number of alleles at a locus and BAF indicates which allele is 
deleted or amplified. The effect size that is required to depart from normality is not a constant; it 
changes with different numbers of the SNPs involved in a specific window size. 
Figure 2.4 Shift in log R ratio (LRR) and B allele frequency (BAF) value plots infer copy number change. 
LRR (top) and BAF (bottom) plotted from one individual for each SNP on chromosome 18. A deletion on 
the q arm can be identified by the shift in the LRR downwards and the loss-of-heterozygosity indicated by 
the disappearance of heterozygous state (0.5) in the BAF (as indicated by the area within the red rectangle). 
Chromosome location coordinates in hg18 (Build 36). 
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2.5.2 Hidden Markov Model based CNV detection algorithms 
 
2.5.2.1 Markov Chain and Hidden Markov Model 
A Markov Chain, named after Russian mathematician Andrey Markov, is a discrete random 
process with the Markov property. A discrete random process is a system which can be in 
various states, and which changes randomly in discrete steps. The random process has the 
Markov property if the conditional probability distribution of future states in the process depends 
only upon the present state, in other words, given the present, the future only depends on the 
present state but does not depend on the previous states (Rabiner, 1989).  
 
Since the Markov property is a simple and mathematically tractable relaxation of the assumption 
of independence, it is natural to consider discrete-time Markov Chains on a finite state space as 
possible models for sequential data, which are not independent from each other, in that space. 
 
The Markov Chain can be represented in terms of a graphical model, as shown in Figure 2.5 
Each node represents a random variable, and the edges indicate conditional dependence structure. 
X0, X1, … Xn-1, Xn are a sequence of random variables on a Markov Chain, which are all with the 
Markov Property; i.e. given the present state, the future and past states of each variable are 
independent: 
                                                                       
The behaviour of a Markov Chain resembles a random walk on the graph shown in Figure 
2.5.The possible values of Xi comes from a finite set S, which is called the “state space” of the 
chain. The changes of state on the chain are called transitions (represented by the horizontal 
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arrows in Figure 2.5.), and the probabilities associated with various state-changes are called 
transition probabilities. The transition probability matrix of the Markov Chain is denoted as Τ. 
Suppose X0  is drawn from a distribution λ. Initially X0 is chosen according to λ at that state Sx0; 
at time t the current position is Sxt. From any position (state) there are two possible transitions, 
either to the next integer or to the previous integer. The transition probabilities at Sxt, denoted as 
Txt (the Xt-th row of the transition matrix Τ), depend only on the current state; therefore the 
values of Xt-1 and Xt+1 are chosen only with respect to Txt, regardless of any prior positions.  
 
Figure 2.5 Graphical illustration of a Markov Chain 
 
λ and Τ are important parameters of a Markov Chain, by studying λ and Τ one can identify 
many properties of Markov Chain. For example, the distribution of X0 is determined by λ, while 
the distribution of X1 is determined by λTx1, etc.  
 
In statistics, a Hidden Markov Model (HMM) describes a probability distribution over a 
potentially infinite number of sequences. The name ‘Hidden Markov Model’ comes from the fact 
that the state sequence is a first-order Markov chain, but only the symbol sequence is directly 
observed. It is an extension of a Markov Chain which is able to capture the sequential relations 
among hidden variables.  
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Figure 2.6 Graphical illustration of a Hidden Markov Model 
 
The illustration of a HMM is shown in Figure 2.6. X0, X1, … Xn-1, Xn  is a Markov Chain and at 
time t, for t=0,1,…,n. Yt is independent of all other variables given Xt. From the graphical model 
for HMM, we can easily see the conditional independence structure of all variables (X0 ,Y0),…, 
(Xn ,Yn). Here the observed sequences Y0, Y1,…,Yn-1, Yn  are influenced by a hidden Markov chain 
X0, X1, … Xn-1, Xn ; and the observed sequences are used to infer the hidden sequences. The 
horizontal arrows represent state transition on the Markov Chain. The vertical arrows represent 
the relationships between each pair of Xt and Yt , called emission probability. The emission 
probability matrix is denoted as Γ (Zhang 2008). 
 
HMM is widely applied in the detection of copy number variation from genotyping data. 
Theoretically, information at each SNP loci along the chromosomes can be considered as a node 
from a sequence of data. The hidden state is the true copy number of the individual’s genome; 
the observed states are the normalized intensity measurements of each probe on the array (Figure 
2.7). The emission probability of allelic intensities for an underlying hidden state of 2 copies 
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(normal state), <2 copies (copy number loss) and >2 copies (copy number gain) is modelled and 
the modelling parameters are determined from calculations which are based on a training set of 
data. The transition probabilities between underlying copy number states is asserted such that 
transitioning out of a state reflecting 2 copies is low, while transitioning within the same state or 
returning to normal copy number is relatively high. 
Figure 2.7 HMM modelling in detection of copy number variation 
 
2.5.2.2 QuantiSNP: 
QuantiSNP is an analytical tool to analyze copy number variation using whole genome SNP 
genotyping data. It was originally developed for Illumina arrays, but later versions of this 
software support Affymetrix data with additional data conversion steps (Collella et al., 2007).  
QuantiSNP uses an Objective Bayes Hidden-Markov Model (OB-HMM) to automatically infer 
regions of segmental copy number abnormalities from genotyping data. The OB-HMM is 
claimed to be highly suited to the analysis of high-throughput genomic data when one of the 
hidden states has special status as a ‘null’ or normal state, in which case OB-HMM allows for 
setting of parameters which ensure certain frequentist coverage properties for excursions of the 
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model out of the null state, while benefiting from Bayesian marginal inference.  
 
Six hidden states used in HMM for QuantiSNP are listed in Table 2.1. A priori probability that 
hidden state change occurs between adjacent SNP loci (the transition probability) is defined by 
an exponential function. The emission probabilities that a set of LLR and BAF values of a SNP 
predict hidden states of the same SNP are defined as a mixture of Gaussian and uniform 
distributions. Most of the hyper-parameters in the above model are estimated via maximum 
marginal likelihood techniques on a training data set, then a expectation maximization (EM) 
algorithm is used to find maximum marginal a posteriori estimates for the parameters of the 
emission distributions, followed by a Viterbi algorithm which to compute the sequence of hidden 
states with highest probability. After corrected for type I error and multiple sample influence, the 
copy number of a DNA segment is determined with a Bayes Factor (BF), which is a 
measurement of confidence of the region being in hidden state in comparison to all other 
sequences in which no part of this region is in this hidden state. The higher BF indicates 
significance of events (Collella et al., 2007) (Table 2.2).  
 
Table 2.1 Hidden states, associated copy numbers and biological interpretation 
Each hidden state z is associated with a given copy number c(z) and genotype number K(z). For 
each copy number there can be a number of genotypes. For example, for copy number3 there can 
be one of four genotypes {AAA, AAB, ABB, BBB}. The genotype number gives the number of 




Table 2.2 Combination of LRR and BAF indicates six hidden states of copy number 
 
 
QuantiSNP version 1.0 (Windows command line based) was downloaded from http://www. 
well.ox.ac.uk/~ioannisr/quantisnp/ after a licence agreement signed between University of 
Edinburgh Medical Genetics Section and University of Oxford, in 2008. Copy number analysis 
was carried out in QuantiSNP following instructions described in the user manual (Yau 2007). 
LLR and BAF data for each individual in the study sample were exported from BeadStudio and 
processed with R software. Individuals with standard deviation of LLR>0.3 were excluded. 
Parameter settings for QuantiSNP analysis were set as: defined length of a CNV—no more than 
3,000,000 bp; maximum number of optimisation steps of expectation maximisation—25; 
correction for local GC content—yes; array data library—Illumina HapMap 550K (which is 
compatible with HapMap 300K array). After calculation, QuantiSNP outputs a list of CNVs with 
chromosomal location, assigned copy number and a Log Bayes Factor (LBF) for each detected 










































PennCNV is also an algorithm based on HMM. It was originally designed for Illumina assays, 
the later versions also support data from Affymetrix platforms. It incorporates multiple sources 
of information, including LRR and BAF at each SNP marker, the distance between neighbouring 
SNPs, the allele frequency of SNPs, and family trio information where available.  
 
The modelling of six hidden states in CNV is the same as that in QuantiSNP (Table 2.1 and 
Table 2.2). The first-order HMM is used to predict copy number states at each SNP. The 
emission probabilities are underlined as that a set of LLR and BAF values of a SNP predicts 
hidden states of the same SNP. These are defined in a manner very similar to that in QuantiSNP, 
but uses uniform distribution to model both random fluctuation of signal measures in chemical 
assays and the possible genome misannotation and misassembly. The modelling and 
interpretation of LRR and BAF values for chromosome X is treated differently, because of the 
hemizygous state in males. The transition probability of hidden states is constructed differently 
from that in QuantiSNP, which incorporates unknown parameters to be resolved by a HMM 
learning process using the Baum-Welth algorithm. The Viterbi algorithm is used to infer the 
most likely path (state sequences for all SNPs along each chromosome) (Wang et al., 2007). 
PennCNV has a module to validate CNVs detected in the former steps using family information, 
specifically the parent-offspring trio information. However, only a small fraction of the 
individuals in the study sample (10.13%) could be placed in family trios. Also this process takes 
5*5*5 CNV matrices to compute and is time consuming. For these reasons this module was not 




PennCNV was downloaded from http://www.openbioinformatics.org/penncnv/. To create a Perl 
environment on Windows system for PennCNV to be performed, ActivePerl was downloaded 
from http://www.activestate.com/activeperl and installed. CNV detection with PennCNV used 
individual LRR and BAF files exported from BeadStudio, and the analysis was performed 
following PennCNV tutorial (http://www.openbioinformatics.org/penncnv/penncnv_beadstudio_ 
tutorial.html). CNVs containing ≤2 SNPs were excluded. 
 
2.5.3 Circular binary segmentation based CNV detection algorithms 
 
2.5.3.1 Circular binary segmentation  
Circular binary segmentation (CBS) is a modified version of binary segmentation method to find 
change points in a sequence of data. For example, it can be applied in aberrant DNA copy 
number detection with chromosomal SNP genotyping data. It allows for tertiary splits by 
connecting the two chromosomal ends (thus called “circular”) (Olshen et al., 2004). 
 
CNVs occur in contiguous regions of the chromosome that often cover multiple markers. The 
markers within a CNV region display aberrant copy number (normal copy number=2); therefore 
the beginning and ending of this region are “change points” on the chromosome underlying 
change of copy number status in the region compassed by the two change points. The CBS 
algorithm provides a natural way to segment a chromosome into contiguous regions and 
bypasses parametric modelling of the data with its use of a permutation reference distribution. 
The SNP array data to be used for change-point detection are the log ratio of normalized 
intensities indexed by the marker locations. There may be multiple change-points in a given 
chromosome, each corresponding to a change in the copy number in the test sample 
 72
(Venkatraman and Olshen, 2007a). The goal of CBS is to identify all the change-points which 
will then partition the chromosome into segments where copy numbers are constant. Once the 
chromosome is partitioned the copy numbers of the segments can be estimated with the help of 
additional information. This will provide the locations of copy number aberrations. 
 
2.5.3.2 DNAcopy 
DNAcopy is a non-parametric method which is based on circular binary segmentation (CBS). It 
splits the chromosomes into contiguous regions of equal copy number by modeling discrete copy 
number gains and losses. Using a permutation reference distribution, it bypasses parametric 
modeling of the data for assessing significance of the proposed splits. The model selection is 
done in the forward way by repeatedly splitting each contiguous segment until no significant 
splits are found, using a maximal t-statistic with a permutation reference distribution to assess 
statistical significance of differences in the LRR values within a segment compared to those in 
the adjacent segments. The computational time required for permutation is exponentially 
correlated with number of markers considered. To tackle the problem of long computational time 
when applying CBS to high-density array data, two speed enhancements to the original CBS 
algorithm are incorporated in DNAcopy: 1) a hybrid approach for the computation of the p-value 
of the maximal t-statistic using a tail probability approximation for the maximal of a Gaussian 
random field; 2) a sequential testing approach for deriving a stopping rule that reduces the 
number of permutations when there is strong evidence for the existence of a change-point. 
DNAcopy outputs the predicted mean LRR of each predicted segment. Because only LRR are 
used in the detection, no specific copy numbers can be assigned for each predicted segment; the 
segments are thus generally classified as “copy number gains” and “copy number losses”.  
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DNAcopy version 1.12.0 was downloaded from http://www.bioconductor.org/packages/ 
2.3/bioc/html/DNAcopy.html. It was installed and run under the R environment. The analysis 
was performed according to the user manual (Venkatraman et al. 2007b). A smoothing step was 
implemented before segmentation.  
 
2.5.3.3 cnvPartition 
The cnvPartition algorithm quickly scans genotyping data sets to identify the existence and 
location of copy number aberrations. This algorithm is best conceptualized as two modules: one 
for breakpoint identification, and another for assigning copy numbers to the regions lying 
between these breakpoints (Illumina Manual 2).  
 
The breakpoint detection module is similar in style to the circular binary segmentation algorithm 
for copy number analysis, but processes samples at a faster rate. For breakpoint detection, two 
hypothetical breakpoints are placed at the 5’ and 3’ ends of a chromosomal region, respectively. 
The algorithm then tries to find one internal breakpoint such that the mean log R ratio between 
the breakpoints is maximally different from the mean LRR on either side of the breakpoints. 
Then, maximal binary splits are determined on both sides of the first single breakpoint in the 
hypothetical region, resulting in the labeling of two more putative breakpoints. The segment 
between two of the 5 breakpoints described above which has the highest difference in LRR 
compared to other segments is identified as a putative chromosomal aberration. Once a putative 
aberration is identified, the significance of its splits is assessed and a confidence score is given 




Following partitioning, copy number estimates are assigned to each identified segment. The first 
step is to compute the median of the segment’s LRR and their robust standard deviation (median 
absolute deviation—MAD). If a segment’s LRR estimate is more than a threshold value 
specified by the programme, it is called a copy number gain, otherwise it is called a copy 
number loss. This is followed by the discrimination between single-copy and homozygous 
deletions using BAF. Specifically, the number of SNPs in this region which have extreme BAF 
values (<0.25 or >0.75) is determined. If this number is greater than what would be expected by 
chance (p < 0.01, sign test), the segment is assigned a copy number of one; otherwise it is 
assigned a copy number of zero. 
 
cnvPartition 1.0.2 as a plug-in for BeadStudio (Illumina Manual 3) was downloaded from 
Illumina Connect website at http://www.illumina.com/software/illumina_connect.ilmn and 
installed on BeadStudio platform. The parameter settings applied for the CNV analysis were: 
minimum probe count (the minimum number of SNPs to define a CNV): 3, because CNVs 
containing ≤2 SNPs are more likely to contain a high fraction of false positives; detect extended 
homozygosity: true; minimum homozygosity region size: 10 Mb; confidence threshold: 35. The 
programme gave an output of a list of detected CNVs with their chromosomal locations, 
estimated copy number and confidence score for each putative CNV. The CNVs with confidence 
score <35 were excluded. 
 
2.6 Data cleaning 
 
SNP coverage in centromeric regions is very low, thus CNVs called in these regions are much 
more likely to represent false positive calls. For this reason all the CNVs spanning centromeres 
were excluded from the analysis (according to the coordinates of centromeres on each 
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chromosome). CNVs on chromosome X and chromosome Y were excluded due to the 
complications of hemizygosity in males and X-chromosome inactivation in females. CNVs 
represented by a single SNP were excluded. It is decided that a CNV region detected by any 
method based on genotyping array data must span at least two markers; therefore any CNV 
reflecting only one marker (length of 1bp) was excluded. 
 
The Croatian samples were genotyped on an earlier version (V1) of the Illumina HumanHap 
300K platform which were designed based upon the Human May 2004 (hg17) sequence 
assembly, while the Orcadian and South Tyrolean samples were genotyped Illumina HumanHap 
300K V2 platform based upon the Human March 2006 (hg18) assembly. To match the single 
Orcadian sample with the Croatian data, the coordinates of each CNV detected for the Orcadian 










































Completion of the first finished sequence of human genome, a global collaboration of scientists 
under the banner of International Human Genome Project (Human Genome Sequencing 
Consortium, 2004; Human Genome Sequencing Consortium, 2001), was a major technical 
achievement that provided a common start point for a wide range of basic science, biology and 
medicine.  It was achieved through automated Sanger sequencing, a robust but relatively costly 
and time consuming chemistry for genome analysis.  Once the first consensus human sequence 
was assembled, acquiring complete new human genome sequence was much easier and faster, 
but still costly and unaffordable on a large scale (Human Genome Sequencing Consortium, 2004; 
Levy et al., 2007). Over the past five years, the technical advances in nucleotide chemistry 
combined with array based methods for templating target sequences, plus massively parallel, 
detection of sequence reactions  have led to a revolutionary shift in genome sequencing , so 
called next-generation sequencing (NGS). NGS platforms include Roche 454, Illumina 
GenomeAnalyzer, Life Technologies SOLiD, Helicos Bioscience HeliScope and Complete 
Genomics. As of February, 2011, at least 33 individual genomes have been fully sequenced 
(Table 4.1), one of which was sequenced twice on two different platforms (Bentley and et al., 
2008; McKernan et al., 2009).  
 
One valuable application of massively parallel sequencing is variant discovery by sequencing 
targeted regions of interest or whole genome. Those genetic variants include single nucleotide 
variants (SNV) and structural variants (SV). To identify SVs using NGS platforms, two 
categories of computational approaches have been developed. The first category are based on 
paired-end read mapping/paired-end read sequencing/end-sequence profiling (PEM/PES/ESP), 
which detects insertions and deletions by comparing the distance or orientation between mapped 
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read pairs to the average insert size of the genomic library (Koboldt et al., 2010). The second 
category detects discrepancies of read depth (RD) between sample genome and reference 
genomes for a DNA fragment, to determine events with either increased or decreased copy 
number (Yoon et al., 2009). In addition to SNV discovery, most of the published individual 
genome sequencing studies has utilized either PEM or RD methods to investigate SV of the 
study genome(s) (Table 3.1). 
 
Whole genome sequencing enables detection of SVs with essentially single base resolution, 
substantially higher resolution than achievable by Comparative Genomic Hybridization (CGH) 
or Single Nucleotide Polymorphism (SNP) genotyping platforms. It is also able to detect 
copy-invariant structural variants, such as inversions, and can pin point structural break-points, 















Table 3.1 Complete individual genomes sequenced on massively parallel sequencing platforms, and the CNVs detected from sequencing data  
 
‘Sequencing Platform’: Illumina GA--Illumina Genome Analyzer.’SNPs’ indicates the number of single nucleotide polymorphisms called, excluding small indels. ‘dbSNP’ 
indicates the proportion of SNPs that were present in dbSNP build 126 or later. ‘Definition of CNV’ indicates what the authors define as a CNV in each study; if such 
definition is absent in the article but CNVs recorded in DGV, the DGV deification of a CNV (1kb-3Mb) is used.  ‘num CNVs by sequencing’ indicates total number of 
CNVs detected from sequencing data (validated and unvalidated), with definition of a CNV by author for the according study. 

















Hemo0001 European Male Hemophilia A Pelak et al. 2010 Illumina GA 2×25 30.4× 3.38 88 >2kb read depth 746
Hemo0004 European Male Hemophilia A Pelak et al. 2010 Illumina GA 2×25 23× 3.29 88 >2kb read depth 788
Hemo0005 European Male Hemophilia A Pelak et al. 2010 Illumina GA 2×25 36.2× 3.39 88 >2kb read depth 847
Hemo0006 European Male Hemophilia A Pelak et al. 2010 Illumina GA 2×25 51× 3.46 88 >2kb read depth 863
Hemo0007 European Male Hemophilia A Pelak et al. 2010 Illumina GA 2×25 34.2× 3.37 88 >2kb read depth 847
Hemo0011 European Male Hemophilia A Pelak et al. 2010 Illumina GA 2×25 31.6× 3.27 88 >2kb read depth 918
Hemo0017 European Male Hemophilia A Pelak et al. 2010 Illumina GA 2×25 33.4× 3.47 88 >2kb read depth 770
Hemo0019 European Male Hemophilia A Pelak et al. 2010 Illumina GA 2×25 20.2× 3.29 88 >2kb read depth 823
Hemo0020 European Male Hemophilia A Pelak et al. 2010 Illumina GA 2×25 36.4× 3.44 88 >2kb read depth 776
Hemo0022 European Male Hemophilia A Pelak et al. 2010 Illumina GA 2×25 38.7× 3.40 88 >2kb read depth 884
Control 1 European Female Epilepsy Pelak et al. 2010 Illumina GA 2×25 32.3× 3.58 88 >2kb read depth 739
Control 2 Hispanic American Male Epilepsy Pelak et al. 2010 Illumina GA 2×25 28× 3.74 85 >2kb read depth 782
Control 3 European Male Control Individual Pelak et al. 2010 Illumina GA 2×25 23.6× 3.36 88 >2kb read depth 819
Control 4 Hispanic American Male Schizophrenia Pelak et al. 2010 Illumina GA 2×25 30.5× 3.66 87 >2kb read depth 765
Control 5 European Male Schizophrenia Pelak et al. 2010 Illumina GA 2×25 27.4× 3.42 89 >2kb read depth 814
Control 6 African American Male Schizophrenia Pelak et al. 2010 Illumina GA 2×25 24.9× 4.02 78 >2kb read depth 809
Control 7 European Male Extreme Memory Pelak et al. 2010 Illumina GA 2×25 23.3× 3.40 88 >2kb read depth 822
Control 8 European Male Extreme Memory Pelak et al. 2010 Illumina GA 2×25 26.9× 3.42 88 >2kb read depth 790
Control 9 European Female Cold Urticaria Pelak et al. 2010 Illumina GA 2×25 29× 3.58 88 >2kb read depth 760
Control 10 European Female Metachondromatosis Pelak et al. 2010 Illumina GA 2×25 31.4× 3.54 88 >2kb read depth 743
Lupski European Male CMT Lupski et al.  2010 Life SOLiD 2×25~50 29.6× 3.42 83 N.A. PEM 84
NA07022 European (CEU) Male N.A. Drmanac et al.  2010 Complete Genomics 2×35 87× 3.08 90 N.A. PEM 2125
NA19240 African (YRI) Male N.A. Drmanac et al.  2010 Complete Genomics 2×35 63× 4.04 81 N.A. none none
NA20431 
(Church)
European  Male none Drmanac et al.  2010 Complete Genomics 2×35 45× 2.91 90 N.A. none none
ABT African Male N.A. Schuster et al.  2010 Life SOLiD 2×25 30× 3.62 89 N.A. none none




NA18507 African (YRI) Male N.A. McKernan et al.  2009 Life SOLiD 2×25 18× 3.87 81 100bp-100kb PEM 4660
P0 (Quake) European Male none Pushkarev et al.  2009 Helicos 1×70 28× 2.81 76 >1kb read depth 752
AK1 Asian (Korean) Male N.A. Kim et al.  2009 Illumina GA 2×106 28× 3.45 83 duplication only PEM 24
SJK Asian (Korean) Male N.A. Ahn et al.  2009 Illumina GA 1×75 29× 3.44 88 0.1-100kb PEM 3335
YH (Wang) Asian (Chinese) Male N.A. Wang et al.  2008 Illumina GA 2×35 36× 3.07 86 >100bp PEM 2682
Watson European Male none Wheeler et al.  2008 Roche/454 1×250 7.4× 3.32 82 1kb-3Mb N.A. 602
NA18507 African (YRI) Male N.A. Bentley et al.  2008 Illumina GA 2×35 41× 3.45 74 50bp-35kb read depth 5704
Venter European Male N.A. Levy et al.  2007 Shotgun 1×800 7.5× 3.07 95 N.A. N.A. 666
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Copy number variation, structural variants of median length (1kb to 3Mb), has been intensively 
studied in recent years. However, CNV detection from SNP genotyping suffers from limited SNP 
coverage in most SNP genotyping platforms and lack of (a) robust algorithm(s) for detection, 
resulting in high error rates and poorly assayed regions of the genome. Some basic but important 
features of CNVs including breakpoint definition and chromosomal distribution are inadequate 
or partial. A complete map of all CNVs from individual genomes would be a valuable resource 
to catalogue Copy Number Polymorphism (CNP) and to understand the origin and formation 
mechanism with the knowledge of genomic features within and spanning CNV regions. 
Although CNVs were reported in most individual whole genome sequencing studies, parallel 
comparisons of CNVs with other studies and with the CNVs in public databases were only 
mentioned briefly in a few of them (Schuster et al., 2010; Wang et al., 2008). 
 
In this Chapter, I describe a) how I brought together CNVs directly and unambiguously called 
from whole genome sequencing data from all available published resources, b) compared the 
distribution and other features of deletions in five individual genomes of three ethnic origins 
(European, African and Asia), in the aim of revealing the difference of panorama CNV make up 










3.2 Materials and Methods 
 
3.2.1 CNV data 
Whole genome CNVs called from sequencing data, from 12 published studies (Ahn et al., 2009; 
Bentley and et al., 2008; Drmanac et al., 2010; Kim et al., 2009; Levy et al., 2007; Lupski et al., 
2010; McKernan et al., 2009; Pelak et al., 2010; Pushkarev et al., 2009; Schuster et al., 2010; 
Wang et al., 2008; Wheeler et al., 2008), were either obtained from the published paper, 
supplementary information or downloaded from Database of Genomic Variants                                                    
(http://projects.tcag.ca/variation/, version 10 of all recorded structural variants, last updated in 
November 2010). The total number of each CNV called from sequencing data (CNVs called by 
further validation methods such as CGH and SNP array were not included), calling method, 
definition of CNV in each of the 12 studies were recorded. 
 
3.2.2 Analysis of deletions 
Deletions within the length range of 1kb to 3Mb in five individual genomes, from six studies 
were selected for comparison. Every genomic location (chromosome coordinates in Build 36) 
was recorded. Deletions detected primarily by CGH or SNP array were not included, as the 
following comparison of deletions focuses on CNV results directly drawn from DNA sequencing 
data. Information of genes overlapping each deletion was obtained from DGV (version 10, last 
updated in November 2010).  
 
A deletion region was defined as the maximum genomic region which was shared among all 
samples carrying a deletion at the same locus. The deletion regions for the five individual 
genomes were determined with in-house scripts compiled by myself, using R. 
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The Mann-Whitney test was performed to test the difference in a) mean lengths of deletion and b) 
gene content in the deletion regions, between groups of individuals. The significance level was 




3.3.1 Overview of CNV detection in completely sequenced individual genomes 
To date, 12 whole individual genome sequencing studies reported their CNV findings from part 
or whole genome sequence data (Table 3.1). Kim et al. used a small number of CNV calls 
generated with sequence data from part of the genome as a training set, while the main method 
they adopted to detect genome-wide CNVs was CGH. Lupski et al. also utilized CGH to detect 
CNVs in sample genome and used sequence data as a complementary method. All other studies 
produced CNV calls directly from sequence data, with other CNV detection methods to validate 
or to complement those CNVs. In these 10 studies, Levy et al. (2007), Wheeler et al. (2008) and 
Bentley et al. (2008) did not describe method of CNV detection from sequence data in their 
research article; the CNV results from these three studies were later deposited to DGV, which 
were not available in the original research article or supplementary information.  Drmanac et al. 
(2010) and Schuster et al. (2010) each selected one sample genome (NA07022 and KB1 
respectively) from their studies to investigate structural variants. 4 studies chose read depth (RD) 
methods to detect CNVs from sequence data; the other 6 studies used end-pair mapping (EPM) 




The number of detected CNVs ranged from 84 to 5704 for each genome, and the definition of a 
CNV by length also varied across the studies (Table 3.1). Schuster et al. and Kim et al. only 
investigated duplications, but not deletions. 
 
3.3.2 Comparison of deletions in five individual genomes 
The CNVs detected directly from sequencing data were at a higher resolution and with more 
complete genome coverage, compared to other CNV detection methods (WTCCC, 2010). The 
released CNV data from genome sequence studies made it possible to reveal some features of 
CNVs from a relatively accurate and reliable source. Among the 12 studies which reported 
sequencing of individual genomes, 7 released lists of CNVs which were obtained from the raw 
sequence data (Ahn et al., 2009; Bentley and et al., 2008; Drmanac et al., 2010; Kim et al., 2009; 
Levy et al., 2007; Lupski et al., 2010; McKernan et al., 2009; Pelak et al., 2010; Pushkarev et al., 
2009; Schuster et al., 2010; Wang et al., 2008; Wheeler et al., 2008). Ahn et al. (2009) only 
tested for duplications and Bentley et al. (2008) only released data of deletions. To generate a 
data set of CNVs comparable across the most of available genomes, only deletions of a certain 
range of length (>1kb and <3Mb) were considered. In all, six genome sequencing studies on five 
human genomes, Venter, Watson, NA18507, YH and SJK, met the starting criteria for analysis 






























Venter European Male Levy et al.  2007 Shotgun N.A. 320 1006-19710 2115
YH (Wang) Asian (Chinese) Male Wang et al.  2008 Illumina GA ESP 487 1004-124100 2443
Watson European Male Wheeler et al.  2008 Roche/454 N.A. 602 1007-38900 4022
NA18507 African (YRI) Male Bentley et al.  2008 Illumina GA read depth 693 1002-50123 2620
NA18507 African (YRI) Male McKernan et al.  2009 ABI SOLiD ESP 4125 1103-937300 1616
SJK Asian (Korean) Male Ahn et al.  2009 Illumina GA ESP 988 1001-99440 2624
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The number of deletions between 1kb and 3Mb varies greatly among individuals (from 320 to 
4125). It is noted that even for the same individual, NA18507, the choice of sequencing platform 
affected detection. Bentley et al. (2008) sequenced the genome of NA18507 using Illumina 
Genome Analyzer in 2008 and reported 693 deletions; a year later McKernan et al. (2009) 
sequenced the same individual on ABI SOLiD platform, while the number of deletions in the 
same size range they found was about 7 times (4125) that from Bentley et al. (2008) study. A 
comparison of deletions from these two studies for NA18507 was carried out. I found that 594 
deletions were found by both studies, corresponding to 85.7% of the deletions in Bentley et al. 
(2008) and 14.4% deletions in McKernan et al.(2009). The number of deletions per genome for 
NA18507 in Bentley et al.(2008) study was more similar to that of other four genomes; and also 
according to a study which constructed a reference set of structure variants for two HapMap 
individuals based on data from four sequencing studies, the average deletion variants in those 
two individuals were about 680 per genome (Mills et al., 2011). Therefore data from Bentley et 
al. (2008) was selected to be included in further analysis, representing deletion profile of 
NA18507. Subsequently a final set of totally 3090 deletions for JCV (J.C.Venter), JDW 
(J.D.Watson), NA18507, YH and SJK were determined. 
 
The distribution of deletion lengths for the five genomes showed an ‘L’ shape: the majority of 
deletions were small in length (<10kb) and only a few detected deletions were large (11.4% 
deletions >10kb). A concordance of trend in deletion length distribution was observed among all 
five individuals (Figure 3.1). The median length of deletions for SJK, NA18507 (2008) and YH, 





The 3090 deletions were grouped into 2053 non-redundant copy number variant regions 
(CNVRs). A CNVR is the maximum region shared among all individuals carrying a CNV at the 
same locus. Among the total 2053 CNVRs, 1502 (73.1%) were detected in only one individual,; 
295 (14.3%) shared by two individuals; 126 (6.1%) by three individuals; 86 (4.2%) by four 
individuals; and 44 (2.1%) by all five individuals. For each individual, except YH, about half of 
the deletions detected did not overlap those in any other genomes (Table 3.3).  
 
The overlap rate of deletion CNVRs in each two genomes selected from the five sequenced 
genomes ranged from 12.9% to 61.7%. The concordance of deletions between the African 
sample NA18507 and each of the two Asian samples (27.8% and 36.8% of deletions from 
NA18507 overlapped those from YH and JSK, respectively) was higher, than that between 
NA18507 and each of the two European samples (15.4% and 22.5% of deletions from NA18507 
overlapped those from JCV and JDW, respectively). The concordance of deletions in the two 
Asian samples was high (61.7% of YH’s and 30.6% of JSK’s deletions were detected in each 
other’s genome), while the concordance was low in the two European samples (28.4% of JCV’s 












Figure 3.1 Deletion length distribution for five sequenced genomes: JCV, JDW, NA18507, YH 
and SJK. Each vertical bar represents deletions in the indicated length range, in proportion to 












Table 3.3 Overlap of deletion CNVRs in paired genomes.  
      
  NA18507  JCV  JDW YH JSK 
#CNVRs 679 320 573 485 977 
Overlap of CNVRs with other genomes (percentage): 
      
NA18507 - 105(32.8%) 153(26.7%) 189(40.0%) 250(25.6%) 
JCV 105(15.4%) - 91(15.9%) 97(20%) 126(12.9%) 
JDW 153(22.5%) 91(28.4%) - 141(29.1%) 178(18.2%) 
YH 189(27.8%) 97(30.3%) 141(24.6%) - 299(30.6%) 
JSK 250(36.8%) 126(39.4%) 178(31.1%) 299(61.7%) - 
private 349(51.4%) 156(48.8%) 329(57.4%) 137(28.2%) 531(54.3%) 
      
Each column presents comparison of deletion CNVRs in one genome to each of other four 
genomes, and also the CNVRs found exclusively in this genome (private CNVRs). In brackets 
are the percentages of CNVRs overlapped by each of the other four genomes, compared to total 
CNVRs in an individual genome. 
 
The overlap of deletion CNVRs in the five samples in the context of their ethnic origins is 
shown in Figure 3.2. The ‘Asian’ deletion set comprised 1163 deletion CNVRs detected in one 
or both of YH and JSK’s genomes; the ‘European’ deletion set comprised 802 deletion regions 
from JCV and JDW, whilst the ‘African’ set,   represented by NA18507 comprised 679 
deletions. 
 
Of the total 2053 deletions, 153 were observed in all three ethnic groups. The number of 
deletions shared between African and European groups (197) was lower than that for African and 




Figure 3.2 Deletions in sequenced individuals from African, Asian and European origins. 
 
 
The gene content in shared and private deletion regions was investigated. A third (1059) of the 
3090 deletions for the five genomes overlapped genes. Gene count in these deletions ranged 
from 1 to 8.  The mean number of genes in 1502 deletions private to one individual was 0.33, 
which was significantly less than the 0.44 genes on average contained in the 551 shared 








The advance of ultra-high-throughput sequencing technologies enabled and greatly accelerated 
the study of full spectrum of genomic variants, from single base change (single nucleotide 
polymorphism) to large scale structural variants, including copy number variants. At the time of 
writing, at least 12 studies have reported whole genome sequencing of 33 human genomes, 
however the focus of variant discovery was still on single nucleotide variants; the description 
and discussion of SV detected directly from sequence data was superficial and mostly without 
comparison to other individual sequenced genomes.  
 
Those studies carried out whole genome sequencing on different platforms, from Sanger shotgun 
sequencing to NGS platforms (Illumina, Roche/454, Life SOLiD, Helicos and Complete 
Genomics). The error rate of NGS is still higher than conventional Sanger sequencing, especially 
elevated at the start and end of a read (Koboldt et al., 2010). It is notable that the generation and 
analysis of data from NGS instruments present numerous challenges, including sample 
contamination, library chimaeras, sample mix-ups, variable run quality and computation issues 
with sequence alignment (Xi et al., 2010).  
 
The algorithm used is another variable and limitation for SV detection from whole genome 
sequencing studies. Even for the same individual, applying different algorithms can result in 
different calls, for example, the concordance of deletion calls of NA18501 from two studies each 
used RD or EPM method was not high (14.4% CNVs detected by EPM were also detected by 
RD). Moreover, an RD and EPM method each has its problems. First of all, due to the short 
length of sequenced bases, many reads cannot be uniquely mapped to the genome. Second, the 
alignment is particularly problematic at segmental duplication rich regions; read-depth methods 
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could detect variants at those locations, but their resolution is relatively poor. Third, PEM-based 
methods have the advantage to detect dosage-invariant SVs, but these algorithms have limited 
power in detecting insertions larger than the insert size. Fourth, the G+C content throughout the 
genome, amplification error and uneven likelihood of fragmentation all may cause different 
representation of certain regions compared to others. Last but not least, many of the data sets do 
not have sufficient coverage to infer all SVs with statistical significance (Xi et al., 2010).  
 
A survey of deletions from five sequenced genomes showed that the majority of deletions 
between 1kb and 3Mb were short in length and at the lower level for robust detection by CGH or 
SNP typing (Figure 3.1). This skewed distribution is also true for CGH or SNP genotyping 
detection methods (McCarroll et al., 2008; Redon et al., 2006), but on a different scale from 
NGS. For example, in a study of CNVs in three European populations from SNP genotyping 
data (Chapter 7 of this thesis), about 60% of all deletions between 1kb and 3Mb were larger than 
10kb, while over 80% of deletions were smaller than 10kb from the sequence data of five 
individuals. This discrepancy of size range reflects limitation of algorithms to detect larger SVs 
from sequence data. Although NGS has a lot of advantages in SV detection than conventional 
methods, it is still not a one-stop solution for SV discovery. Improvements in the pipeline for SV 
detection from sequence data are needed. Some endeavors have been made by combining several 
complementary algorithms, to predict SVs more accurately (Hormozdiari et al., 2009). It is also 
advised that future studies may need to use multiple libraries with different insert sizes to 
discover SVs of a wider size range (Medvedev et al., 2009). One the other hand, CGH or SNP 
genotyping based methods are useful in detecting larger SVs, especially large insertions which 
are technically difficult for sequencing based methods, therefore applying these two categories 
of SV detection for the same individual and combining result from both platforms would enable 
the discovery of SVs across the full size range.  
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The overlap of deletions among the five whole genome sequenced individuals was low (2.1%). 
About half of all discovered deletions for each individual were unique to that individual. 
Compared with single nucleotide variants, which were 74% to 95%, concordant with the 
reference human sequence in dbSNP (table 4.1), structural variants were much less congruent, 
reflecting in part the technical limitations on robust detection and alignment. Concordance of 
deletions was higher between two Asian genomes but lower between two European genomes, 
but many more examples will be needed to draw any fair conclusions about potential variations 
in frequency or distribution between individuals and ethnic groups.  An analysis which 
compared deletion variants in three ethnic groups showed that the rate of sharing was lower 
between African and Europeans than that between African and Asians or Asians and Europeans, 
which was similar to SNV sharing in five individuals (NA18507, JCV, JDW, YH, AK1) from the 
same three ethnic groups (Ahn et al., 2009 ). This result may reflect the genetic origin of 
structural variants, but again with such a small sample size of sequenced genomes, those 
between-group differences could not be studied at a population level.  
 
In this small set of individuals, I noted that those deletions observed in a single individual 
overlapped with fewer genes than those shared in multiple individuals (P=0.0001314). Deletions 
are generally considered to be more likely to be harmful than insertions (Conrad et al., 2006), 
being more likely to directly disrupt gene function. Consequently, deleterious deletions would 
not survive purifying selection and are less likely to be fixed over generations. Neutral deletions 
are less sensitive to purifying selection so they would be expected to be more common than 




In conclusion, platforms and algorithms for detecting SVs from sequence data needs to be 
improved and one should consider incorporate other SV detection method into the pipeline to 
produce most accurate calls of SVs in the whole size range, covering wider regions in the 
genome. The comparison of deletions detected for five sequenced individuals showed that CNVs 
in human genomes were ubiquitous but the understanding of them, including basic features like 
distribution of all CNV loci, was still far from complete. Difference of some characteristics, for 
example gene content was observed between CNVs restricted to one genome and those shared 
by multiple individuals, however more samples were needed to draw a conclusion at population 
level. Recently, the 1000 Genome Project (http://www.1000genomes.org/) has published their 
primary CNV map based on whole genome DNA sequencing data from 185 human genomes, 
which consist of 22,025 deletions and 6,000 additional SVs (Mills et al., 2011). They found 
common deletions were more often shared across populations, whereas rare alleles were 
frequently observed in only one population. They also pointed out that due to limitations of 
current SV calling methods which depend on mapping reads onto their genomic locus of origin, 
only a fraction of the total SVs could be detected. With the advance of projects which aimed at 
sequencing more individuals, including the 1000 Genome Project and The Cancer Genome Atlas, 
(http://cancergenome.nih.gov/) and technological development of sequencing platform and SV 
detection algorithms, it is believed that our knowledge of structural variants, including copy 
number variation, will substantially increase and the full spectrum of CNVs in human genomes 
will be revealed.          
 
 
















Single nucleotide polymorphism (SNP) oligonucleotide genotyping arrays are widely accepted 
to analyze copy number variants (CNVs). Profiling CNVs from SNP data has become popular in 
established Genome Wide Association Studies because of the convenience of data acquisition 
and processing. However, in the absence of completed high-resolution, genome-wide maps of 
variation, the extent to which commercially available SNP platforms accurately capture CNVs 
remains unknown. Moreover, genotyping platforms and CNV calling algorithms vary largely 
across studies, making it difficult to assess the robustness of SNP-based CNV detection.  
 
The probe coverage for four commonly used SNP arrays (Illumina HumanHap 300, Affymetrix 
500K, Illumina Human 1M and Affymetrix 6.0) had been investigated, in nine human genomes 
whose variants had been systematically detected by fosmid ESP mapping and validated by 
orthogonal approaches (Cooper et al., 2008). With the fine-scale map of genomic structural 
variation determined (Kidd et al., 2008), these nine HapMap genomes provide reliable 
information of the locations, breakpoints and copy number status of their CNVs, therefore can 
serve as a good bench mark to evaluate the CNV discovery results generated by other methods. 
It has been found from Cooper (2008)’s study that probes in older genome-wide platforms such 
as Illumina HumanHap 300 and Affymetrix 500K only cover about 25% of deletions, and fewer 
than 20% of deletions harbour multiple markers (most detection algorithms call CNV events 
only if the CNVs span at least two markers). Even when newer arrays (Illumina Human 1M and 
Affymetrix 6.0) were considered, about 30% deletions annotated by complete fosmid sequencing 
were not covered by the markers on those platforms. With probe coverage of 25%-70%, one can 
presume that the detection rate of actual CNV calling methods using probe intensity data from 
 97
any of these arrays will turn out to be even lower.  
 
The International HapMap project (The International HapMap Consortium, 2003) provides a key 
resource for researchers to study human DNA sequence variation, by characterizing sequence 
variants, their frequencies, and correlations between them, in DNA samples from four major 
world populations with African, Asian and European ancestry.  The HapMap resource includes 
genotype data on over 4 million single nucleotide polymorphisms (SNPs), gene expression data 
using various microarray platforms and other phenotypic data such as drug response as well as 
structural variation data. In recent years, many researchers who are interested in human genome 
structure variants have taken advantage of HapMap genotyping data to study copy number 
variants and to test or validate their CNV calling algorithms.(Conrad et al., 2006; Cooper et al., 
2008; Kohler and Cutler, 2007; Korn et al., 2008; Lin et al., 2008; Locke et al., 2006; McCarroll 
et al., 2008; Redon et al., 2006; Wang et al., 2007; McCarroll et al., 2005) 
 
With CNV detection from SNP data becoming a routine for GWAS studies, a reliable protocol is 
required to guarantee accurate CNV detection. But a golden standard has yet to be discovered. In 
this chapter, a structured review of all the SNP-based CNV studies to date using HapMap 
samples is conducted, and the data from each included study were extracted and analyzed. By 
comparing CNV calls made in those studies with the baseline CNV from the same HapMap 





4.2 Structured literature search and data extraction 
 
4.2.1 Literature search across databases 
Research articles included in three major databases, ISI Web of Knowledge, Medline and 
Embase were searched. ISI Web of Knowledge was searched for the key words "SNP or single 
nucleotide polymorphism" in combination with "copy number" and yielded 864 articles. Ovid 
databases-Medline and Embase were searched for the key words "SNP or single nucleotide 
polymorphism"  in combination of  "copy number", with the result limited to human, 
non-review, published between 1995 and September 2009 and yielded 344 articles. These key 
word combinations were adopted to target all potential studies that detect CNVs from SNP 
genotyping arrays. The results of the two searches were merged. After deleting 411 duplications 
and 20 articles published before 1995 (from the ISI search), finally 778 potentially informative 
articles remained for further study. 
 
The title and abstract of each of the 778 articles was read. Any studies focusing on non-human 
data or which did not utilize whole-genome SNP data to infer CNVs were excluded. At this stage 
263 articles remained. Among these, 17 articles have “HapMap” in their titles or abstracts. Full 
texts and supplementary data of these 17 articles were obtained and examined, to identify the 
studies with extractable data. Some of these only used HapMap samples as a reference set; some 
made use of the HapMap SNP information to test CNV calling methods but the list of CNV calls 
are not shown. Finally, 7 studies (McCarroll et al., 2005; Conrad et al., 2006; Cooper et al., 2008; 
Kohler and Cutler, 2007; McCarroll et al., 2008; Redon et al., 2006; Wang et al., 2007), each 
with detailed information of identified CNVs or CNVRs (Copy Number Variant Regions), 
fulfilled the inclusion criteria and the CNV data from each study were extracted.  The searching 
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process is indicated in Figure 4.1. It was found in the search that all related articles analyze all or 
subsets of HapMap phase I and phase II samples from a total of 270 individuals: 30 
adult-and-both-parents trios from Ibadan, Nigeria (YRI), 30 trios of U.S. residents of northern 
and western European ancestry (CEU), 44 unrelated individuals from Tokyo, Japan (JPT) and 45 
unrelated Han Chinese individuals from Beijing, China (CHB). None of the CNV studies has 
used HapMap phase III data, which consists of genotypes of a total 1397 individuals and PCR 







Figure 4.1 Literature search for research articles which detect CNVs from whole-genome SNP 






Table 4.1 Summary of selected information from 7 SNP-based CNV studies in HapMap samples: sample description, genotyping strategy and 
CNV detection methods 
Pop: population formation, CEU-central European, YRI-Yoruba in Ibadan, CHB-Beijing,China, JPT-Tokoyo,Japan; #Prob: number of SNP probes in the 
genotyping assay (in thousands); CNV calling: name and algorithm of CNV calling software, the number of CNVs called, number of CNV carriers and average 
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Table 4.1(continued) Summary of selected information from 7 SNP-based CNV studies in HapMap samples: CNVs, CNVRs and validation      
Number of deletions and amplifications in each study; length of each type of CNVs; CNVR: calling-the definition of a CNVR in each study, #CNVRs-number of 
CNVRs defined in each study; validation: methods-the way a subset of the CNVs being validated, #tested CNVs-number of CNVs selected for validation, 
#validated CNVs-number of CNVs validated by other methods out of the tested CNVs in each study              
All Del Amp Calling # CNVRs Methods # tested CNVs # validated CNVs
McCarrol  et
al
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4.2.2 Overview of seven relevant studies 
The information from these 7 studies is extracted and tabulated into spreadsheets, including 
author, publishing year, population composition, genotyping platform, number of probes, 
SNP selection criteria, CNV calling strategy, number of CNVs, CNV length and validations. 
The summary of information from these studies is displayed in Table 4.1.  
 
All these studies applied certain platform/algorithm combinations to the whole (Redon 2006 
and McCarroll 2008) or a subset (the other 5 studies) of the HapMap sample collection. The 
SNP content ranges from 475,000 (Redon) to over 1,300,000 (McCarroll 2005). Three 
studies (McCarroll 2005, Conrad 2006, and Kholer 2007) directly adopt SNP genotypes from 
the HapMap project genotype collection, and inferred copy number change via mendelian 
incompatibility, genotyping error and missing genotypes. Due to technology limitations, 
these 3 studies were only able to present deletions (copy number loss events). The other four 
studies used signal intensity data obtained from commercial SNP genotyping platforms 
(Affymetrix Early Access 500K, Affymetrix SNP 6.0, Illumina HumanHap 550 and Illumina 
HumanHap 1M) to detect both deletions and amplifications. Hidden Markov Model based 
algorithms are utilized in these studies to simultaneously indicate copy number status of the 
SNPs on these arrays. In all studies, each sample is detected to posses one or more CNVs. It 
was shown in these four studies that there were more deletions than amplifications detected 
in HapMap samples. Although the samples by all seven studies were drawn from the same 
HapMap collection, the average numbers of detected CNVs per carrier by different 
platform/algorithm were obviously different, from 2 events per CNV carrier to 174 events 
per CNV carrier. Redon, Kohler (2007) and McCarroll (2008) group CNVs into 
non-redundant copy number variation regions (CNVRs) each by a different CNVR definition. 
Instead of presenting raw CNVs with chromosomal locations, McCarroll (2008) identified 
common CNPs by searching for genomic regions across which copy number probes show 
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cross-sample patterns of same status (copy number gain or loss), then assigned each 
individual corresponding CNVRs rather than the original CNVs. Kohler (2007) only 
presented CNVRs which contained any evidence of copy number variants but not original 
sample-wise CNVs detected in his samples.  
 
4.2.3 Platforms and CNV detection methods 
 
4.2.3.1 HapMap genotypes 
McCarroll (2005), Conrad and Kholer obtain the SNP genotyping data from HapMap phase I 
data release. During phase I, genotyping of over one million SNPs was carried out by 10 
centres across the world, using seven different genotyping technologies. The genotyping data 
generated for 270 individuals was placed in the public domain and is available for download 
(http://hapmap. ncbi.nlm.nih.gov/). 
 
Redon (2006), Wang (2008), McCarroll (2008) and Cooper (2008) use probe signal intensity 
data from commercially available Affymetrix Early Access 500K (500K EA), Illumina 
HumanHap 550, Affymetrix SNP 6.0 and Illumina HumanHap 1M genotyping arrays, 
respectively.  
 
4.2.3.2 Whole Genome genotyping arrays by Affymetrix and Illumina 
Affymetrix’s 500K EA array is a precursor version of the GeneChip® Human Mapping 
500K array set, comprising 534,500 SNPs on two arrays and is used in conjunction with the 
whole genome sampling assay (WGSA). The median physical distance between SNPs is 2.5 
kb and the average distance between SNPs is 5.8 kb on the 500K EA array. The latest version 
of Affymetrix genotyping array, Genome-wide Human SNP Array 6.0 contains 1.8 million 
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genetic probes, including more than 906,600 SNPs and more than 946,000 probes for the 
detection of copy number variation. The inclusion of CNV probes makes Affymetrix Human 
SNP Array 6.0 the only platform to date with analysis tools to truly integrate copy number 
and association analysis simultaneously on a single array. It is claimed to have the highest 
physical coverage of the genome (http://www.affymetrix.com/). 
 
Illumina’s HumanHap550 Genotyping BeadChip enables whole-genome genotyping of over 
550,000 tag SNPs derived from the International HapMap Project on a single BeadChip.The 
assay combines specific hybridization of genomic DNA to arrayed probes with 
allele-specific primer extension and signal amplification, therefore effectively increasing the 
signal-to-noise ratio in genotype calling (Wang et al., 2007). The Human 1M DNA Analysis 
BeadChip interrogates nearly 1.2 million SNP probes per sample, providing Illumina’s most 
comprehensive genome-wide coverage of SNPs. The uniform genome-wide coverage results 
in a median spacing of 1.5 kb between markers and fewer large gaps. There are around 
60,000 probes, developed in collaboration with deCODE Genetics, covering regions likely to 
contain undiscovered CNVs—segmental duplications, megasatellites and region lacking 
SNPs. This feature makes the Human 1M array of high value for CNV detection, in addition 
to genome-wide SNP genotyping (http://www.illumina.com/products/human1m_ 
duo_dna_analysis_beadchip_kits.ilmn). 
 
4.2.3.3 Deletion discovery from SNP genotypes 
McCarroll et al (2005) argue that segregating deletions can cause SNP genotypes to appear 
‘abnormal’, such as apparent deviations from mendelian inheritance, apparent deviations 
from Hardy-Weinberg equilibrium and null genotypes. Based on this principle, they 
developed a procedure to identify deletions from SNP genotypes. First of all, they detected 
indications of the potential presence of deletions from mendelian incompatibility (i.e. the 
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deviation from mendelian inheritance), Hardy-Weinberg disequilibrium and null genotypes, 
in family trios or unrelated individuals. They then looked for regions of the genome in which 
the same type of “failed” profile appeared repeatedly at nearby markers in a manner that is 
statistically unexpected based on chance. Finally a subset of ‘failed’ SNP genotyping assays 
which are likely to reflect structure variants was determined.  
 
Conrad et al (2006) adopted a similar approach for deletion detection from SNP genotypes. 
They examined consecutive SNPs transmitted from parent to child and flagged the regions of 
SNPs whose genotypes appeared to violate mendelian transmission. Then they distinguished 
between two classes of mendelian incompatibility which were either the mendelian 
incompatibility consistent with a deletion or inconsistent with a deletion. At last, they 
detected deletions which appear to be regions of runs of SNPs displaying mendelian errors, 
each in a single HapMap family trio. Due to the nature of this method, deletions only in the 
offspring of a family trio are represented. Compared with McCarroll (2005), this method 
only concentrates on Mendelian incompatibilities and doesn’t take into account other types 
of apparent genotyping errors (H-W disequilibrium, null genotypes) which might be resulted 
from deletions, and so gave results which appeared to be more stringent and conservative.  
 
4.2.3.4 Methods to identify copy number change from signal intensity data 
Redon (2006) used an algorithm described in Komura et al (2006) to identify copy number 
from Log2R ratio of SNPs in the whole-genome SNP genotyping arrays. This approach 
comprised three major steps: intensity pre-processing, CNV detection and Copy-Number 
inference. After step one, CNV detection began with pairwise comparisons of probe 
intensities for all possible pairs of samples (n-1 comparisons for n samples), an adapted 
Smith-Waterman algorithm helped to find isolated islands of substantially higher (or lower) 
intensity ratios and assigned significance to each finding by a permutation test. Then the 
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results for all comparisons were merged to extract candidate CNV regions for each sample. 
During step three, each CNV region was assigned a copy number and the boundaries were 
determined, by using a maximum clique algorithm to define the diploid samples for any 
given region based on the results from the large reference data.  
 
Wang (2007), McCarroll (2008) and Cooper (2008) each facilitate a Hidden Markov Model 
based program (PennCNV, Birdseye and HMMseg) to detect CNV by analysing both Log2R 
ratio and B Allele Frequency (BAF) of the SNPs. The Hidden Markov Model is a statistical 
technique that models a Markov process, where the probability of observing a particular state 
at a particular time point only depends on the state at previous time points. This feature 
makes HMM widely used in the field of SNP array based CNV detection, when practice it to 
model status of copy numbers at nearby SNPs (Wang et al., 2007). In this model, a sequence 
of SNPs are each assigned a most likely copy number based on the calculated probability of 
copy number status, then the copy number variable fragments are  assessed and determined 
(details of HMM in the Methods chapter).  
PennCNV:  this was developed by an academic group for the Illumina genotyping platform 
and is freely available to users to apply to their own data. The standard output from this 
package is a list of detected copy number variant events and brief summary statistics to be 
used for quality check. It can run using command line options or integrated into Illumina’s 
BeadStudio data analysis software as a plug-in. It has a few downstream analysis options, 
such as using family trio data to increase accuracy of prediction(Wang et al., 2007)  . 
Birdseye: this is a component in the Birdsuite analytical solutions. The Birdsuite set 
developed by Korn et al (Korn et al., 2008) combines SNP genotyping, copy number 
detection and genotyping of common CNP. (The concept of CNP genotyping is similar to 
SNP genotyping: instead of SNP probes, probes which represent common copy number 
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polymorphism are arrayed and hybridized with DNA samples, and then the CNP genotypes 
are determined.) Four different software programs are integrated into Birdsuite for 
Affymetrix dataset: The Canary algorithm genotypes common CNPs; Birdseed yield SNP 
genotyping results; Birdseye uses the HMM to identify and assess previously unkown CNVs 
in the data set and Fawkes merges all the results from the three previous stages. 
HMMseg: this is a command line operated algorithm for segmenting continuous genomic 
datasets on a scale-specific basis using HMM. Scale specificity is achieved by an optional 
smoothing step. HMMseg uses Gaussian emission distributions to detect consecutive SNPs 
in the genome with aberrant signal intensities, with diagonal covariance for multiple datasets, 
and supports both the Viterbi and posterior decoding methods for copy number state 
assignments(Day et al., 2007). 
 
4.3 Comparison of CNV findings of two individuals in six HapMap 
studies 
Among the seven studies which are included in this review, all but one (Kohler (2007)) 
provide CNV call results for each of the HapMap sample in their studies. On the other hand, 
Kohler (2007) groups sample-wise CNVs into CNVRs and only showed the constructed map 
of CNVRs instead of listing the original CNV calls. The lists of CNVs for each sample in the 
rest six studies were downloaded from supplementary information of each of these six 
studies; the chromosomal coordinates for each CNV were all converted to hg17 (Build 35) 
using liftOver (http://genome.ucsc.edu/cgi-bin/hgLiftOver). The entries which could not be 
mapped to hg17 were discarded.  In the remaining six studies, 2 same individuals, 
NA12878 and NA19240, were used by each of them. They were both in the HapMap sample 
collection; NA12878 is of European ancestry and NA19240 is of African ancestry. 
Genome-wide fosmid end-sequence-pair (ESP) maps have been developed for nine humans, 
which also include the same two individuals. To address the extent to which existing 
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SNP-based CNV detection methods accurately capture true CNVs, the CNV results of each 
study for NA12878 and NA19240l were compared to CNVs detected using ESP sequencing 
for the same individual.  
 
4.3.1 Deletions for NA12878 and NA19240 
McCarroll (2005) and Conrad et al (2006) only investigate the deletion polymorphism in 
their studies, therefore to construct a paralleled comparison of copy number variants across 
the six studies, only autosomal deletions were considered. 
 
The number of deletions for the same two HapMap individuals from each study is shown in 
Table 4.2. Between 12 and 69 deletions were identified for NA12878 and between 9 and 57 
for NA19240. The SNP density of each platform did not affect the number of deletions 
detected (P value=0.838, not significant). Two categories of CNV detection methods were 
used: McCarrol (2005) and Conrad (2006) chose to detect deletions based on Mendelian 
error/genotyping error in SNP genotypes, while the other four analyse signal intensity. 
Considering the rational of the two categories of methods, the genotyping analysis methods 
also takes into account the family trio information, therefore one may argue the results might 
be conservative and the number of deletions of the same individual might be underestimated. 
However, the difference of the number of detected deletion events between two categories of 























low 15(755.8Kb) 9(850.1Kb) 24 49.7
Conrad et al genotype high 12(537.9Kb) 20(614.8Kb) 32 20.8
Wang et al 
signal 
intensity





high 69(1.564Mb) 57(1.325Mb) 126 9.7
Cooper et al 
signal 
intensity
high 43(2.367Mb) 20(537.2Kb) 63 27.7
 
For NA12878 and NA19240, the number of deletions indicated in each of the six studies was listed. 
The total lengths of genomic regions covered by those deletions were listed in brackets.  
 
The median length of detected deletions generated by the different platform/algorithm 
combination varied (from 9.7 to 49.7 kb). The deletions detected by Redon (2006) were 
longer than any other studies (median length 49.7kb, almost two fold of the second longest 
detected deletion median size in Cooper (2008)’s study). It was suspected that the deletions 
identified by genotype analysis might be shorter since family information provides more 
evidence of true deletion boundaries; but no significant difference of deletion length was 
found between two categories of detection methods (p=0.5745). Both number of detected 
deletion and the chromosomal region covered by those deletions vary greatly for the same 
individual across the six studies. 
 
4.3.2 Cross comparison of deletions from six studies 
The locations of each deletion for the same individual were compared across the six studies 
(Table 4.3). The results from two genotype analysis studies (McCarroll (2005) and Conrad 
(2006)) were widely validated in at least one other study (recovery rate of 64.5% and 62.5%, 
respectively), while most of the deletions (84.9%) from McCarroll (2008) could not be found 
in any other studies. Correlation tended to be better when both studies in a pair to be 
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compared adopt the same methods, for example, deletions from McCarroll (2005) 
concordant with those from Conrad (2006) best, which both used genotype/family 
information analysis, Wang (2007) had more deletions also detected in studies in which they 
analyzed signal intensity rather than genotype/family information.   
 
 
















low 24 2 - 5 9 5 8 10 (41.7%)
Conrad et 
al
genotype high 32 13 5 - 7 4 8 12 (37.5%)
Wang et al 
signal 
intensity






















Note: The number in each cell is the number of CNVs detected in each corresponding pair of studies. 
For ease of comparison across multiple studies, CNVs in each of the two genomes were grouped into 
CNVRs (CNV loci), eg. in McCarrol(2005) study, 16 deletions of NA12878 were at 16 CNV loci, 16 
deletions of NA 19240 were at 15 CNV loci, therefore those deletions were at 31 sample-wise CNV 
loci. 
 
4.4. Concordance with deletions determined by ESP sequencing 
 
4.4.1 Reference deletions detected by ESP sequencing 
Kidd et al (2008) applied the clone-based Fosmid end-sequence pair (ESP) technology to 
determine structure variants in nine human genomes, including four individuals of Yoruba 
Nigerian ethnicity, three of Western and Northern European ethnicity and two of Eastern 
Asia ethnicity. For each individual a whole genomic library of about 1 million clones was 
constructed, by using fosmid subcloning strategy. Each library was arrayed and both ends of 
each clone insert were sequenced to generate a pair of high-quality end sequences. At the end 
a physical clone map for each individual human genome was generated, the regions 
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discrepant by size or orientation on the basis of the placement of end sequence against the 
reference assembly were flagged. Following approaches of validation, 2725 sample-wise 
insertion, deletion and inversions more than 8kb in length were identified. The scale of this 
CNV discovery study is the finest to date compared with other platforms/methods, therefore 
in this chapter this data set was taken as the baseline reference to assess the robustness of 
CNV detection platforms/methods mentioned above. The list of all copy number variants 
identified in this study was downloaded from the supplementary information to this article. 
 
In total those CNVs could be merged into 1607 non-redundant CNVRs. A CNVR was 
defined as the region containing any SNP showing CNV. If CNVs in multiple samples are at 
the same locus, they were assigned to be in the same CNVR. The boundaries of each CNVR 
were the locations of outmost reach of SNPs showing CNV at this locus. 1129 of the 1607 
CNVRs were only observed in single individuals, among them, 475 belong to the African 
population, 362 to the European population and 292 to the Asian population. 478 (29.7%) 
CNVRs were shared by more than one individual. 133 of these CNVRs were shared by three 
populations; 110 only shared between European and Asian populations, 94 only shared 
between European and African populations and 69 only shared between African and Asian 
populations. (Figure 4.2.) 
 
The same pattern of CNVR sharing among three populations was observed in Cooper 
(2008)’s data. The 368 CNVs from Cooper et al were grouped into 278 CNVRs, in the same 
manner as analysing Kidd (2008)’s results. Most of these CNVRs (243 out of 278) belong to 
a single population; most of the population specific CNVRs are found in African population. 
Only a small fraction of the CNVRs (8 CNVRs) were shared by three populations; European 





Figure 4.2 CNVR sharing in 9 HapMap individuals from Kidd et al (2008).  
Note: numbers in the shaded areas indicate the numbers of shared CNVRs. 
 
 
Figure 4.3 CNVR sharing in 9 HapMap individuals from Cooper (2008) et al.  
Note: numbers in the shaded areas indicate the numbers of shared CNVRs. 
 
155 autosomal deletions (7.48Mbp) were detected for NA12878 and 142 (5.76Mbp) for 
NA19240. Among those deletion regions, 143 for NA12878 (7.01Mbp) and 130 for 
NA19240 (5.29Mbp) covered multiple SNPs (the reference SNPs are from the Illumina 
Human 1M array SNP collection which represented one of the highest SNP densities in the 
six studies), which means maximally 92% of the baseline reference deletions could have a 
chance to be recovered by any SNP based detection methods (“detectable”), because it 
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always takes more than 2 consecutive SNPs which shown evidence of a shift of copy number 
status away from normal towards the same direction (either gain or loss).  
 
4.4.2. Overlap with fosmid ESP map 
The positions of deletions for NA12878 and NA19240 were compared to the fosmid ESP 
map of deletions for the same two individuals. Of the 143 detectable deletions for NA12878 
on the fosmid ESP map, 42 were also detected in at least one study from the six SNP-based 
CNV studies (3.72Mbp). On the other hand, 26 (1.11Mbp) out of the 130 detectable 
deletions for NA19240 were recovered each by one or more other studies. Thus the rate for 
the fosmid ESP validated deletions to be recovered by any SNP-based technologies 
discussed in this chapter was 29.3% (or 53% by length) for NA12878 and 20% (or 21.0% by 
length) for NA19240. The average recovery rate for both individuals was 24.9% (or 34.2% 
by length). 
 
To demonstrate the breakdown of concordant deletions by each study, the results of 
comparison with Kidd (2008)’s data is shown in Table 4.4. The concordance rates for the six 
studies range from 25.4% (McCarroll 2008) to 58.73% (Cooper). Except for McCarroll 
(2008), other three studies working on signal intensities tended to be more robust in 
identifying reference deletions (54.17%, 44.12% and 58.73% vs. 40.63% and 31.25%). 
Despite the low density of SNP genotyping platform chosen by Redon et al (2006), their 
algorithm still yielded a concordance rate of over 50%.  
 
4.5 Discussion 
Comparison of detected events in the same dataset by different methods is a good way of 
assessing accuracy of detection algorithms. The HapMap samples are considered the most 
intensively studied genetic sample collection; various studies on the whole or a subset of 
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these samples produced genotyping results generated on various SNP genotyping array 
platforms, as well as fosmid ESP sequencing results. With the development of methodology 
to detect copy number variable events and construct maps of structural variation for HapMap 
samples based on those data, the HapMap collection can serve as a resource for CNV 
detection algorism comparison. Seven CNV discovery studies were targeted from a 
structured literature search, which aimed to identify all SNP-based CNV studies to date on 
the well characterized HapMap samples. Those were published between 2005 and 2008, 
either directly used HapMap genotypes (Kohler and Cutler, 2007; McCarroll et al., 2005; 
Redon et al., 2006; Conrad et al., 2006) or analyzed signal intensity data of SNP genotyping 
arrays for those samples (Cooper et al., 2008; McCarroll et al., 2008; Redon et al., 2006; 
Wang et al., 2007). The principles of inferring copy number variation via SNP genotypes are 
to identify the ‘imprints’ in the genome which might be caused by deletions, such as missing 
genotypes, deviations from Mendelian inheritance and violations of Hardy-Weinberg 
equilibrium. On the other hand, implying copy number status from signal intensities of a 
series of SNPs on a chromosome can yield results of both copy number gains and copy 
number losses.   
 












low 24 10 3 13 54.17%













high 63 28 9 37 58.73%





The existence of structural variance is ubiquitous in human genomes. Despite 
platform/algorithm choices, multiple CNVs were found for every sample in all seven studies. 
This fact is supported in many other human genetics studies. CNVs are also commonly 
found to be widely spread in other species, for example mice, chimpanzees, pigs and 
maize(Perry et al., 2008; Springer et al., 2009; Adams et al., 2005; Fadista et al., 2008). It is 
possible that for any single genome there may be regions displaying different levels of copy 
number polymorphisms.  
 
The genotype-analysis based methods (in McCarroll 2005 and Conrad 2006) tend to detect 
less deletion events per sample (although the difference was not significant) compared with 
signal intensity-based methods (Table 4.1). It might be explained by the nature of these two 
categories of methods. The genotype analysis assessed missing genotypes, H-W 
disequilibrium and Mendelian incompatibilities in family trios, screened regions of genome 
which carried above events but possibly were caused by deletions rather than being true 
genotyping errors. It is presumed that incorporating family information and assess 
transmission of these inheritable genetic features might increase accuracy in deletion 
detection, but at the same time more deletions in these trios might have been missed out, for 
example homozygous deletions in the offspring is undetectable by this method, and if all 
three samples in a trio appear to be homozygous for a number of consecutive SNPs, it is hard 
to tell if they are truly all homozygous or if some of them are hemizygous for a deletion in 
this region, when no apparent Mendelian incompatibility is detected in this trio. Conrad et al 
(2006) performed a simulation to calculate power of their method, and claimed it has 
moderate power to detect deletion events in family trios. They also predicted the total 
number of deletions based on simulations, that the CEU children were estimated to carry 
around 30 deletions and the YRI children about 50 deletions of >5 kb (Conrad et al., 2006). 
Their method detected 14.4 deletions of >5kb, which was less than half of the estimated 
number of deletions in the 60 HapMap offspring. The simulations suggested that the number 
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of events may be underestimated by genotype-analysis methods. 
 
The density of SNPs in the seven studies was not the same; the earlier studies (Redon (2006) 
and Wang (2007)) used arrays containing about 500k SNPs while others analyzed above 1M 
SNPs. The relationship of SNP density and the number of CNVs detected (deletions were 
considered instead of looking at both deletions and amplifications, because three of the seven 
studies only studied deletions) was investigated and no significant association was found. 
The median size of deletions in these studies were between 5.7 kb and 48.7 kb, meanwhile 
the median physical distance between SNPs on one of the lower SNP density genotyping 
platform (Affymetrix 500K EA array) is 2.5 kb. The deletion length suggested most detected 
deletions spanned multiple SNPs; the sufficient length of deletions made them already 
detectable by both lower and higher density SNP genotyping arrays.  
 
The shared HapMap samples, NA12878 and NA19240, are the basis of the method 
comparison among six studies which provided detected individual CNVs. The cross 
comparison showed that generally some deletions found in one study could be also found in 
other studies; it is assumed that the larger numbers of similar events across different 
platform/methods could mean higher true positive rate, therefore all the programmes were 
able to detect at least a proportion of true deletion events. The proportion of deletions 
detectable by other studies was above 40% for all studies except for McCarroll (2008). 
Although some studies had lower percentage of overlapping events, it is important to also 
consider the number of events as well as the proportion, for example about 60% of the events 
detected by Redon (2006) were confirmed but other algorithms had detected more events in 
total. In McCarroll’s study, CNV identification was split into two steps: an initial detection of 
common copy number polymorphisms (CNPs) captured by CNP probes followed by a HMM 
based algorithm (Birdseye) to further detect rare events.  The HMM model adapted in 
Birdseye was different from that by others (PennCNV and HMMseg): it took into account 
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the probe intensities from both copy number and SNP probes to indicate true underlying 
hidden states (e.g. copy number status of each probe) while others analyze solely SNP probe 
intensities. The novelty of McCarroll’s platform might result in the lower overlapping rate 
with results from other studies, including studies which also utilized HMM. 
 
A difference in the size of the predicted deletions between platform/algorithms was notified 
for NA12878 and NA19240. This was to be expected when using different genotyping arrays 
as probe location and SNP density vary. On the other hand, this kind of effect can also be 
caused by simply altering algorithm parameters and CNV definitions.  
 
It has been claimed by inter-population CNV investigations that more copy number variable 
events were to be expected in African populations rather than in European populations. A 
small subset of the HapMap collection which consists 9 samples from Europe (CEU), Africa 
(YRI) and Asia (CHB+JPT) were studied for structural variants, by Cooper (2008) et al and 
Kidd et al (2008) using SNP genotyping and sequencing, respectively. Similar CNV sharing 
patterns were found in these two studies, which confirmed the more frequent observation of 
CNVs in Africans and there was an median overlap of same CNV events between two 
distinct populations. In the comparison of deletions of NA12878 and NA19240, in most of 
the cases more deletions for NA12878 were detected than for NA19240, among various 
platform/algorithm combinations. This violation of predictions might just due to sampling. 
 
When taking the deletions which Kidd et al (2008) detected for the same two samples by 
ESP sequencing as reference, the comparison of findings between each of the six studies and 
Kidd et al (2008) showed a variety of concordance that the detected deletions overlaps Kidd 
(2008)’s results. Despite SNP density difference, most of the signal intensity-based HMM 
algorithms outperformed genotype analysis methods. The two studies (McCarroll 2005 and 
Conrad (2006)), which identified deletions in family trios by analyzing SNP genotypes, not 
 119
only found less events compared with reference but also had lower concordance rate. 
McCarroll et al 2008 which used intensity-based method had only 15% of the detected 
deletions in concordance with Kidd et al (2008), suggesting a possible high false-positive 
rate of their method. But one should also notice the number of overlapping events with Kidd 
(2008) in McCarroll 2008’s study was one of the largest, showing their ability to detect 
confirmed events. Winchester et al. (Winchester et al., 2009) performed four algorithms 
(including cnvPartition, GADA, PennCNV and QuantiSNP) on the same set of SNP signal 
intensity data on one HapMap individual and they also found a significant discrepancy in 
results among different algorithms. 
 
Considering all six studies together, only about a quarter of deletions from Kidd’s ESP 
sequencing results, which were potentially detectable on SNP genotyping arrays, were also 
discovered in at least one of the six SNP-based studies. Although the platform and 
algorithms to detect CNVs from SNP genotyping arrays discussed in this chapter were not 
exhaustive, this finding revealed the limitation of current SNP-based CNV detection methods 
to discover true CNVs. Winchester et al also compared their results from multiple algorithms 
to Kidd (2008)’s deletion predictions and the same low level of consistency was claimed.  
 
Several challenges remain in SNP-based CNV discovery: first of all, on commercial SNP 
genotyping arrays, probes are not uniformly distributed across the genome and are 
particularly sparse in regions of segmental duplication and complex CNV regions, for 
example 10% deletions identified by Kidd (2008) for two HapMap individuals do not cover 
at least two consecutive SNPs on any of the SNP platforms discussed in this chapter. To 
overcome this limitation, newer platforms, such as Affymetrix SNP 6.0 and Illumina 
HumanHap 1M were developed; Affymetrix SNP 6.0 revolutionarily included a huge 
number of CNV probes in the hope of targeting more common CNVs.  However the results 
showed the concordance rate even for the newer platforms are low. Secondly genotype 
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analysis methods which use genotyping error to predict CNVs are only capable of detecting 
deletions and require family information so these should be considered as a useful additional 
method to identify CNVs from genotyping data rather than a direct discovery tool (Carter, 
2007). Another major concern for the detection of CNVs utilizing array technology is the 
definition of putative CNV when assessing shifts in relative signal intensity changes from 
arrays. Some define a CNV as a change in the intensity of certain number of consecutive 
SNPs that exceed a pre-defined threshold and some define a CNV through more complex 
statistical models. The robustness of CNV detection depends on an accurate algorithm which 
distinguishes a region in which SNPs have unusual signal intensity from the rest of the 
genome. Last but not least, technical issues such as signal-to-noise ratio and the choice of 
reference to be compared with putative CNV regions can also cause problems in CNV 
calling (Carter, 2007).  
 
From the comparison of different platform/algorithm combination for the same subset of 
HapMap samples in this chapter, one can argue that gaps still exist in software development; 
it is important to improve the methods to make them more sensitive and powerful in 
detecting CNV from SNP data. But it is also important to take into account the information 
different algorithm provided and it is sensible to utilize the different advantages of each 
algorithm. In two studies comparing CNV calling from multiple algorithm or 
algorithm/platform combinations which utilized SNP genotyping data for HapMap samples, 
a large discrepancy in the calling results was also identified (Winchester et al., 2009; Zhang 
et al., 2011). It is recommended to take a second algorithm on a single dataset to assist to 
produce the most confident predictions (Winchester et al., 2009). At last, a range of 
platform/algorithms for the same dataset are presented in this chapter, however one can not 




























Various algorithms and programs have been developed to detect copy number variants 
(CNVs) from genome-wide single nucleotide polymorphism (SNP) arrays. However, their 
reliability and performance has remained uncertain. I compared four CNV detection methods: 
QuantiSNP, cnvPartition, PennCNV and DNAcopy using SNP data from 966 individuals 
genotyped on the Illumina Human Hap 300K array. Both QuantiSNP and PennCNV are 
based on the Hidden Markov Model (HMM) algorithm, while cnvPartition and DNAcopy 
are based on Circular Binary Segmentation (CBS) algorithm (details in Chapter1, 1.3.4.2). 
 
It is important to attempt to assess the performance of the analytic methods when applied to 
data from this less than optimal genotyping platform (Illumina 300K arrays), in being able to 
identify true CNVs. An approach relying on the concordance rate in duplicated genotyped 
samples was used to estimate false positive and false negative rates for each of the four 
analytic methods. It was found that setting a threshold for filtering less reliable CNV calls 
helped to increase the accuracy and power of CNV detection by QuantiSNP and cnvPartition. 
It was also stated that QuantiSNP and cnvPartition outperformed other two methods in terms 
of false positive and false negative rates. Another independent approach was employed 
which assessed the ability of one of the detection methods, QuantiSNP, to recover true CNVs 
from genotyping data, based on a HapMap data set from eight humans who had their CNVs 
determined and whose SNP genotyping data was publically available. The results suggested 
that QuantiSNP was a conservative method which had a high specificity (low false positive 
rate) but low sensitivity (high false negative rate). 
 
A discrepancy in the occurrence, length, type of CNVs detected by the different methods was 
observed. When the CNVRs derived from CNVs called by the four methods were compared 
it was found that QuantiSNP and cnvPartition had the best concordance in terms of CNVRs 
detected.  
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5.2 Materials and methods 
 
5.2.1 Samples 
965 samples from Croatia and 1 sample from Orkney were included in the analysis. To 
assess the false positive and false negative rates of each CNV detection method, duplicate 
samples were needed. A duplicate is defined here as an individual who was genotyped 
multiple times (twice) at the same platform. CNV results were independently obtained from 
each genotyping dataset and then these were compared so that false positive/false negative 
rates could be calculated. Initially an individual in the Croatian population, Kom388, was 
selected to serve as a duplicate and was genotyped twice. However, one of the two 
genotyping datasets did not pass the quality control step and so these data could not be used. 
For the above reason, an Orcadian individual, ORC2091, was genotyped twice in order to 
serve as a duplicate sample.   All 966 samples had passed quality control (details in 
Methods chapter). 
 
5.2.2 Parameter setting of the four methods to detect CNVs from SNP array data 
 
CNVs were determined for each sample using QuantiSNP (version 1.0), cnvPartition 
(version 1.0.2), PennCNV and DNAcopy, respectively. These represented the four analytic 
methods available at the time of the analysis (between year 2007 and 2008) which had been 
reported in published articles. QuantiSNP and PennCNV are based on a Hidden Markov 
Model (HMM), which indicates copy number status of each SNP depending on information 
from neighbouring SNPs. CnvPartition and DNAcopy are both Circular Binary 
Segmentation (CBS) methods, which divide the chromosomes into segments to extract 
segments of aberrant signal intensities which indicate a copy number deviation from the 
normal copy number of such segments. 
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PennCNV and DNAcopy didn’t have a filter option whereas various parameter options could 
be individually selected in the QuantiSNP and cnvPartition software.  
 
The QuantiSNP filter includes times of permutation (EMiters), characteristic length of CNVs 
(L), GC correction option (doGCcorrect) and threshold of Bayes Factor (Yau, 2007; Colella 
et al., 2007). QuantiSNP uses an expectation maximization (EM) algorithm to fit HMM 
model parameters to the data and after permutations the model was optimized and 
convergence was achieved. The more permutation steps taken, the better the model fits the 
data but longer computation times are required. The parameter EMiters determines the 
maximum number of optimization steps to be used. A recommended value of 25 was chosen 
which was believed to balance both the precision of model optimization and computational 
time. In CNV detection, longer CNVs may be called with more confidence as LogR ratio and 
B allele frequencies of more markers were taken into account. This might be expected to 
reduce the false positive rate of CNV calls. For this reason, QuantiSNP requires a defined 
characteristic length of CNVs (denoted L) for filtering possible false positives. 
L=3000000bp was chosen to be the maximum length in this analysis. It had been reported 
that correcting Log2R ratio for local GC content would reduce noise and increase accuracy of 
CNV detection (Colella et al., 2007), so the GC correction option was selected. For each 
CNV event given by the EM algorithm, a Bayes Factor (BF) was reported to indicate the 
degree of confidence for the event being of significance. Greater BF values indicate more 
confidence in the validity of the CNV call. A BF value of above 30 was recommended to 
reduce false positive calls (Colella et al., 2007). In this analysis both unfiltered CNV calls 
and CNV calls with BF>=30 were analyzed separately and were compared to assess the 




For cnvPartition (version 1.0.2), alterations can be made in setting parameters including 
“Confidence Threshold”, “Include Mitochondrial Chromosomes”, “Include Sex 
Chromosomes” and “Probe Gap Size Threshold”. For the analysis which was limited to 
autosomes the two parameters “Include Mitochondrial Chromosomes” and “Include Sex 
Chromosomes” were set to be false. The Probe Gap Size threshold is the upper limit of 
region length between probes and regions within probe gaps whose size is greater than this 
value would not be considered to be within CNV regions. Setting such a threshold would 
help prevent CNVs from being called across large probe gaps, such as centromeres. The 
default value of 1,000,000 bp was adopted in the current analysis. cnvPartition incorporated 
an algorithm to assign a Confidence Score to each CNV call. A higher Confidence Score 
value denotes greater confidence in the validity of the CNV call. The recommended 
threshold for this Confidence Score was 35 (Illumina Manual 3). In this analysis both 
unfiltered CNV calls and CNV calls with Confidence Threshold of 35 were analyzed 
separately and were compared to assess the possible advantage of setting a Confidence 
Threshold. 
 
5.2.3 Computation  
QuantiSNP, cnvPartition and PennCNV required Log2R ratio and B allele frequency data for 
each SNP within each sample while DNAcopy required only Log2R ratio data. HMM based 
methods such as QuantiSNP and PennCNV are fast with QuantiSNP taking only 6-7 minutes 
to process per sample. CBS methods are more computationally intensive with a processing 
time for DNAcopy of 12 to 15 minutes to process a sample. cnvPartition adopted an 
improved method to decrease computation time, which resulted in a processing time of less 
than 10 minutes per sample. QuantiSNP, cnvPartition and DNA copy were run on a desktop 
computer with a 2.76GHz processor and 4GB of RAM. PennCNV were performed on a 
computer of 1.77GHz processor and 3GB of RAM.  
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5.2.4 Copy number assignment for DNAcopy 
Unlike the other three methods, the DNAcopy procedure didn’t result in a list of CNV 
segments each with a copy number. DNAcopy segments a chromosome according to the 
Log2R intensity ratio values and only highlights chromosome regions with abnormal values 
which could indicate either deletions or amplifications. I adopted a method which was 
developed for cnvPartition (Illumina, 2007) to determine the copy number status of each 
potential copy number variant region identified by DNAcopy. Due to the lack of B allele 
frequency information, each region was assigned either ‘deletion (copy number<2)’ or 
‘amplification (copy number>2)’ instead of an exact number (0,1,3, 4 etc). 
 
5.2.5 Assessment of sensitivity and specificity of algorithms 
The computation of sensitivity and specificity of the algorithms considered in this chapter 
comprises two parts. 
 
The first part is to test the false positive and false negative rate of CNV detection for each of 
the four methods (and with different filtering options) by using 966 samples, one of whom 
had been genotyped twice. In the current study design, the “truth” of individual observations 
is viewed as unknown (that is the true positives and true negatives and unobserved in the 
study sample without any further validation). Under these circumstances, a strategy of 
relying on concordance of replicates was employed (Jakobsson et al., 2008).  
 
In a population of sample size n, in total M CNVs were detected at m loci. Several 
individuals in that population had been genotyped twice and CNVs were detected 
independently for each replicated pair, but only one genotyping data for each individual were 
added to the total population. Denote false positive rate by α and false negative rate by β and 
these values can be obtained by equations: 
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     (1) 
      (2) 
Where τ denotes the probability that an allele is called as a CNV, χ denotes the concordance 
of CNV calls in replicated pair and ρ denotes the probability that a CNV is truly present for a 
given allele. Equations 1 and 2 provide the basis of estimating false positive and false 
negative rate. In these cases, α and β are each determined by 3 parameters, τ, χ and ρ. The 
first 2 parameters can be estimated while only the last one is unknown. ρ can be estimated 
as:                            ρestimated=M/(2×m×n)                      (3) 
and χ is the number of concordant CNV loci (m1) divided by total number of CNV loci 
called in a replicated pair for the same individual (m2).  
                           χestimated=m1/m2                                                (4) 
 
Inserting the calculated value of ρ and χ, α and β are then presented as functions of 
unknown parameter ρ. If an approximate range of ρ can be estimated, the range of false 
positive and false negative rates can be determined.   
 
Define τ as the probability that an allele is called as a CNV, ρ as the probability that a CNV 
is truly present for a given allele, an allele is called as a CNV either when 1) a true positive 
CNV present at a true positive loci and 2) the CNV, detected at the loci which wasn’t a true 
location for CNV is a false positive. Therefore there is Equation 5: 
τ=α(1−ρ)+(1−β)ρ                                   (5) 
 
Specificity (also termed ‘accuracy’), which equals to 1-α, is defined as the ratio of number 
of true negatives to number of total negatives (true negatives + false positives). Sensitivity 
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(also termed ‘power’), which equals 1-β, is defined as the ratio of number of true positives to 
number of all positives (true positives + false negatives). Therefore lower false positive rate 
indicates higher sensitivity and lower false negative rate indicates higher specificity. 
 
Duplicate genotypes were needed for this assessment. An individual from Orkney, ORC2091, 
had been independently genotyped twice. These data were then combined with data from the 
965 Croatian samples for this analysis, making the total sample size 966 individuals. Two 
sets of genotyping data from the same individual were assessed for CNVs when the true 
copy number status is unknown. Data from two genotyping panels of the same individual 
were each processed with QuantiSNP and cnvPartition to yield CNV results. Only one set 
(set A) CNVs of ORC2091 was combined with Croatian population, the other set (set B) was 
compared with set A but not CNVs from other samples. All CNVs of each combined data set 
(Croatian+ORC2091(A)) were mapped on chromosomes; CNV loci are defined as 
non-redundant chromosomal regions which harboured at least 1 CNV from at least one 
individual. 
 
The second part is to test sensitivity and specificity of QuantiSNP to detect CNVs, using 
genotyping data from 8 HapMap samples (NA12156, NA12878, NA15510, NA18507, 
NA18517, NA18555, NA18956 and NA19129). These individuals had been end-sequenced 
and two array-CGH platforms were also used to validate CNVs detected by end-sequencing 
(Kidd et al., 2008). The CNV calls of the 8 HapMap samples were downloaded from 
Database of Genomic Variants (http://projects.tcag.ca/variation/) as a reference set to 
represent the ‘true’ CNVs within those samples. These individuals had also been DNA 
genotyped on Illumina Human1M arrays which comprises 1,072,820 SNPs SNP intensity 
files for these 8 humans were downloaded from the Illumina ftp site (http://www. 
illumina.com/ forms/ftp.ilmn). QuantiSNP was run on the intensity data to generate CNV 
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calls. The CNVs called by QuantiSNP were then compared to those in the reference set for 




5.3.1 SNP coverage of the 300K array for verified CNVs  
The Illumina HumanHap 300K genotyping array (earlier version) comprised 308,330 
autosomal SNPs. To assess the probe coverage of CNV events, verified CNVs from four 
human genomes, of J. Craig Venter
 
(Levy et al., 2007), James Watson (Wheeler et al., 2008), 
NA18507 (Bentley and et al., 2008) and YH (Wang et al., 2008), whose whole-genome DNA 
has been sequenced were extracted to constructed a reference set (details in Chapter 3).  
 
The 308,300 SNPs were then mapped to each of the reference CNVs and the number of 
overlapping SNPs for each reference CNV was recorded (Table 5.1). It was found that the 
HumanHap 300 platform had a poor coverage of CNVs; it lacked probes within on average 
85% of the reference CNVs in the four genomes, and about 93% couldn’t be tagged by 
multiple probes (Table 5.1).  
 
 
5.3.2 Occurrence, type, length and frequency of CNVs detected by four methods 
SNP data from each of the 965 Croatian samples were processed by QuantiSNP (BF>30), 
cnvPartition (confidence score>35), PennCNV and DNAcopy, respectively. An overview of 
number of events, CNV type, length, and CNV burden per sample is given in Table 5.2. 
 
QuantiSNP detected 29964 CNV events, of which the majority were deletions. After 
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applying a Bayes Factor threshold of 30, the number CNVs remaining was 1619. Thus the 
filtered data reduced the number of CNV calls by about 20 fold. Many of the small CNVs 
didn’t meet the threshold, which suggested a trend with the QuantiSNP algorithm to give 
more confidence to longer CNVs. Of the excluded CNVs, most were deletions. This could be 






Table 5.1 Illumina HumanHap300K genotyping array probe coverage of CNVs in four sequenced individuals.  
 





300K array probe coverage** 
0 SNP 1 SNP ≥2 SNPs Missing* 
Levy et al  (2007) J.C. Venter  Caucasian 
Sequencing & 
arrays 
382 18470 1006 to 920100 345 8 29 0.92 
Wheeler et al (2007) James. Watson Caucasian 
Sequencing& 
arrayCGH 
625 14210 1007 to 1580000 448 84 93 0.85 
Bentley et al (2008) Anonymous  
South 
African 
Solexa 693 4072 1002 to 50000 624 57 12 0.98 
Wang et al (2008) Anonymous  Chinese 
Illumina 
Sequencing 
494 6227 1004 to 158300 443 30 21 0.96 
Average       549 9952 1002 to1580000 465 45 39 0.93 
 
* “Missing” denotes the missing coverage rate which was the proportion of CNVs that didn’t overlap at least two consecutive SNPs on the 300K 
platform  
** “300K array probe coverage” denotes the number of CNVs in the individual genomes covered by 0,1 or ≥2 SNPs  
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cnvPartition identified more amplifications than deletions before filtering. The confidence 
score threshold of 35 limited the total number of CNVs to half of the unfiltered number. 
After applying the confidence score threshold an elevation in median length of both deletions 
and amplifications was observed, which might suggest that cnvPartition also placed 
confidence in longer CNVs (as with QuantiSNP).  
 
A discrepancy in the features of CNVs detected by different methods was observed (Table 
5.2). QuantiSNP (filtered) and cnvPartition (filtered) identified a similar number of deletions 
and amplifications; PennCNV identified 2 fold more deletions than amplifications; and 
DNAcopy identified mainly deletions, with only 11% events being amplifications. The 
median length of CNVs detected by QuantiSNP and cnvPartition was significantly longer 
than those detected by the other two methods; DNAcopy identified a large number of smaller 
deletions, which make the median length of CNVs it detected the shortest among the four 
methods. The lengths of the CNVs detected by the 4 methods all follow an L shape, with 
many small events and few large events (e.g. length of CNVs called by QuantiSNP, as in 
Figure 5.1). Only 1.7 and 3.4 events per sample were detected by QuantiSNP and 
cnvPartition, respectively (filtered data). DNAcopy detected 11.8 events per sample and 
PennCNV detected 30.1 events per sample. None of these numbers exceeded 39, which was 
the average number of true CNV events which can be captured by 2 or more SNPs on the 















Table 5.2 Type, length and occurrence of CNVs detected by four methods.  












BF>30 1619 747 872 154.4 97 160.3 1.7 
unfiltered 29964 20916 9048 40.1 35.5 52.6 31.1 
cnvPartition 
confidence>35 3293 1367 1926 136.7 68.6 185.2 3.4 
unfiltered 6328 2707 3626 92.9 56.2 51.6 6.6 
  PennCNV 29062 19252 9810 50 64.7 53.7 30.1 
  DNAcopy 11380 10091 1289 11.5 10.5 11.7 11.8 
 
Summary of both unfiltered and selected (Bayes Factor>30) CNVs detected by QuantiSNP are listed. Also unfiltered and selected (confidence score>30) 














Figure 5.1 Distribution of CNV length (between 1kb and 1Mb) detected by QuantiSNP 
 
5.3.3 Test of the validity of threshold setting parameters of QuantiSNP and 
cnvPartition 
Both QuantiSNP and cnvPartition introduced parameters for quality control purposes, as 
described in 5.2.2.  The unfiltered CNVs detected were far greater in number than the 
CNVs called after filtering the data (Table 5.2). 
 
29982 unfiltered CNVs at 7484 loci for 966 samples were identified by QuantiSNP. 18 and 
33 CNV loci were each detected for the two independent genotyping panels of ORC2091, of 
which 10 were concordant. The filter of BF=30 resulted in 1621 CNVs at 416 loci for total 
samples, 2 identical CNV loci were found in the two genotyping panels of ORC2091. The 
estimated probability value that an allele is called a CNV (τ) in 966 samples and the 
concordance rate (χ) of two observations for the same individual, ORC2091, were calculated. 
Details and calculations of τ and χ for cnvPartition were also listed in Table 5.3.
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Table 5.3 Estimated probability value that an allele is called a CNV (τ) in 966 samples and the concordance rate (χ) of two observations for the same 












 P of an 
allele called 




(A) and (B) 
ORC2091 





BF>30 1619 2 1621 416 0.0020  2 2 2 1.00  
unfiltered 29964 18 29982 7484 0.0021  33 10 31 0.32  
cnvPartition 
confidence>35 3293 2 3295 776 0.0022  2 2 2 1.00  
unfiltered 6328 5 6333 1435 0.0023  5 3 7 0.43  
PennCNV 29062 7 29069 5385 0.0028  7 4 10 0.40  
DNAcopy 11380 4 11384 3485 0.0017  9 3 10 0.30  
The CNVs were detected by four methods; both unfiltered and filtered results were included in the table. ORC2091 (A), the one of two datasets to be 
combined with 965 Croatians; ORC2091 (B), the other dataset of the duplicated sample. ORC2091 (A) and (B): the number of CNV loci detected in 
both duplicates (m1); ORC2091 (A) or (B): the number of CNVs detected at least one duplicate (m2). τ was calculated according to Equation 3 and c 








Inserting value of τ and χ into Equations 1 and 2, false positive and false negative rates 
could be plotted as functions of ρ. A comparison of false positive and false negative was 
made between the filtered and unfiltered CNV results for QuantiSNP and cnvPartition, 
respectively (Figure 5.2 and Figure 5.3).  
 
The threshold of 30 notably reduced both false positive and false negative rates of CNVs 
detected by QuantiSNP (Figure 5.2). The false positive rates for both threshold settings 
were low, bounded above by 0.22% (unfiltered) and 0.17% (filtered). The false negative 
rates approximated to zero from ρ=0.0019 and ρ=0.0033, for unfiltered and filtered CNVs 
respectively.  
 
Similar results were observed with cnvPartition. The performance improved after setting the 
confidence score filter at a value of 35 both in term of reducing false positive and false 
negative rates (Figure 5.3). However, the difference before and after applying the filter was 
not as great as with QuantiSNP: the departure of unfiltered and filtered curves in both Figure 
5.3 (a) and (b) was not as great as in Figure 5.2 (a) and (b). 
 
5.3.4 False positive and false negative rates of four methods 
In Table 5.3, the number of CNVs, number of CNV loci in the 966 sample and a comparison 
of the two sets of genotyping data for the same duplicated individual were tabulated. As 
stated in Section 6.4.3, applying filters significantly improved power and accuracy for both 
QuantiSNP and cnvPartition; therefore only filtered CNVs were used in this further analysis. 
The average probability of an allele being a CNV (denoted by τ) and concordance rate in the 
pair of duplicated datasets (denoted by χ)  were calculated based on the information 







Figure 5.2 Estimated false positive and false negative rates as functions of the unknown true 
mean frequency of CNVs detected by QuantiSNP, with different threshold settings, across all loci 











Figure 5.3 Estimated false positive and false negative rates as functions of the unknown true 
mean frequency of CNVs detected by cnvPartition, with different threshold settings, across all 
loci in the 966 samples. (a) False positive rates, (b) False negative rate.
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The average probabilities of an allele being a CNV across all loci was similar for the four 
methods were between 0.0017 and 0.0028. QuantiSNP and cnvPartition had very close 
τ values (0.0020 and 0.0022) while PennCNV had the highest and DNAcopy the lowest 
values. 
 
QuantiSNP and cnvPartition had the best concordance rate of 1. Both of them detected two 
identical CNVs from the pair of duplicated datasets of ORC2091. DNAcopy had the lowest 
concordance rate of 0.3.  
 
With the estimated τ and χ values, the false positive rate α and false negative rate β could be 
plotted from Equations 1 and 2 as functions of the only unknown parameter, r. The plots of 
false positive and false negative rates for the four methods were shown in Figure 5.4 and 
Figure 5.5.  
 
The intercept of the y axis on Figure 6.4 was 0.0018 for QuantiSNP, 0.0017 for cnvPartition, 
0.0015 for PennCNV and 0.0025 for DNAcopy. Note that under the assumption for any 
useful test that the true positive rate 1-β is greater than or equal to the positive rate α, a 
rearrangement of Equation 5 result in α≤τ, so the false positive rate of DNAcopy should be 
bounded by the probability t, which being 0.0017 for DNAcopy (Table 5.3). Thus the false 
positive rates for the four methods were all very low at under 0.18%. 
 
Figure 5.5 showed β values for the 4 analytic methods with ρ ranging between 0 and 0.05. 
QuantiSNP and cnvPartition seemed to have the lowest false negative rate, while DNAcopy 
had the highest false negative rate. Even when the probability of an allele being called a 
CNV was as low as 0.01, DNAcopy lost over 70% of its power to detect true CNVs, while 
QuantiSNP and cnvPartition still had about 50% of the power. 
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Figure 5.4 Estimated false positive rates as functions of the unknown true mean frequency of 
CNVs detected by QuantiSNP, cnvPartition, PennCNV and DNAcopy, across all loci in the 966 
samples.  
Figure 5.5 Estimated false negative rates as functions of the unknown true mean frequency of 




5.3.5 Estimation of false positive and false negative rate of QuantiSNP with validated data 
 
1959 autosomal CNVs were confirmed by fosmid end-pair analysis and validated by array-CGH 
and/or DNA sequencing for these 8 individuals, with median length of 23.4 kb (length range: 
701 bp-930kb), which had been downloaded from Database of Genomic Variants.  
 
The SNP intensity files for these 8 humans were downloaded from the Illumina ftp site 
(http://www.illumina.com/forms/ftp.ilmn). Using the 1M SNP data, 1694 unfiltered autosomal 
CNVs were detected by QuantiSNP. 207 of them had a BF>30. The median length of these 
CNVs is 85 kb (length range: 942bp-4981 kb). SNPs in the Human1M array were densely 
distributed across the genome with the average gap between two SNPs being approximately 
3000bp.  
 
67 out of 1959 validated CNVs were recovered in the dataset of CNVs detected by QuantiSNP 
(the length of the overlapped part should exceed 50% of the length of the shorter sequence to be 
compared in a pair), while 140 CNVs detected by QuantiSNP were not true. n CNVs segmented 
a chromosome into n+1 regions of no CNVs, thus the total 1959 CNVs resulted in 8 human 
autosomes 1959+22×8=2135 non-CNVs. Therefore, the false positive rate of QuantiSNP to 
detect CNVs in these 8 samples was 140 / (140+2095) =6.55% and false negative rate is 







Table 5.4 The positive, negative, false positive and false negative CNV events detected by 






Positive 67 (true CNV detected) 
140 (detected CNVs are not true) 
Type I error 
 Negative  
1892 (true CNVs which 
are not detected) 
Type II error 




5.3.6 Concordance of CNVs detected by four methods 
For 966 individuals from Vis and Orkney, the 1619 CNVs detected by QuantiSNP were grouped 
into 430 CNVRs; 3293 CNVs detected by cnvPartition were grouped in 857 CNVRs; 29062 
CNVs detected by PennCNV were grouped in 6528 CNVRs; and 11380 CNVs detected by 
DNAcopy were grouped in 3624 CNVRs (Table 5.5).  
 
All of the CNVRs detected by any of the four methods were combined and aligned together. 
This resulted in 8873 non-redundant CNVRs along the chromosomes, each detected by one to 
four methods. Two DNA segments were considered to be overlapped if they mapped to 
approximately the same location on the genome and the length of overlapping part exceeded 
50% of the length of the shorter segments. It was found that a number of CNVRs were detected 
by multiple CNV detection methods, however the majority of CNVRs were only detected by 
only one method, especially for PennCNV (4847 private CNVRs) and DNAcopy (2129 private 








Table 5.5 Concordance of detected CNVRs between each pair of methods 
 QuantiSNP (%) cnvPartition (%) PennCNV (%) DNAcopy (%) 
QuantiSNP 430 357 (41.7) 360 (5.5) 263 (7.3) 
cnvPartition 357 (83.0) 857  662 (10.1) 493 (13.6) 
PennCNV 360 (83.7) 662 (77.2) 6528  1368 (37.7) 










The concordance of CNVRs detected by QuantiSNP was higher with both cnvPartition (357 out 
of 460) and PennCNV (360 out of 460). 77% of the CNVRs detected by cnvPartition were also 
detected by PennCNV. Only 25% of the CNVRs detected by PennCNV were also detected by 
other methods, with the highest concordance with CNVRs detected by DNAcopy. DNAcopy 




Length of overlapped CNVRs among QuantiSNP, cnvPartition and PennCNV are shown in 
Figure 5.7. DNAcopy result was excluded from this analysis, because it had poor concordance 
with other three algorithms and it has highest false positive and false negative rate in detecting 
CNVs, indicated in section 5.3.4. 74.8Mb of 357 CNVRs was detected by both QuantiSNP and 
cnvPartition, 185 Mb of 360 CNVRs was detected by both QuantiSNP and PennCNV, and 
131.4Mb of 662 CNVRs was detected by both cnvPartition and PennCNV. 65.7Mb of 307 
CNVRs was detected by all three methods, which in length was 87.8% of the overlap between 
QuantiSNP and cnvPartition, 50% of the overlap between cnvPartition and PennCNV, and 
35.5% of the overlap between QuantiSNP and PennCNV. 
 









The SNPs contained in Illumina 300K arrays were mapped to genomic regions which showed 
evidence of CNV in four whole-genome sequenced genomes, to determine SNP coverage of the 
300K arrays. On average only 39 CNVs per genome (7.1%) were covered by multiple (≥2) 
SNPs. This would be the maximum number of CNVs per genome which could possibly be 
detected on the 300K platform. In practice, this proportion might further decrease due to 
limitations in the sensitivity of CNV detection algorithms to detect CNVs using SNP genotyping 
arrays. However, limitations of sequencing could lead to false negative observations (discussed 
in Chapter 3) and the CNV profiles in different individuals might vary. This may result in an 
overall underestimation of the true number of CNVs in these four genomes.  
 
A statistical model, which calculates false positive and false negative rates based on concordance 
of replicated data with population CNV information, was utilized in the analysis of this chapter. 
The limitations of this analysis include: 1) the assumption was that the CNVs were common 
therefore might not hold well for rare CNVs; 2) there was only one duplicate for the current 
study, which may introduce bias in the estimation of concordance rate; 3) the range of true mean 
frequency of CNV at all loci for a population was uncertain, which makes the calculation of 
power difficult. Notwithstanding these limitations, a comparison was made for the same method, 
sample samples and same duplicate but only varying CNV detection algorithms and parameter 
setting.  
 
It was shown that setting filtering parameters for QuantiSNP and cnvPartition resulted in lower 
false positive and false negative rates for CNV detection. Applying can be recommended for use 
with these analytic approaches. 
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The result of the comparison of false positive and false negatives, when the true status of an 
allele being a CNV at a locus is unknown, indicated that for the 966 samples studied, QuantiSNP 
and cnvPartition outperformed other two analytic methods and DNAcopy had the worst 
performance of the four methods (Figure 5.4 and Figure 5.5). 
 
These very low false positive rates suggested the majority of errors came from false negatives. 
However, one should note that this estimation is based on the very low probability of that an 
allele is called as a CNV (Table 5), which may not always be the true case. For example, in the 8 
HapMap samples described above, in total 2444 true CNVs at 1368 loci represent a probability 
of 0.11, which is much larger than the estimated rates in Table 5 without known true copy 
number status of each loci in the population. The false negative rate is hard to determine due to 
the uncertainty in ρ. QuantiSNP was only robust in detecting CNVs if the average frequencies of 
true CNVs were low: to achieve the power of 80% (β=0.2), the true frequency should below 
0.0033 if applying a filter; at the same frequency, power for detecting CNV by QuantiSNP 
without setting a BF threshold would be only 60%. QuantiSNP without setting this threshold lost 
its power much faster than performing with a filter.  
 
The approach discussed above was based on the assumption that the true probability of an allele 
being a CNV at a locus was unknown, which coincided with the real situation of the current 
study: CNVs were detected from SNP genotyping arrays without further validation, so the 
authenticity of those CNVs could not be assessed directly. To directly access performance of 
CNV detection algorithms, a dataset of published CNVs for 8 human genomes was constructed 
as a reference set.  This reference set was used to demonstrate performance of QuantiSNP, 
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which is one of the better algorithms of the four based on result from former analysis (section 
5.2.5). The false positive rate of QuantiSNP was far higher than the estimates in section 5.2.5 
(<0.2%) but it was still in an acceptable range which promised reasonable accuracy of detecting 
true CNVs. However, the false negative rate was very high, indicating that there was the risk that 
QuantiSNP would discard a high proportion of true CNVs. It is noted that all 1959 laboratory 
validated CNVs were included in this analysis, some of which might be unable to be detected by 
1M array therefore the false negative rate could be inflated. The 1M array SNP coverage of 
CNVs in these 8 genomes was not assessed in the current study, but previous study suggested 
60% of the deletions from the same 8 HapMap samples were covered by the SNPs on Illumina 
1M array platform (Kidd et al., 2008). Based on the estimate above, the majority of errors were 
false negatives in which case many true CNVs were not detected by QuantiSNP. The low false 
positive rates and high false negative rates suggested the algorithm and filter which QuantiSNP 
adopted was conservative. Thus this limitation resulted in a low detection rate (sensitivity) for 
QuantiSNP to detect true CNVs from SNP genotyping data. 
 
The comparison of overlapped CNVs detected by four methods showed that the overlap of 
results from different algorithms was low. QuantiSNP and cnvPartition had higher percentage of 
CNVs detected also by another algorithm (Table 5.5). Events detected by multiple methods 
were considered to be of more confidence that the events were true (Winchester et al., 2009); 
65.7Mb of 307 CNVRs was detected by QuantiSNP, cnvPartition and PennCNV, which in length 
was 87.8% of the overlap between QuantiSNP and cnvPartition, compared to the percentage of 
those more confident CNVs to the overlap between cnvPartition and PennCNV, and the overlap 




After the point of time of the method comparison in current study, several studies published 
results for comparison of CNV calling algorithms (Dellinger et al., 2010; Tsuang et al., 2010; 
Winchester et al., 2008; Zhang et al., 2011). Winchester et al. used Affymetrix 6.0 and Illumina 
1M Duo data from a well characterized CEPH sample, NA10861, to test the performance of 
seven algorithms: Birdsuite, CNAT (Chromosome Copy Number Analysis Tool, Affymetrix, 
Inc.), cnvPartition, GADA, Nexus (Biodiscovery Inc.), PennCNV and QuantiSNP. The overlap 
of results from any two algorithms range from 2% to 100%, mostly below 60% with highest 
resemblance between data generated on the same genotyping platforms. Taking the structural 
variants identified by fosmid end-pair sequence (EPS) method for the same individual (Kidd et 
al., 2008) as reference, the false positive rate (based on lack of overlapping with the EPS result) 
range from 51% to 80%. Using the events detected by Kidd et al (2008). on another sample, 
NA15510 as reference, the result from four algorithms, cnvPartition, GADA, PennCNV and 
QuantiSNP, showed the false negative rates were between 77% and 96% (Winchester et al., 
2009). Dellinger et al. ran each of the seven methods on their 10 samples from Myopia 
case-control study: CBS, CNVFinder, cnvPartition, gain and loss of DNA, PennCNV and 
QuantiSNP. They evaluated statistical power, false positive rates and receiver operating 
characteristic (ROC) curve residuals by simulation studies. They showed that QuantiSNP 
outperformed other methods based on ROC curve; Nexus had low specificity and high power; 
PennCNV detected the fewest numbers of CNVs (Dellinger et al., 2010). Tsuang et al. compared 
outputs from four algorithms, QuantiSNP, cnvPartition, pennCNV and HelixTree for 48 
Caucasian schizophrenia cases and 48 matching controls. They found substantial discrepancy in 
the results from different algorithms, from the aspects of total number, size, and number per 
person of events (Tsuang et al., 2010). Zhang et al. evaluated the performance of four software 
packages, Birdsuite, Partek, HelixTree and PennCNV in two datasets, one consists of 90 
HapMap CEU sample and the other of 1001 bipolar cases and 1033 controls. Birdsuite recovered 
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the highest percentages of known HapMap CNVs of median length. It also called the most 
CNVs consistent with qPCR validation in one CNV region, but the accuracy in other two regions 
was extremely low. Birdsuite and Partek predicts more rare event than other algorithms (Zhang 
et al., 2011).  
 
Despite difference in choice of algorithms to be included in each study, all method comparison 
studies mentioned above, together with the current study suggest nonnegligible discrepancy of 
results from different CNV calling algorithms for SNP data. Therefore it is advised to choose 
appropriate algorithms with caution in the planning stage of CNV research. The number and 
features of CNV called depends on algorithms utilized, and also choice of filtering settings. For 
example, Zhang et al. found PennCNV called fewer events than QuantiSNP, which is contrary to 
the finding in the current study; this discrepancy is explained that Zhang et al. used a lower 
filtering threshold for QuantiSNP outputs, which leads to much larger number of events detected 
compared to those might have been resulted from a higher filtering threshold (as in the current 
study). Combining results from two algorithms is recommended (Winchester et al., 2008), 
however, while decreasing false positive rate, it might also increase false negative rate. Without 
a ‘true’ gold standard (complete set of CNVs in the whole genome), the sensitivity and 
specificity of any particular algorithm or combination of algorithms are impossible to estimate 
accurately. More comprehensive and sophisticated CNV detecting method and denser SNP 
coverage of genotyping platform (for example Affymetrix SNP 6.0) are desired, and a reliable 















Copy Number Variation across European Populations 
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6.1 Preface 
Copy Number Variation (CNV) is defined here as DNA segments of 1kb or longer in length 
and present at variable copy number in comparison with a reference genome (Redon et al., 
2006). CNVs are commonly found in the genomes of human and other species (Cutler and 
Kassner, 2008; Dopman and Hartl, 2007; Fadista et al., 2008; Zhang et al., 2009). To date, 35% 
of the human genome demonstrates evidence of coverage by CNVs (Database of Genomic 
Variants, DGV, http://projects.tcag.ca/variation/).  It is suggested that CNVs, in the form of 
deletions, insertions, duplications and complex multi-site variants, may contribute to human 
phenotypic variation, either directly by gene dosage and proportionate variation in gene 
expression (Stranger et al., 2007), and/ or indirectly through a) position effects on expression 
levels per se or developmental patterns of expression, or b) by affecting recombination rates 
and thus genome evolution (Redon et al., 2006).Indeed, several studies have reported evidence 
for a direct contribution of CNVs to complex disease phenotypes in human populations, such as 
Schizophrenia and Autism (Int Schizophrenia Consortium, 2008; Pinto et al., 2010; Sebat et al., 
2007), and in other species (Garshasbi et al., 2008; Kamatani et al., 2008; Williams et al., 2010; 
Yang et al., 2009; Perry et al., 2007; Jackson et al., 2007; Pielberg et al., 2002; Norris and 
Whan, 2008).  
Copy number variation can be directly assayed by quantitation of hybridisation to specialist 
oligonucleotide (Bailey et al., 2008; Cowell and Lo, 2009) or clone arrays (Fiegler et al., 2006) 
or by direct genome sequencing (Bentley and et al., 2008; Wang et al., 2008), but also 
conveniently extracted from single nucleotide polymorphism (SNP) array data (Jakobsson et al., 
2008; Cooper et al.,2008). As well as being applied to the search for genetic contributions to 
disease phenotypes, several studies have provided global estimates of CNV frequency and 
distribution in HapMap samples ((Redon et al., 2006; Stranger et al., 2007) and large 
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population cohorts (Jakobsson et al., 2008; Zogopoulos et al., 2007; Franke et al., 2008; 
McQuillan et al., 2008), but relatively little attention has been given to potential variation 
within major population groups. Comparisons of CNV frequency and distribution between 
independent studies have also been hampered by discrepancies in study design, platform choice 
and analytical methods between studies.  
Geographical population isolates are valuable resources for the dissection of complex genetic 
traits and disease outcomes (Peltonen, 2000; Shifman and Darvasi, 2001; Wright et al., 1999) 
Genetic isolates have reduced genetic heterogeneity, as measured by fewer net mutations and 
numbers of polymorphic SNPs compared with outbred populations (Shifman and Darvasi, 
2001). Furthermore, by virtue of population bottlenecks, genetic drift and high kinship, each 
isolate will have a different evolutionary history and thus different genetic makeup. For 
example, isolate populations have been reported to show increased linkage disequilibrium and 
reduced haplotype diversity relative to outbred populations, consistent with reduced effective 
population size and increased genetic relatedness (Vitart et al., 2006).  
Here, I take the opportunity provided by the EUROSPAN project (Mascalzoni et al., 2009) 
which brings together several groups working on the genomic and phenotypic analysis of 
population isolates across Europe. Our objective was to make use of high density genome-wide 
genotyping data to describe and compare frequencies of each CNV and their distribution within 
and between these population isolates, and thus determine to what extent CNVs can be used as 
measures of relatedness and identifiers of population origin. Using Illumina whole genome data 
with more than 300,000 SNPs from each of three European population isolates, spanning from 
Northern to Southern Europe, 4016 CNVs in 1964 individuals were detected, which clustered 
into 743 copy number variable regions (CNVRs). The frequency and distribution of these 
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CVNRs was compared and shown to differ significantly between the Orcadian, South Tyrolean 
and Dalmatian populations. Consistent with the inference that this indicated population-specific 
CNVR identity and origin, it was also demonstrated that CNVR variation within each 
population can be used to measure genetic relatedness.  
6.2 Materials and Methods 
 
6.2.1 Study sample 
2789 individuals with data passing quality control (QC) from the island of Vis, Croatia (the 
CROAS study (Vitart et al., 2006), n=965), the Orkney Isles, Scotland (The Orkney Complex 
Disease Study, ORCADES (McQuillan et al., 2008), n=691) and South Tyrol, Italy (The 
Genetic Study of Three Population Micro-isolates in South Tyrol, MICROS (Pattaro et al., 
2007), n=1133) are included in the CNV analysis. These studies followed similar study 
procedures as part of the EU FP7 EUROSPAN study (Mascalzoni 2010) All three projects were 
approved by the relevant ethics committees. Data collection was carried out between 2003 and 
2007 in the three locations. Informed consent and blood samples were received from all study 
participants. (See Chapter 2 for details). 
6.2.2 Genotyping 
The Dalmatian samples were genotyped on the Illumina Infinium HumanHap 300 v1 platform 
while the Orcadian and South Tyrolean samples were genotyped on the Human Hap 300 v2 
platform (Illumina, San Diego, CA, USA). The genotyping was done in two sites: Individuals 
with less than 90% call rate were removed. Sex checks and IBD sharing between first- and 
second-degree relative pairs were performed with the PLINK program 
(http://pngu.mgh.harvard.edu/purcell/plink/) (Purcell et al., 2007), and individuals with 
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discordant pedigree and genomic data or falling outside expected ranges were removed from 
the study. SNPs on the sex chromosomes were excluded. Finally 300,938, 309,200 and 308,396 
SNPs remained in Dalmatian, Orcadian and South Tyrolean datasets, respectively. 
6.2.3 CNV calling 
For each individual, the Log2R ratio and B allele frequency of each SNP were processed by 
QuantiSNP and cnvPartition software to generate CNV calls.  
The two independent sets of CNV calls made for the same individual were then assessed. The 
output from QuantiSNP and cnvPartition both provide information for each CNV on the 
chromosome number and chromosomal coordinates of the start and end of each CNV 
(breakpoints). One sample possessing >35 CNVs detected by cnvPartition was excluded from 
the further analysis. Genomic coordinates of each CNV detected in each person were mapped 
to hg18 sequence assembly using LiftOver (http://genome.ucsc.edu/ cgi-bin/hgLiftOver). 
SNP coverage in centromeric regions is very low, thus CNVs called in these regions are likely 
to be false positive. For this reason all the CNVs spanning centromeres were excluded from the 
analysis (according to the coordinates of centromeres on each chromosome). CNVs smaller 
than 1kb or larger than 3Mb were excluded.  
QuantiSNP and cnvPartition outputs were combined to produce a list of sample wise CNVs. A 
confirmed CNV call was made if 1) the CNV was identified by both methods at the same locus 
and the overlap indicated by both methods exceeds 50% in length; 2) the type of a copy number 
change event (copy number loss or copy number gains) called by both methods was consistent 
and 3) overlap length was between 1000 bp and 3Mbp. The boundaries of a CNV were taken as 
the beginning and end of the overlapped section. 
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To locate CNVs on chromosomes, individual-wise CNVs were merged into Copy Number 
Variable Regions (CNVRs). A CNVR is the maximum region shared among all individuals 
carrying a CNV at the same locus.  
6.2.4 Haplotype and SNP tagging 
9 and 22 CNVRs from Vis and Orkney, respectively, each with a population frequency of >1%, 
were analyzed with Plink (http://pngu.mgh.harvard.edu/~purcell/ plink/) (Purcell et al., 2007). 
SNP genotyping data were exported from BeadStudio and merged with CNV genotypes of the 
same individuals. Tagging SNPs were investigated with a window size of 3Mb spanning each 
CNVR. For each CNVR, the adjacent SNPs 1Mb upstream and downstream to the genomic 
location of each CNVR were selected in haplotype analysis. 
6.2.5 Genetic clustering analysis 
Genetic clusters of a selected set of CNVRs, in which each CNVR was shared by two or more 
individuals, were inferred by the software Structure [35], under assumptions of admixture, 
correlated allele frequencies and no prior population information. For each number of clusters 
(K) from 2 to 4, a Burnin length of 10,000 iterations followed by 10,000 Markov Chain Monte 
Carlo iterations was used. The second order rate of change of logarithmic probability of data 






6.2.6 Analysis of CNV kinship correlation  
The kinship coefficient is a measure of overall genetic similarity relative to some base 
population in two diploid organisms. 
For each population, P, with T individuals in total, suppose there are N CNVRs: CNVR1, 
CNVR2, …, CNVRN, each with M1, M2,…,MN CNV carriers ({M}>=2 and {M}<T). For the 
nth CNVR (1≤n≤N), CNVRn , there are Mn people carrying the same CNVR. 
Extract a sub kinship matrix from the population kinship matrix with those carriers C1, C2, …, 
CMn  for CNVRn: 
                                  C1,     C2,     C3,   …, CMn   
                        C1     0.5      -        -      …    - 
                                       C2     k12     0.5       -     …    - 
                         C3     k13      k23      0.5   …    - 
                          :       :         :         :       : 
                          CMn    k1Mn      k2Mn    k3Mn    …  0.5 
This is a Mn*Mn matrix, which is symmetrical around the diagonal line. Let kij denote the 
pairwise kinship coefficient between individuals Ci and Cj (i={1,2,3,…Mn}, j={1,2,3,…Mn}). 
At the diagonal line of this matrix, kij|i=j =0.5, because when considering the probability of a 
random chosen allele to be IBD between two identical genomes, the same allele can be drawn 
twice.  
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In this sub-matrix for CNVRn, let Kn denote the non-redundant collection of all pair-wise 
kinship coefficients between any two individuals out of all Mn carriers. 
Kn={( k12), (k13, k23), (k13, k23 , k33), …( k1Mn, k2Mn, k3Mn,… ,k(Mn-1)Mn)}  
Let Kpop denote the non-redundant collection of all pair-wise kinship coefficients between any 
two individuals out of all T individuals in the population 
Kpop={( k12), (k13, k23), (k13, k23 , k33), …( k1T, k2T, k3T,… ,k(T-1)T)}  
Therefore Kn has (Mn-1)! elements and Kpop has (T-1)! elements.   
Then a t-test is performed to test the difference of means between Kn and Kpop.  The 
probability, pn is calculated to indicate significance of this difference. A permutation procedure 
is taken to adjust pn: another Mn*Mn matrix is randomly drawn from population kinship matrix, 
with the pair-wise kinship coefficients 
Krandom={( k12), (k13, k23), (k13, k23 , k33), …( k1Mn, k2Mn, k3Mn,… ,k(Mn-1)Mn)}  
A p value, pperm is obtained from a t-test of comparing means of Krandom and Kpop. The same 
random process repeats 1000 times, result in 1000 Pperm values. pn is then ranked among the 
permutated p values, the adjusted  pn,  pnadjust is the number of permutated p values which do 
not exceed pn, divided by the number of permutations. 
6.2.7 Statistical analysis 
The reference CNV list was downloaded from DGV. The record of known genes and 
recombination rates in the human genome was downloaded from the UCSC genome browser. 
Intra- and inter-chromosomal segmental duplications (SDs) of >90 identity and >1kb in length, 
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which cover 150.8Mbp of human genome (5.3%) (She et al., 2004; Bailey et al., 2002) were 
downloaded from the public Segmental Duplications Database      (http://humanparalogy.gs. 
washington.edu/, build 36).  
All calculations and alignments were performed with the R 2.10.1 software package, with 
scripts compiled by myself. The test of difference in means was conducted using student’s t-test 

















6.3.1 Overview of copy number variation in Dalmatian, Orcadian and South Tyrolean 
populations 
The study samples were recruited from three populations across Europe, namely the Island of 
Vis, Croatia, Orkney Islands, Scotland and South Tyrol, Italy (Figure 2.1). 2789 individuals 
who passed quality control were included in the analysis. To generate more informative results 
(Winchester et al., 2009), two algorithms, QuantiSNP (Colella et al., 2007) and cnvPartition 
(Illumina Manual 2) were utilized to detect CNV events from SNP genotyping data (see chapter 
5 for details). The combined analysis of CNV calling by QuantiSNP and cnvPartition software 
(see Methods) identified 4016 autosomal CNVs in 1964 individuals, out of the total 2789 
samples, which makes 70.4% of them CNV carriers, with an average number of 2.05 detectable 
CNVs per carrier.  7.8% of the all autosomal SNPs were covered by CNVs. A correlation of 
SNP density and CNV length was observed, with higher SNP density in shorter CNVs and 
lower SNP density in longer CNVs (p<2.2*10-16). 
Fewer CNVs were detected on average in Orcadians (0.91 CNV per person) than in 
South Tyroleans (1.77 per person) or Vis islanders (1.43 per person). Equal numbers of 
amplification and deletion events were detected in each of the populations (Table 6.1). 
The overall length distributions of observed CNVs were also very similar between the 
three population isolates (Figure 6.1). Most CNVs were small in length (94.1% of the 
CNVs were between 1kb to 300kb, mean length was 205.1kb, Table 1 and Figure 
2).The lengths of amplifications (259kb) were significantly greater (Mann-Whitney U 
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test, P<2.2*10-16) than those of deletions (142.4kb) (Table 6.1). 3778 out of 4016 
CNVs (94.1%) overlapped with CNVs reported in the Database of Genomic Variants. 
The 4016 CNVs (Appendix 1) were clustered into 743 non redundant CNVRs (Appendix 2) 
which covered a total of  187.95 Mb (6.6%) of the 22 autosomes. 649 CNVRs (87.3%) 
overlap reported CNVs in DGV. Most of the CNVRs contained either only deletions or only 
amplifications, but 59 regions harbored both types of variants (Table 6.2). In these 
‘gain-and-loss’ CNVRs, all of them contained at least one pair of CNVs whose boundaries 
were not equivalent from two individuals.  
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Amplifications Deletions CNV mean 
length (kb) 
Vis  965 702 (72.7%) 1384 1.43 803 581 216 
Orkney 691 367 (53.1%) 630 0.91 324 306 192.6 
South Tyrol  1133 895 (79.0%) 2002 1.77 1033 969 201.6 















Table 6.2 Copy Number Variable Regions (CNVRs) in the three genetic isolate populations 

















Vis  365 332 184 164 17 304.5 
Orkney 210 193 93 105 12 281.8 
South Tyrol 380 334 156 207 17 256.9 






6.3.2 CNV frequency and CNV sharing among populations   
Each CNVR was found in from 1 to 253 individuals, which made the overall frequency range 
of CNVRs to be from 0.00051 to 0.12882 (median=0.00102). The CNVs identified were 
generally of low frequency. 337 CNVRs (45.4%) were detected in only one individual and 321 
(43.2%) were shared by between 2 and 10 individuals. Only 37 CNVRs (5%) were present at a 
frequency >1% in all three population isolates.  
Different patterns of CNV frequency were observed in different populations (Figure 6.2); 588 
CNVRs (79.1%) were specific to just one of the three population isolates: 244 of them were 
detected only in Dalmatians, 112 only in Orcadians and 239 only in South Tyroleans; 96 
CNVRs were shared by two of the three populations (57 between South Tyroleans and 
Dalmatians, 25 between South Tyroleans and Orcadians, and 14 between Dalmatians and 
Orcadians); and 59 were present in all three populations, none of which were novo. Less than 
half of these population-specific CNVRs (279 out of 588) were reported previously, according 
to DGV. Rare CNVs were found to be mostly restricted to a single population, while more 
frequent CNVs were often shared by two or three populations (Figure 6.3a). A gradual 
increase of population mixture was observed as the frequency of CNVRs increased: more 
common CNVRs were often shared in more than one population whereas lower frequency 
CNVRs were more likely to present in a single population (Figure 6.3b). The more frequent 
CNVRs in one population (population frequency>1%) were often observed to be also frequent 
in other populations. In South Tyrol, the frequencies of more common CNVs closely correlated 
with those of Dalmatian and Orcadian CNVs (Pearson’s r=0.73, P=7.5*10
-18
 and r=0.43, 
P=0.005, respectively); the frequent Dalmatian CNVs also correlated with the frequent 




respectively), but there was no significant correlation between Orcadian and either Dalmatian 
or South Tyrolean CNVs of frequency>1% (Pearson’s r=0.38, P=0.1347 and r=0.22, P=0.4046, 
respectively).   
Of the 588 population specific CNVRs, more than half (337 CNVRs) contained only one CNV 
event. The mean length of CNVs in those population specific CNVRs was 250.3kb, 205.5kb 
and 195.6kb in length, for Vis, Orkney and South Tyrol, respectively, which were on average 
longer than the ones for shared CNVRs (mean length 198.4kb) (P=0.04). 
Figure 6.2 Venn diagram showing the number of CNVR shared between the three European 




Figure 6.3 CNVR sharing in Dalmatian, Orcadian and South Tyrolean populations. (a) The population make up for each shared CNVR 
(shared by at least two individuals): each vertical bar represents for a CNVR, the height of each bar is the number of CNV carriers for each 
CNVR; colour blocks depict the proportions of CNV carriers from each of the three populations, green=Vis, red=Orkney, blue=South Tyrol. 
(b) Summary of population presentations for CNVRs of different frequencies: each bar represents a group of CNVRs of a certain frequency 
(from occurring twice to more than 10 times), different colours indicate the proportion of CNVRs private to only one population (in dark 
grey), CNVRs present in 2 populations (in grey) and CNVRs present in all 3 populations (in light grey).  
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Figure 6.3 CNVR sharing in Dalmatian, Orcadian and South Tyrolean populations (Continued). 
CNV occurrence is the number of individuals carrying CNVs at a certain loci.  
 
6.3.3 Haplotype and SNP tagging for CNVs 
To determine if the CNVs in our study sample were tagged by SNPs and to explore haplotype 
structure around CNVs, a correlation analysis was carried out on the common CNVRs in Vis 
and Orkney samples (population frequency>1%): 2 of the 7 CNVRs in Vis, 1 of the 17 in 
Orkney and 15 of the 47 in South Tyrol were population specific, respectively. No tagging 
SNPs were found for any of these CNVRs with r
2
>0.8. 36 of these CNVRs overlapped CNVRs 
discovered in a large scale survey of tagging SNP for CNVs in UK samples (WTCCC, 2010). 
Tagging SNPs were found in only 8 of these 36 regions. Haplotype block detection was 
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performed for the 7 Vis and 17 Orkney CNVRs with SNPs 3Mb upstream and downstream of 
each CNVR boundary. One CNVR (CNVR271, Chr6:67058287-67111682), could be placed in 
a haplotype block with 5 adjacent SNPs in all three populations. In addition, two CNVRs 
(CNVR367, Chr8:15987084-16065839 and CNVR386, Chr8:106005821-106293050) formed 
two haplotype blocks with nearby SNPs in the South Tyroleans.  
 
6.3.4 Genetic Clustering of individuals according to CNV genotypes 
406 CNVR loci were observed multiple times in 1893 individuals (664 Dalmatians, 354 
Orcadians and 875 South Tyroleans). Each of those loci were coded for these individuals as 
“CNV locus” or “non-CNV locus”, then software programme Structure (Jakobsson et al., 2008; 
McQuillan et al., 2008; Pritchard et al., 2000) was used to determine how the individual 
clustered according to their possession of CNV. Graphical representation of membership in 
clusters for K=2, 3 and 4 is shown in Figure 6.4. The distribution of the probability of the data 
between successive values of K showed a peak at K=3 (Ln probability of data=-16991.8 for 
K=2, -16962.6 for K=3 and -17449.1 for K=4), therefore it is inferred that the most likely 
number of genetic clusters for these individuals was three, with clusters roughly corresponding 
to the three geographical locations. 284 of 875 South Tyroleans (32.4%) were assigned to 
Cluster 1, 259 of 663 (39.1%) Dalmatians assigned to Cluster 2 and 136 of 354 (38.4%) 






Figure 6.4 Genetic Clustering of individuals according to CNV genotypes. Cluster membership according to analyses of genotypes at 406 
CNVR loci in 1893 individuals, for K=2, 3 and 4. Each inferred cluster is represented by a different color. Cluster 1, Cluster 2 and Cluster 3 






6.3.5 Gene content 
To test whether the detected CNVs were biased in any way towards genetic regions or were 
evenly distributed across the genome, the gene content of CNVs in the data set were 
investigated. 2211 CNVs in 441 CNVRs overlapped UCSC known genes. The mean number of 
genes covered by a CNV was 4.8, which was greater than the average gene content on 
autosomes (P=0.00574). After introducing SNP density as a covariate into this regression 
model, the significance still remains (P=0.00042). This result suggested a higher concentration 
of genes in CNVs. It was also found that the population specific CNVs overlapped more genes 
(on average 3.1) compared with common CNVs which were shared in more than one 
population (on average 2.3. p=3.097*10
-5
). No elevated G+C content was detected (on average 
40.41% in CNVRs) compared with the autosomal average G+C content (40.35%). 
6.3.6 Distribution along chromosomes 
To test whether there was any bias in the overall chromosomal distribution of CNVs, CNV 
density was compared in pre-specified chromosomal regions (i.e. peri-telometric regions, 
defined as the 10Mb region from the two most distal SNP on both chromosome ends and 
sub-centromeric regions, defined as the 10Mb region from the two SNPs which were most 
close to centromere) to that in the rest of the chromosome. A trend was observed towards 
enrichment in peri-telomeric and/or sub-centromeric regions (define 1Mb from both telomeres 
on a chromosome as peri-telomeric regions and 1Mb from centromere as sub-centromeric 
regions, the difference of CNV density in those regions compared to the rest of genome was 




Figure 6.5 The schematic distribution of CNVs on all autosomes, in a physical map. The length 
of each chromosome arm is adjusted to be 100Mb. Each bar comprises CNVs in a 1Mbp bin on 
the chromosomes. 
 
6.3.7 Segmental duplications and CNVRs 
Of the 743 CNVRs, 222 (98.1Mb, 3.4% of all autosomes) overlap reported segmental 
duplications (SDs) or putative rearrangement hotspots: 102 CNVRs (41.3Mb) overlap SDs but 
did not expand into the intervening regions between two SDs on the same chromosome; 153 
CNVRs (68.5Mb) were located in between two SDs of known rearrangement hotspots; the 
remaining 488 CNVRs (89.9Mb) were not in SD regions or known rearrangement hotspot 
regions; of these 488, 409 (62.2Mb) were population-specific. 
Though no difference in G+C content was detected in CNVRs in general, a small increase of 
G+C content (41.79%) was found in CNVRs outside SDs, compared with that of CNVRs which 




The proportion of CNVRs overlapping SDs was significantly lower for population-specific 




6.3.8 Kinship correlation of CNVs 
We were interested to test whether carriers of shared CNVs showed more than average 
relatedness and developed a method to do so by incorporating a kinship coefficient, k, into the 
analysis (see Methods). The kinship coefficient is a parameter not dependent on population 
frequencies that measures the overall genetic similarity relative to some base population 
between a pair of individuals. For each CNVR with at least two carriers, the pair-wise kinship 
coefficients were calculated for all carrier pairs, then the value of those kinship coefficients 
were compared to the population mean of pair-wise kinship coefficients of all pairs of 
individuals in the corresponding population. It was observed that for most CNVRs (63.4% in 
Vis, 76.8% in Orkney and 83.4% in South Tyrol), CNV carriers had higher values of kinship 
coefficients compared to the population mean, indicating that carriers of shared CNVs are 
indeed more related to each other. (Table 6.3) 
Many CNVs with higher mean kn could be found to segregate in known families. Two 
examples were presented to illustrate the segregation of CNVs in pedigrees (Figure 6.6). 
CNVR686, an amplification on chromosome 19, was detected in 6 individuals who all turned 
out to have come from the same family (Figure 6.6 a) and b)). The inheritance pattern of this 
CNVR appeared to be autosomal dominant. CNVR54, an amplification on chromosome 2, was 
detected in 8 individuals. 4 of them were from the same known family, 2 of them were 




Table 6.3 Mean kinship coefficients of CNV carriers for CNVRs in three populations. 
kpop, pair-wise kinship coefficients in one population. kn, pair-wise kinship coefficients of CNV carriers for the nth CNVR. pnadj is the 






Population Vis Orkney South Tyrol 
Mean kpop(±s.d) 0.000402±0.008027 0.001061±0.013336 0.001291±0.0137502 
Range of Mean kn 0 to 0.3125 0 to 0.3125 0 to 0.3125 
Total CNVRs (of more than one carrier) 172 112 205 
No. CNVRs with pnadj<0.05 (%) 109(63.4%) 86(76.8%) 171(83.4%) 
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Figure 6.6 Two examples of segregation of CNVs in pedigrees: CNVR686 and CNVR54. (a) The 
kinship matrix of 6 carriers for CNVR686. They are all from the same population. The mean kinship 
coefficient of any pair of these 6 carriers is k691=0.175, which is significantly higher than the 
population mean (adjusted p value<0.001) (b) The carriers for CNV686 placed in pedigree. Squares 
indicate male sex, circles indicate female sex. Filled squares or circles indicate CNV carriers. A cross 
through a square or a circle indicates the individual is either deceased or ungenotyped. (c) The 
kinship matrix of 8 carriers for CNVR54. They are all from the same population. The mean kinship 
coefficient of any pair of these 8 carriers is k55=0.078, which is significantly higher than the 
population mean (adjusted p value<0.001) (d) The inheritance of CNV54. The key to the pedigree 




Copy Number Variation was profiled in three population isolates from UK, Italy and Croatia 
and representing a North-South, West-East geographical cline and components of the genetic 
diversity across Europe. This comparison of CNV characteristics was made possible by virtue 
of common choice of genotyping platform and copy number detection methods. 
In common with previous reports from various populations and cohorts, the great majority of 
individuals (70%) were found to be carrying at least one CNV. CNVs were also widespread in 
the genome: 6.6% in length of all autosomal regions showed evidence of CNV in one or more 
samples. The proportion of SNPs covered by CNVs was 7.8%. The density of SNPs in CNVRs 
was 175.3 SNPs per Mb, while that in non-CNVRs was 117.1 SNPs per Mb (p<2.2*10
-16
). The 
lower density of SNPs in regions outside of detected CNVRs indicates that CNVs which reside 
in the SNP-sparse regions might not be captured on the commercial SNP genotyping platforms 
which lack coverage in certain chromosomal regions. The SNPs distribute more sparsely in 
longer CNV regions compared to those in shorter regions, therefore the boundaries determined 
for longer CNVs were less certain, which reflects the limitation of the HumanHap 300K arrays 
in terms of SNP coverage. A number of detected CNVRs were represented by both gains and 
losses. These ‘gain-and-loss’ CNVRs could reflect cases where the reference genome contains 
both CNV alleles, but individual genomes are homozygous for one or other allele. If true, then 
gains and losses within the same CNVRs should have equivalent boundaries. However, in all 
observed cases the gain-and-loss CNVRs in fact contained at least one pair of CNVs from two 
individuals whose boundaries are not equivalent. Although precise boundary determinations 
were subject to some technical uncertainty, it does appear that these gain-and-loss CNVRs most 
likely reflect recurrent CNV changes at the same locus, which are initiated and/or resolved at 
slightly different points.  
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Similar to other genetic polymorphisms such as microsatellites and SNPs, it is show here that 
CNVs differ greatly among different populations. Indeed, the majority of CNVRs (588 out of 
743 CNVRs) were restricted to one population and were often of very low frequency, their 
non-sharing across populations could be due to sampling variances or the fact that they were 
recent and/or possibly deleterious events. On the other hand, only the most frequently occurring 
CNVs, which were likely of more ancient origin, were shared between the three population 
isolates, consistent with a more ancient and neutral evolutionary histories, and also their 
geographic separation. The longer length and higher gene content of the population-specific 
CNVRs compared to those of the common CNVRs also supported the hypothesis that they may 
be more deleterious and therefore kept to low frequencies, or, those are more recent mutations 
that have had insufficient time to experience disruptive recombination events.  
Wether SNPs can serve as a good proxy for CNVs has long been debated (Redon et al., 2006; 
McCarroll and Altshuler, 2007). Some studies suggested that deletion polymorphisms are 
generally in strong linkage disequilibrium and segregate on ancestral SNP haplotypes (WTCCC, 
2010; McCarroll et al., 2005; Hinds et al., 2006) while some others argue that although a 
number of CNVs are in strong linkage disequilibrium with nearby markers, accurate genotypes 
can only be captured for a small proportion of the tested CNVs (Redon et al., 2006). I attempted 
to investigate LD between SNPs and CNVs, but due to the general low frequencies of the 
CNVRs in our populations, only a small number were available for testing. No tagging SNPs 
were found for 7 CNVRs in Vis, 17 CNVRs in Orkney and 47 CNVRs in South Tyrol.  
These CNVRs were also found to be poorly tagged by SNPs in the WTCCC samples 
(supplementary information, WTCCC, 2010). Haplotype analysis revealed only three tagged 
CNVR, of which one CNVR (CNVR271, Chr6:67058287-67111682) was notable for being 
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shared by all three populations. It was argued in a survey of LD between CNV and SNP that 
most (77%) highly frequent (MAF>5%) CNVs could be well tagged by SNPs, whereas only 
23% of the rare CNVs could be similarly tagged (Conrad et al., 2010). The CNVs selected in 
the current study for LD analysis were generally of low frequency. Analysis of an expanded set 
of CNVRs is warranted before firm conclusions on this issue can be drawn. 
The CNV profiles in Vis and South Tyrol were more similar to each other compared to that of 
Orkney, in terms of number of shared CNVRs, correlation of CNV lengths and frequency. This 
may reflect their relative close geographical distances: Orkney is at 59 degrees north, whereas 
Vis and South Tyrol are both in Southern Europe. 
Genetic clustering analysis formally demonstrated that CNVs can be used to classify the three 
population groups studied here and one can predict that the same will be true for other human 
populations, providing a potentially useful and applicable genomic tool for ancestry and 
evolutionary studies.  
Consistent with other recent studies (Nguyen et al., 2006; McCarroll et al., 2008), it was found 
that CNVs tended to cluster in peri-telomeric /sub-centromeric regions, and commonly 
overlapped with segmental duplications and recombination hotspots, again consistent with the 
idea that they may serve well as ancestry markers.   
As in many other studies (Kim et al., 2008; Perry et al., 2008; Nguyen et al., 2008), a higher 
gene content was discovered in CNVRs. It is argued that there is a high G+C content in gene 
rich regions (Nguyen et al., 2008), which are more frequently subject to copy number change. 
However, no elevated G+C content was detected in the observed CNVRs in this study. 
Although high gene content could be due to the bias of SNP choice in commercial genotyping 
 179
arrays, after correcting for SNP density, the significance still remained.  Some have argued 
that most of these genes are under negligible selective constraint; the CNVs influencing disease 
genes might have been eliminated by purifying selection. It is also noted a significantly higher 
gene content within recent, population specific CNVRs. Further studies are warranted to test 
whether these are due to length of population specific CNVs being longer or they are under 
positive selection or can be linked (or elevated / diminished) to quantitative traits specifically in 
population isolates.  
Finally, it is shown by the application of kinship coefficients that the majority of rare CNVs are 
passing through germ-lines rather than being de novo variants, and therefore are heritable and 
provide an index of relatedness. The inheritance of CNVs could be observed in actual pedigrees, 
which confirmed the increased relatedness between CNV carriers. The similar relationship 
between genetic variants and kinship was observed in a study of the same population in Vis, 
which found kinship inferred from pedigree information was consistent with segregation of 
SNPs in the population (Vitart et al., 2010).  
Illumina HumanHap300 SNP genotyping platforms were used to determine copy number 
variant events in our analysis. Despite the relatively lower SNP content of the 300K microarray 
compared with products such as Illumina Human 1M and Affymetrix snp 6.0, the power of our 
method to detect CNVs from the 300K platform was adequate, and it was able to detect a large 
number of CNV events in the three isolated populations and draw conclusion of the differences 
between individuals from distinct communities in the context of CNV. However, it is argued 
that due to insufficient coverage of informative probes in certain chromosome regions (eg. gene 
sparse and segmental duplication regions) and the inability to discriminate higher number of 
copies (copy number>4) of a duplicated region for most CNV calling algorithms for SNP arrays, 
 180
it is hard to accurately quantify the true extent of human copy number variation (Cooper et al., 
2008). In light of whole genome sequencing project such as the 1000 Genome Project 
(http://www.1000genomes.org/), which provides a resource of whole genome sequences of 
multiple individuals (Sudmant et al., 2010), it is believed that we can benefit from high quality 
CNV detection directly from sequence data of samples, to better understand the diversity of 
CNVs within and between populations. In the meantime, mining the widely available SNP 
arrays coupled with family data of CNV calling represents a useful way of validating CNV 






































The rationale behind genome wide association studies (GWAS) is the common disease, common 
variant hypothesis, which assumes that the heritability in common diseases can be captured by 
relatively few common genetic variants in the form of single nucleotide polymorphisms (Wang 
et al., 2005). However, GWAS based upon SNPs have discovered that SNPs only account for a 
modest proportion of the total genetic variation, while a substantial proportion of the heritability 
of many diseases examined in GWAS remain unexplained. It is argued that other genetic variants, 
for example CNVs, may be a potential source of this so-called missing heritability (Manolio et 
al., 2009). On the other hand, rare variants of moderate to large effect sizes can also contribute to 
disease outcome (Wright et al., 2003), and studies which sequence a large fraction of the genome 
in people with extreme phenotypes (those at the extremes of trait distributions) may be 
particularly informative in identifying rare as well as common variants associated with common 
disease (Wang et al., 2005).    
 
The incorporation of the study of CNVs, as well as SNPs, in genetic association studies in 
becoming increasingly common. There are a growing number of reports of the impact of 
common and rare CNVs in various diseases, including in AIDS (Gonzalez et al., 2005), autism 
(Pinto et al., 2010; Wang L.et al., 2010), schizophrenia (Glessner et al., 2010a; The International 
Schizophrenia Consortium, 2008),  bipolar disorder (Zhang et al., 2009; Chen et al., 2010), and 
obesity (Wang K. et al., 2010; Glessner et al., 2010b). However, the association between CNVs 
and quantitative traits has rarely been studied. Only a few have been reported to date including 
those with body mass index (Wineinger et al., 2011; Sha et al., 2009) and aortic root diameter 
(Wineinger et al., 2011).  
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Metabolic syndrome comprises a combination of several risk factors for cardiovascular disease 
and is related to disorders such as type 2 diabetes (T2D), obesity, dyslipidemia, and hypertension 
(Lanktree and Hegele, 2008). Measurement of a combination of metabolic-related traits such as 
body mass index (BMI), fasting serum concentrations of lipids, indicators of glucose 
homeostasis (glucose and insulin) and blood pressure is used to identify individuals with 
metabolic syndrome (http://www.metabolicsyndromeinstitute.com). The study of genetic 
components for these traits can shed light on the etiology of metabolic disorders.    
 
In this chapter, the association of CNVs and seven metabolic-related quantitative traits (body 
mass index, waist circumference, hip circumference, subscapular skinfold thickness, suprailiac 
skinfold thickness, glucose and insulin) were investigated in 978 individuals from two European 
populations. Association analysis was performed between common CNVs and measures of these 
metabolic traits. The role of rare CNVs was also investigated. The results suggested that CNVs, 
(both common and rare) might contribute to variation in common disease risk and the level of 




7.2.1 Study sample, genotyping and phenotyping 
Study participants were enrolled in the CROAS study and ORCADES study, from Island of Vis, 
Croatia and Orkney Isles, Scotland, respectively. Informed consent was given by all participants 
and Ethical approval by the relevant Research Ethics Committees.  
 
The Dalmatian samples were genotyped on the Illumina Infinium HumanHap 300 v1 platform 
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while the Orcadian samples were genotyped on the Human Hap 300 v2 platform (Illumina, San 
Diego, CA, USA). Individuals with a call rate less than 90% were removed. Quality checks of 
recording of gender and IBD sharing between first- and second-degree relative pairs were 
performed with the PLINK program (http://pngu.mgh.harvard.edu/purcell/plink/), and 
individuals with discordant pedigree and genomic data or data values falling outside expected 
ranges were removed from the study. 1656 individuals (965 from Vis and 691 from Orkney Isles) 
passed quality control and were included in the CNV investigation.  
 
DNA copy number gain/loss was determined by a joint analysis using QuantiSNP and 
cnvPartition (see details in Chapter 6) which utilize signal intensity data from SNP probes and 
implement Hidden Markov Model and Circular Binary Segmentation algorithms respectively to 
identify abnormal copy numbers,.. A list of CNVs was generated in each population, defined by 
those CNVs which were identified by both approaches. After prediction of CNV intervals in 
each individual, overlapping CNVs were merged into CNV regions (CNVRs). A CNVR is a 
region spanning the boundaries of all CNVs at this locus; i.e., it represents a union of 
overlapping CNVs (Figure 7.1).   
 
Among the individuals for whom the CNVs had been determined, 1005 unrelated individuals 
were selected for association analysis. Those comprised 914 singletons (individuals who had no 
genotyped relatives), with the remainder being probands (the eldest genotyped member) and 
their genotyped spouse (if applicable) from families of size >=2.   
 
978 of the 1005 unrelated individuals genotyped took part in the biometrical examinations. 
Measurements were recorded on age, gender, height, weight, body mass index, waist 
circumference, hip circumference, subscapular skinfold thickness, suprailiac skinfold thickness, 
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and fasting glucose level and insulin level. Some individuals had one or more missing values for 
one or more of the above measurements. The descriptive statistics of the final set of participants 
in the association analysis is shown in Table 7.1. 
 
7.2.2 Construction of a list of candidate genes for metabolic phenotypes 
The CNVs which showed evidence for association in the analysis of metabolic phenotypes were 
compared with a list of candidate genes related to the seven metabolic traits. Only the core 
regions of each CNV were considered. The core region of a CNV was configured as in Figure 
7.1.  
 
The candidate genes for metabolic phenotypes came from four sources: 1) a literature review on 
candidate genes identified from association analysis on metabolic-related quantitative traits 
(BMI, glucose, insulin, low density lipoprotein cholesterol, high density lipoprotein, 
triglycerides); 2) a review of candidate genes for type 2 diabetes disease risk based on data from 
association studies (including meta-analyses), animal models of the disease, pharmacological 
and physiological studies, or studies of the Mendelian forms of the disease (Hancock et al., 
2008); 3) a review of candidate genes for obesity risk from the same author as in 2) (Hancock et 
al., 2008);  4) a study of CNVs categorised in DGV which overlapped candidate genes for  
metabolic syndromes (Lanktree and Hegele, 2008).  The gene names from each source were 
extracted and assembled as a list of all candidate genes for metabolic phenotypes which were 








Figure 7.1 Copy number variant regions (CNVR) defined in the study sample and configuration of 
the “core region” of a CNVR. The core region of a CNVR is the maximum region shared by all the 
individuals carrying CNV within the same CNVR. 
.  
7.2.3 Statistical analysis 
Statistical analysis was performed using R version 2.8.1.  
For common CNVs (frequency >1% in total sample defined by the above procedure) linear 
regressions were performed to identify associations between CNVs and the seven quantitative 
traits: body mass index, waist circumference, hip circumference, subscapular skinfold thickness, 
suprailiac skinfold thickness, glucose and insulin. A linear regression analysis was performed for 
each trait to evaluate the effects of possible covariates (age, sex, BMI, cohort), with only 
significant (P<0.05) covariates corrected for (Table 7.1). The residues of trait values (adjusted 
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for significant covariates) were then rank normalized with the R package GenABEL (Aulchenko 
et al., 2007) and were taken as trait values in the following analysis. A linear regression of 
individual copy number at each CNV locus upon trait values was performed for each of the traits, 
to test if the copy numbers were associated with metabolic phenotypes. Nominal significance 
was taken as P<0.05, and a Bonferroni correction was further performed to account for multiple 
testing (Blauw et al., 2008). The genes covered by CNVs which showed evidence for association 
were then compared with a list of candidate genes for metabolic syndromes. 
 
For rare CNVs (population frequency<1%), it is hypothesized that multiple rare CNVs may 
collectively contribute to phenotypic variation of the seven metabolic traits. First of all, the 
general burden of rare CNVs in individuals with moderate and extreme trait values was tested. 
Two methods were used: 1) a regression of number of rare CNVs carried on trait values to 
determine if the overall number of rare CNVs had an effect on the trait values; 2) a regression of 
rare CNV status (carrying no rare CNV or carrying one or more CNVs) on trait values, to find 
out if being a carrier of rare CNVs has any effect on the trait values. Secondly, a pathway 
analysis was conducted to find out if there was an enrichment of genes involved in metabolic 
pathways, in individuals with extreme trait values. For each trait, the samples were divided into 
two groups: a “moderate group” with trait values ranked in the 25%-75% range of distribution of 
all the values for this trait and an “extreme group” with trait values distributed in the upper 25% 
and lower 25% of the spectrum of all values.  The number of rare CNVs in each group was 
counted, and also the number of genes covered by those CNVs in the two groups. The rare 
CNVs which only belonged to the “extreme group” were selected and analyzed using both Gene 





7.3.1 Basic Characteristics of the study sample 
The basic characteristics of the study sample, including age, sex, height, weight, BMI, waist and 
hip circumference, subscapular and suprailiac skinfold thickness, fasting glucose and insulin 
concentration are summarized in Table 7.1. The significant covariates (which were adjusted for 
in the following analysis) for each trait are also listed. 
 
7.3.2 Construction of candidate genes for metabolic phenotypes 
A literature review of association studies on quantitative traits (body mass index, low density 
lipoprotein cholesterol, high density lipoprotein cholesterol, and glucose, insulin, and 
triglycerides concentrations) for metabolic syndromes identified 46 candidate genes in 12 studies 
(Table 7.2). 177 candidate genes were identified in a literature review of genes which 
contributed to type 2 diabetes disease risk and 374 candidate genes for obesity disease risk 
(Hancock et al., 2008). 19 candidate genes for metabolic syndromes overlapped with reported 
CNVs in DGV (Lanktree and Hegele, 2008).    
 
The genes identified from the above sources were combined to generate a list of candidate genes 





















BMI (kg/m2) 28.0µU/ml4.6 sex
Waist circumference (cm) 972 959.8±128.1 age, sex, BMI, cohort
Hip circumference (cm) 971 1035±100.6 age, sex, BMI
Subscapular skinfold thickness (cm) 971 249.9±111.5 age, sex, BMI
Suprailiac skinfold thicknesss (cm) 972 276.7±140.6 age, BMI, cohort
Glucose (mmol/L) 931 5.6±1.3 age, sex, BMI, cohort




Table 7.2 Genes associated with body mass index, low density lipoprotein cholesterol, high 
density lipoprotein cholesterol, and glucose, insulin, and triglycerides concentrations in 12 
studies 
 
BMI: body mass index, LDL: low density lipoprotein cholesterol, HDL: high density lipoprotein 
cholesterol, GLU: glucose concentration, INS: insulin concentration, TC: triglycerides 
concentration 
Gene Symbol Trait Method Reference
ABCA1 HDL GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
ABCB11 GLU GWAS Chen et al.(2008)
ACAA2 HDL meta-analysis Kathiresan et al.(2008)
ADCY5 GLU meta-analysis Dupuis et al.(2008)
ADRA2A GLU meta-analysis Dupuis et al.(2008)
ANGPTL3 TC GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
APOA1-C3-A4-A5 HDL,TC GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
APOB LDL,TC GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
APOE-C1-C4-C2 LDL GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
ATG4C TC meta-analysis Kathiresan et al.(2008)
BCL7B TC meta-analysis Kathiresan et al.(2008)
BUD13 HDL,TC meta-analysis Kathiresan et al.(2008)
C2CD4B GLU meta-analysis Dupuis et al.(2008)
CELSR2 LDL GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
CETP HDL GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
CILP2 LDL,TC GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
DGKB GLU meta-analysis Dupuis et al.(2008)
DOCK7 TC meta-analysis Kathiresan et al.(2008)
FADS1 GLU meta-analysis Dupuis et al.(2008)
FTO BMI candidate gene Frayling et al.(2007),Loos et al.(2008)
G6PC2 GLU GWAS,meta-analysis
Bouatia-Naji et al.(2008,2009),                      Dupuis
et al.(2008),Prokopenko et al.(2009)
G6PC3 GLU GWAS Chen et al.(2008)
GALNT2 HDL,TC GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
GCK GLU GWAS,meta-analysis







Dupuis et al.(2008),Kathiresan et al.(2008),     Orho-
Melander et al.(2008),                           Sparso et
al.(2008),Willer et al.(2008)
GLIS3A GLU meta-analysis Dupuis et al.(2008)
HMGCR LDL meta-analysis Kathiresan et al.(2008)
LDLR LDL GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
LIPC HDL,TC GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
LIPG HDL GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
LPL HDL,TC GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
MADD GLU meta-analysis Dupuis et al.(2008)
MC4R BMI candidate gene Loos et al.(2008)
MLXIPL TC GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
MTNR1B GLU
candidate gene,       meta-
analysis
Bouatia-Naji et al.(2008),Dupuis et al.(2008),
Lyssenko et al.(2009), Prokopenko et al.(2009)
MVK/MMAB HDL GWAS Willer et al.(2008)
NCAN LDL,TC GWAS Willer et al.(2008)
PBX4 LDL,TC meta-analysis Kathiresan et al.(2008)
PCSK9 LDL GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
PROX1 GLU meta-analysis Dupuis et al.(2008)
PSRC1 LDL GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
SLC2A2 GLU meta-analysis Dupuis et al.(2008)
SORT1 LDL GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
TBL2 TC meta-analysis Kathiresan et al.(2008)
TRIB1 TC GWAS,meta-analysis Kathiresan et al.(2008),Willer et al.(2008)
ZNF259 TC, HDL meta-analysis Kathiresan et al.(2008)
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7.3.3 Common CNV association 
A total of 1164 individual CNVs were identified. All these CNVs could be merged into 407 
non-redundant CNVRs. 19 of these CNVRs (Table 7.3) had frequencies of more than 1% and 
were selected for association analysis with the seven quantitative traits. The CNVs in the 
selected 19 CNVRs covered 9.2 Mb with a mean length of 190.9 kb. Seven of the 19 CNVRs 
contained both copy number gains and copy number losses. 
 
Three common CNVs were associated with three metabolic traits with nominal levels of 
statistical significance (uncorrected p<0.05) (Table 7.4). CNVR729 was associated with BMI 
(p=0.0235), CNVR122 with waist circumference (p=0.0366) and CNVR447 with both waist 
circumference (p=0.0217) and insulin concentration (p=0.0226). None of these associations 
remained statistically significant after Bonferroni correction.  
 
The core region of CNVR122 overlapped two genes, GPR128 (G protein-coupled receptor 128) 
and TFG (TRK-fused gene). The core region of CNVR447 overlapped no known genes. The 
core region of CNVR729 overlapped with four genes, DGCR2, DGCR5, DGCR6 (DiGeorge 
syndrome critical region gene 2, 5 and 6) and PRODH (proline dehydrogenase (oxidase) 1). 











Table 7.3 Characteristics of 19 common CNVs (frequency>1%) for association analysis with 




Table 7.4 CNVRs showed nominal significance (uncorrected p value of <0.05) in association 






CNVR5 1 5 9223195 9310031 86837 16 16 0 1.636
CNVR122 3 122 101804733 101955538 150806 12 12 0 1.227
CNVR271 6 271 67058287 67111682 53396 28 0 28 2.863
CNVR297 6 297 168078929 168352184 273256 23 23 0 2.352
CNVR320 7 320 61075979 62372905 1296927 13 13 0 1.329
CNVR322 7 322 64144339 64593616 449278 12 3 9 1.227
CNVR390 8 390 137747933 137932941 185009 11 0 11 1.125
CNVR410 9 410 11430880 12227417 796538 18 0 18 1.840
CNVR447 10 447 47013328 47173619 160292 62 60 2 6.339
CNVR464 10 464 134913018 135284293 371276 26 23 3 2.658
CNVR491 11 491 133749532 134225383 475852 11 11 0 1.125
CNVR494 12 494 7876208 8121428 245221 28 19 9 2.863
CNVR501 12 501 31101381 31311573 210193 45 45 0 4.601
CNVR569 15 569 29704566 30721385 1016820 19 19 0 1.943
CNVR648 18 648 1917798 1970668 52871 14 0 14 1.431
CNVR727 22 727 15412698 15674251 261554 11 11 0 1.125
CNVR729 22 729 17257787 19792353 2534567 16 10 6 1.636
CNVR730 22 730 20659747 20897762 238016 11 9 2 1.125





ID Chr Region Start (bp) End (bp)
Trait CNVR p value
BMI CNVR729 0.0226
Waist  circumference CNVR122 0.0366
CNVR447 0.0217
Insulin CNVR 447 0.0226
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7.3.4 Rare CNVRs and metabolic traits 
388 CNVRs had a population frequency of <0.01. The mean length of CNVs in these rare 
CNVRs was 197.9 kb, which in total covered 106.4 Mb of the genomic DNA. No correlation 
was found between the number of rare CNVs and trait values in any of the seven traits. Neither 
was there any observed correlation between the number of overall CNVs (both common and rare) 
and trait values. When comparing rare CNVs in “moderate” and “extreme” groups for each trait, 
no difference was found in the number of rare CNVs. However, there was a statistically 
significant enrichment of unique genes (genes only covered by rare CNVs from moderate group 
and genes only covered by rare CNVs from the extreme group) overlapped by CNVs from the 
extreme group (Table 7.5).  
 
For each of the seven traits, unique rare CNV-overlapped genes in moderate and extreme groups 
were each tested for enrichment in metabolic pathways. In GO and KEGG pathway enrichment 
analysis, no statistically significant enrichment (p>0.05) was found in either moderate groups or 














Table 7.5 Number of rare CNVs and unique genes in individuals of moderate and extreme values for each of the seven traits 
 
Moderate: CNVs or unique genes in individuals whose trait values were in the middle 50% of the trait value distribution. Extreme: CNVs or unique genes 







Moderate Extreme p Moderate Extreme p
BMI 239 229 0.6439 77 153 1.651*10
-5
Waist  circumstance 240 238 0.9271 70 147 1.495*10-5
Hip  circumstance 238 237 0.9634 71 144 4.194*10-5
Subscapular skinfold thickness 229 245 0.4624 71 152 5.938*10-5
Suprailiac skinfold thickness 230 233 0.8891 66 152 2.843*10-6
Glucose 233 236 0.8898 66 148 6.182*10-6
Insulin 233 246 0.2882 56 142 1.696*10
-6
Trait




Copy number variants, which are known to account for a significant proportion of human 
genetic polymorphism, have been predicted to play a role in the genetic susceptibility to 
common disease and disease-related quantitative traits. In this chapter, both common and rare 
CNVs were investigated in metabolic phenotypes.  
 
Type 2 diabetes (T2D) and obesity are two metabolic disorders characterized by a high glucose 
level in the context of insulin resistance and relative insulin deficiency and high value of body 
mass index (BMI), respectively. Other quantitative traits, such body fat mass, waist and hip 
circumference, subscapular and suprailiac skinfold thickness and blood triglycerides levels, are 
also important indicators of risk for metabolic syndromes. Despite successes in identifying 
genetic contributions to metabolic phenotypes, only a small part of the heritable component of 
these traits has so for been explained, mainly by common SNP variants. It has been reported that 
many of  the identified CNVs overlapped genes with important functions in metabolic 
pathways (Lanktree and Hegele, 2008), therefore one may hypothesise that copy number change 
in these genes could lead to functional alteration at the expression level, and thus affect 
susceptibility to metabolic syndrome and metabolic quantitative trait values. In the last few years, 
some studies have attempted to extend the investigation of effects of SNPs to CNVs on these 







Shtir et al. studied genome-wide association between CNVs and T2D in 194 Caucasian patients 
from the Framingham Heart Study, but found little evidence of such an association (Shtir et al., 
2009). In a genome-wide CNV association study of body mass index (BMI) in the Chinese 
population, 3 CNVs were found to show a suggestive association with BMI; one of the genes 
covered by these CNVs was PPRR1 (pancreatic polypeptide receptor 1) which was a known 
gene related to obesity (Sha et al., 2009). The Wellcome Trust Case Control Consortium 
(WTCCC) carried out a genome-wide CNV association analysis using large samples and array 
comparative genomic hybridization and found a weak (p=3.9*10
-5
) association between a CNV 
and T2D. This CNV overlapped TSPAN8 which was reported to be associated with T2D in 
previous SNP studies (WTCCC, 2010). In a recent study of obesity with a focus on 39 CNVs in 
the Prader-Willi syndrome (PWS) critical region in 1000 unrelated Caucasians, 3 CNVs were 
found to be associated with increased body mass at nominal statistical significance. The known 
genes for PWS and obesity which were close to these 3 CNVs included NDN (necdin homolog), 
C15orf2 (Chromosome 15 open reading frame 2) and PWRN1 (Prader-Willi region 
nonprotein-coding RNA1). None of these genes showed evidence of association in the 
genome-wide SNP study with the same sample (Chen et al., 2011). None of the above 
associations remained statistically significant after adjustment for multiple testing. 
 
In the present association analysis of CNVs for seven metabolic traits (body mass index, low 
density lipoprotein cholesterol, high density lipoprotein cholesterol, and glucose, insulin, and 






Three common CNVs were associated with three metabolic traits with nominal statistical 
significance: CNVR729 with BMI (p=0.0235), CNVR122 with waist circumference (p=0.0366) 
and CNVR447 with both waist circumferences (p=0.0217) and insulin concentration (p=0.0226). 
The three CNVs overlapped six genes: GPR128 (G protein-coupled receptor 128), TFG 
(TRK-fused gene), DGCR2, DGCR5, DGCR6 (DiGeorge syndrome critical region gene 2, 5 and 
6) and PRODH (proline dehydrogenase (oxidase) 1). GPR128 is involved in the G-protein 
coupled receptor protein signaling pathway. TFG encodes several fusion oncoproteins and 
participates in several oncogenic rearrangements. DGCR2, DGCR5, DGCR6 all reside in 
chromosome 22q11.2 region. Deletions of the 22q11.2 have been associated with a wide range 
of developmental defects (notably DiGeorge syndrome, velocardiofacial syndrome, conotruncal 
anomaly face syndrome and isolated conotruncal cardiac defects) classified under the acronym 
CATCH 22. The DGCR2 gene encodes a novel putative adhesion receptor protein which could 
play a role in neural crest cells migration, a process which has been proposed to be altered in 
DiGeorge syndrome. DGCR6 is a candidate for involvement in DiGeorge syndrome pathology 
and in schizophrenia. However, the six genes’ molecular function and the relationship with 
metabolic traits and the onset of metabolic syndromes are still unknown. The above associations 
were also weak; none of them retained statistical significance after correction for multiple testing. 
Further analysis, both replication of the association analysis findings utilizing a larger sample 
size and functional studies, are needed to identify their potential role on metabolic phenotypes.  
 
The association analysis is based on the common disease-common variant hypothesis, therefore 
only common CNVs were considered. However rare CNVs, on the other hand, could also play 
an important part in explaining genetic variation in disease risk or levels of quantitative traits. 
Several studies found significant enrichment of rare CNVs in cases of mental disorders 
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compared to those in control individuals, and many of the rare CNVs overlapped genes which 
had functional relevance to those diseases (Pinto et al., 2010; The International Schizophrenia 
Consortium, 2008; Walsh et al., 2008; Williams et al., 2010). In order to identify rare variants 
related to metabolic traits, Cohen et al  sequenced candidate regions from individuals with 
extreme values of high density lipoprotein cholesterol (HDL-C), and found that nonsynonymous 
sequence variants were significantly more common in individuals with low HDL-C values than 
in those with high HDL-C values (Cohen et al., 2004). These findings suggest that rare variants 
may collectively contribute to variation in metabolic phenotypes. However, little attention has 
been paid to rare CNVs in genome wide CNV studies for metabolic syndromes. One of the few 
examples was an observation of enrichment of multiple large and rare CNVs in obesity cases, 
which disrupt several obesity candidate genes (Wang K. et al., 2010).  
 
In this chapter, the overall burden and gene content of rare CNVs for seven metabolic traits were 
examined. No excess burden of rare CNVs (either the sum rare CNVs possessed or the 
presence/absence status of any rare CNVs for an individual) was observed in individuals who 
had more extreme trait values for any of the seven traits. However, a significant enrichment of 
unique genes overlapped by rare CNVs in individuals with extreme trait values was found for all 
the traits. This result could suggest a functional difference of the rare CNV covered genes in 
individuals with moderate and extreme metabolic trait values. An enrichment analysis was then 
performed for the unique genes in the moderate and extreme groups, to test if there was an 
enrichment of genes involved in metabolic pathways in individuals with more extreme trait 
values. However, no statistically significant enrichment was found by neither GO nor KEGG 




The results in this chapter should be interpreted cautiously due to several study limitations 
recognised. First, the HumanHap 300K genotyping array might not be ideal to profile all CNVs 
in an individual genome. The SNP density of 300K genotyping array is comparatively low, and 
this platform is not primarily designed to capture copy number variants. SNPs in some regions 
such as segmental duplications are sparse. Therefore a proportion of CNVs might have gone 
undetected on the 300K platform. Second, the frequencies of common CNVs selected in the 
current study is generally low (only one of the 19 common CNVs had a frequency of >5%), 
which might lead to reduced power in association analysis. Additionally, at the time of this study 
the methods of analyzing rare CNVs for disease and disease-related QTs were still limited. The 
pathway enrichment analysis is only a primary approach to illustrate the general picture of all 
rare variants and to categorize those in grouped pathways for different biological functions. 
However, even if enrichment was found for genes in a particular pathway, it is still hard to 
determine which ones of all the rare variants were causative and which ones were not relevant. 
Finally, as SNP association has only identified a fraction of the loci contributing to phenotypic 
variation, it follows that CNVs may have an impact on the unrecognized risk loci. The present 
study is underpowered to conclude whether CNVs contribute to metabolic trait variance, but is 
will be of interest to investigate whether the impact of CNVs indicated in the current study is 
substantial,  by combining data from multiple large studies.  
 
In conclusion, there was some suggestive evidence of association between several common 
CNVRs and metabolic phenotypes, although none overlapped known candidate genes for 
metabolic phenotypes. No association with overall burden of rare CNVRs was observed, but 
significant enrichment of unique genes was found in individuals with extreme values of 
metabolic quantitative traits. Those genes, however, failed to show enrichment in metabolic 
pathways. These results suggest that CNVs may be potentially important for metabolic 
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phenotype variation. Further research is required to confirm or reject these initial findings. This 
should include studies employing improved (more sensitive) methods of identifying CNVs, 
(much) larger sample sizes and study populations in several global regions. In addition these 
should be complemented by molecular biological experiments to investigate functions of the 
















Summary of thesis and future directions 
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Copy number variation is a type of genetic variation which has been extensively studied in 
recent years. With advances in methods/platform development for CNV detection which have 
enabled CNVs to be identified in multiple individuals in an efficient manner, numerous studies 
have endeavored to reveal features of CNVs in human population and their relevance to disease 
and disease-related phenotypes. However, our understanding of this kind of genetic variation is 
still limited.  
 
One very basic but still unanswered question is the scale of individual CNVs. In Chapter 3, 
using CNV data gained from five sequenced human genomes, I surveyed 12 studies which 
sequenced 33 human genomes, and obtained information of copy number loss (deletions) from 
five individuals, from three different ethnic groups. Generally, the deletions detected from 
sequencing data were short in length, compared to those detected from SNP or CGH arrays. The 
overlap of deletions between the five individuals was low. The two Asian genomes had more 
deletions in common but the concordance of deletions was low for the two European genomes. 
The CNVs shared by multiple individuals covered fewer genes than those private to only one 
individual. These differences could have true biological relevance, but could also be due to 
differences in platforms/algorithms choice and the small number of individual complete 
genomes available for analysis.  
 
Mining of genome wide SNP data can be used to extract CNV calls in large number of samples, 
which enables CNV studies at the population level. However, the choice of a reliable protocol to 
call CNVs from SNP data is an important issue to consider. In Chapter 4, to find out comparable 
CNV data at the population level, I selected seven studies which reported CNVs in HapMap 
samples, from a structured literature search including 778 articles which detected CNVs from 
SNP genotyping data. Large discrepancies were observed for CNVs identified in terms of total 
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occurrence and length. For the two HapMap samples common to six studies, concordance in 
CNV calling was low and results showed dependence on the genotyping platform and/or calling 
algorithm employed. Moreover, for two individuals in whom a direct physical mapping method 
was used, it was clear that only a small portion of CNV calls were detected from SNP 
genotyping data. This Chapter demonstrated that platform/algorithm choice could greatly 
influence the results of CNV calling and limited the use of SNP genotyping platforms to detect 
CNVs.  
 
In the following chapter I used Illumina 300K SNP intensity data from 965 individuals together 
with 8 HapMap samples to assess the performance of four CNV detection algorithms: 
QuantiSNP, cnvPartition, PennCNV and DNAcopy. Based upon concordance rates in duplicates, 
QuantiSNP and cnvPartition outperformed the other two algorithms on both sensitivity and 
specificity. However, it was also noted from the comparison of CNVs called from QuantiSNP 
and those validated from a previous study (Kidd et al., 2008) for the same 8 HapMap samples, 
that the algorithm only could recover a small portion of CNVs validated by direct physical 
methods, such as ESP mapping and array-CGH.  
 
In Chapter 6 I used a combination of QuantiSNP and cnvPartition to profile CNVs in 2789 
individuals from three European population isolates (Vis, Orkney and South Tyrol) who had 
been genotyped on the Illumina HumanHap 300K platforms. 4016 CNVs in 1964 individuals 
were detected, which clustered into 743 copy number variable regions (CNVRs). The frequency 
and distribution of these CVNRs was compared and shown to differ significantly between the 
Orcadian, South Tyrolean and Dalmatian populations. Consistent with the inference that this 
indicated population-specific CNVR identity and origin, I also demonstrated that CNVR 
variation within each population can be used to measure genetic relatedness.  
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In the last section, I looked for evidence of association between CNVs and seven 
metabolic-related quantitative traits: body mass index, waist circumstance, hip circumference, 
subscapular skinfold thickness, suprailiac skinfold thickness, glucose and insulin, in 978 
individuals from Vis and Orkney. Three out of 19 common CNVs tested showed nominal 
significance for association with one or more traits, but the significance didn’t remain after 
multiple-testing correction. None of them overlapped with known candidate genes for metabolic 
phenotypes. No excess burden of rare CNVs was observed in individuals with extreme trait 
values for any of the traits analyzed, but I did find that more genes were affected by rare CNVs 
in the individuals with extreme trait values. However, pathway analysis showed no significant 
enrichment of those genes in metabolic pathways.  
 
In summary, this thesis investigated current CNV detection methods, conducted a discovery 
study of CNVs in three European populations and attempted to test association of those CNVs to 
metabolic-related quantitative traits. This thesis made some contribution to the understanding of 
copy number variation, but future work is needed to further clarify the features and impact of 
CNVs on phenotypic outcomes in human populations.  
 
It was noted that the genotyping data gained from Illumina 300K arrays was not ideal for CNV 
detection, and there were various problems with current CNV calling algorithms. Therefore, 
improvements in genomic technologies are needed for more accurate CNV detection in the 
future. These include higher-resolution and higher-throughput platforms (SNP/CGH arrays), 
advances in next-generation sequencing technologies and more robust algorithms for CNV 
detection on those platforms. Molecular biology experiments are needed to validate CNVs 
detected in the current samples from SNP genotyping data. CNVs at the population level merit 
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further study. Studies such as the 1000 Genome Project (http://www.1000genomes.org/), which 
aim to accurately detect and genotype CNVs in multiple individuals, will shed more light on 
individual by individual variation, and on the origins and evolution of CNVs. Preliminary 
knowledge of genome-wide association between common CNVs and common diseases was 
gained, benefitting from large study design (WTCCC, 2010), however for complex traits and 
diseases, the ‘hidden’ heritability void left by GWAS would not always be accounted for by 
common CNVs (Conrad et al., 2010). Therefore one should consider and assess the impact of 
both common and rare CNVs on phenotypic outcomes. Last but not least, genetic analysis on 
CNVs alone is not sufficient to unravel all contributing factors for complex human traits. The 
combination of genetic approaches combining SNP and CNV variants in association studies, 
better algorithms to assess association between CNVs and disease or disease related phenotypes, 
functional studies of putative genes influenced by CNVs, refined bioinformatics tools for 
pathway analysis, systems biology and animal models need to be integrated and combined in 
order to provide a complete picture of the origins, structure and functional consequences of copy 
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